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ABSTRACT 
 
Eric Rubenstein: The broader autism phenotype in parents of children with autism spectrum 
disorder: implications for the diagnostic process and relationship to child autism spectrum 
disorder phenotype 
(Under the direction of Julie Daniels) 
 
 
 Parents of children diagnosed with autism spectrum disorder (ASD) often exhibit social 
tendencies similar to ASD, but functioning is not impaired nor reaches levels of clinical 
significance. This constellation of sub-threshold diagnostic ASD traits is referred to as the 
broader autism phenotype (BAP) and includes features like pragmatic and communication 
difficulties and poor social skills. BAP is more common in families with children who have ASD 
and has neurological components and genetic origins, which make it a promising area for 
etiologic ASD research.  
The purpose of this dissertation was to explore two questions related to BAP in parents 
of children with ASD: 1) to assess the effect of BAP on discordance between maternal reported 
and clinician observed or estimated instruments reporting child ASD and 2) examine whether 
child ASD phenotype differs by parental BAP status. Data from the Study to Explore Early 
Development, a multi-site, community-based, case-control study of children aged 3-5 years with 
ASD, were used for all analyses.  
 For our first aim, we used a sample of 712 mother-child dyads referred to SEED from 
educational and health providers of children with developmental delays who completed BAP 
and child ASD evaluations. BAP was positively associated with mothers meeting thresholds for 
child ASD on screeners or interviews when clinician reported instruments of child ASD did not 
 
iv 
(Risk ratios ranging from 1.45 to 2.52). Reporting discordances should be acknowledged and 
accounted for when diagnosing ASD. 
 In aim two, we used SEED data to derive latent classes for child ASD phenotype from 
multiple behavioral and developmental measures. BAP in at least one parent was associated 
with the child having increased odds of being in the class with average non-verbal functioning, 
mild language and motor delays, and co-occurring conditions like anxiety and depression (OR: 
2.44, 95% CI: 1.16, 5.09). Exploratory analyses show similar results if the father alone had BAP. 
Child sex did not modify this relationship. Children of parents with BAP were more likely to have 
a phenotype qualitatively similar to BAP presentation; this may have implications for work 
exploring etiologic origins and crafting parent-mediated interventions. 
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CHAPTER 1. INTRODUCTION 
Autism spectrum disorder (ASD) is marked by impairment in social communication and 
social interaction as well as repetitive and restricted behaviors and interests (1). ASD is of major 
public health concern due to high prevalence (14.7 cases per 1000 8-year old children) (2) and 
high financial and emotional burden (3-5). Early intensive ASD specific interventions 
implemented among young children are seen to improve developmental outcomes (6-8); 
however, too many children are diagnosed outside the age in which these interventions are 
most effective (2). Early screening and accurate diagnostic evaluation are critical to reducing 
age at diagnosis (9).  
ASD diagnosis is a complex process, often beginning with the mother (or other primary 
caregiver) completing a screening questionnaire, followed by trained clinicians observing the 
child and interviewing the mother. The clinician (or team of clinicians) synthesizes all information 
to give a final diagnosis based on Diagnostic and Statistical Manual-5 (DSM5) criteria (1, 10). 
Identifying biases and inefficiencies in this process can reduce age at diagnosis. Earlier 
identification of ASD allows for increased intervention during crucial developmental periods, 
which improves outcomes and reduces costs for families and on health systems (11). Exploring 
issues in diagnostic instruments is also important for public health research: ASD research often 
relies on population-based screening and inaccuracy in these instruments may bias results. 
 A source of variance in screening or evaluation may be how the informant (usually the 
mother) interprets and reports child characteristics. When reporting on child psychiatric 
conditions like depression and anxiety, parents who have those conditions often report that their 
child has those conditions or traits of the condition when clinicians or their child report that they 
do not (12-15). This may also be the case if a mother has the Broader Autism Phenotype (BAP).  
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 BAP reflects a set of sub-clinical characteristics of ASD that are commonly seen in 
families of children with ASD. Traits include pragmatic and broadly defined communication 
difficulties, poor social skills, and aloofness (16). BAP in parents is a risk factor for ASD in 
offspring (17-20) and prevalence estimates of BAP in parents of children with ASD range from 
10-50% (17-19, 21-24). To our knowledge, no study has assessed patterns in reporting child 
ASD traits during screening and evaluation instruments by maternal BAP status.  
The specific objectives for the first aim of this dissertation was to examine the 
association between maternal BAP and discordance between maternal-reported and clinician-
observed or clinician-estimated ASD evaluation instruments. For our analysis, we capitalized on 
the large, multi-site and community-based data in Study to Explore Early Development. These 
data include assessment of BAP in mothers and clinical use of multiple gold-standard ASD 
evaluation instruments that characterize child ASD phenotype.  
To accomplish this objective, we evaluated the following sub aims:  
Aim 1.1: Assess whether maternal broader autism phenotype status is associated with 
discordance between an ASD screening instrument completed by the mother and 
clinician-observation or clinician-best estimate of whether child has ASD. 
Hypothesis 1.1: Mothers with BAP, compared to those without, will be more likely to report that 
a child reaches the threshold for ASD risk on screening instruments when a clinician does not 
observe or deduce that the child has ASD. 
Aim 1.2: Assess whether maternal broader autism phenotype status is associated with 
discordance between maternal reports on interview based ASD evaluation instruments 
and clinician observation or clinician best estimate of whether child has ASD. 
Hypothesis 1.2: Compared to mothers without BAP, mothers with BAP will be more likely to 
report on an ASD interview instrument that their child meets ASD thresholds when a clinician 
observation or best estimate does not meet ASD thresholds. 
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Aim 1.3: Explore whether patterns in discordance are similar for maternal self-reported 
past history of depression or anxiety diagnosis as compared to BAP.  
Hypothesis 1.3: There will be little or no difference in discordance between maternal-reported 
and clinician-observed or estimated child ASD evaluation instruments with regard to maternal 
past history of self-reported depression or anxiety disorder diagnosis. 
Aim 1 is significant because it is one if not the first study to assess the association 
between ASD screening and evaluation instruments and maternal BAP. Our approach is 
innovative in its usage of a large, well-characterized sample to evaluate this association 
through comparing multiple maternal and clinician instruments. These differences in reporting 
may delay diagnosis, which is repeatedly shown to lead to sub-optimal outcomes and increased 
financial burden. In addition, they may provide further insight into how BAP manifests in settings 
where a mother acts as an informant. Outcomes of this work will reinforce the importance of 
multi-method ASD evaluations and the need for a clinician to carefully weigh all available 
information when giving an appropriate diagnosis. 
In our second aim we explored the association between BAP in parents and child’s ASD 
phenotypic presentation. ASD is a phenotypically and genetically heterogeneous disorder that 
creates complexities when trying to deduce etiology and craft therapeutic intervention. 
Phenotypic traits like verbal ability, age at developmental milestones, and many other diagnostic 
features and associated traits vary greatly between individuals with ASD (1, 25). While genetics 
are known to be important, specifics regarding how chromosomal abnormalities, copy number 
variants, rare penetrant genes, and gene by environment interactions account for the 
constellation of ASD symptoms are limited (26). With such variability, it is vital to parse ASD into 
similar phenotypic and genotypic subgroups, to increase efficiency in etiologic research and 
better tailor intervention (27-29).  
 By evaluating the relationship between phenotypic ASD subgroups and BAP in parents, 
we can identify a subset of ASD that is more homogenous in phenotype and likely genotype. 
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Using BAP as a tool to efficiently parse genetic heterogeneity is promising because it will 
facilitate identification of endophenotypes. Endophenotypes are specific traits or group of traits 
that define a subset of people who share genetic or neurobiological origins from the full set with 
a specific psychological disorder (30, 31). Endophenotypes increase efficiency in etiologic 
studies by focusing investigations to known heritable traits rather than the whole phenotype 
(31). Finding groups of these traits that present together will help adapt parent-implemented 
intervention to account for areas that affect both parent and child.  
 For our second aim, we explored how child subgroups (derived from latent class 
analysis) were associated with parental BAP. Again, we use SEED data, which is ideal for this 
project due to its expansive collection of multi-modal phenotypic data, and a large more diverse 
sample. 
Our specific aim 2 objectives were: 
Aim 2.1: Determine whether parental broader autism phenotype is associated with child 
ASD phenotype subgroups  
Hypothesis 2.1 a: Parental BAP will be associated with child phenotype subgroups that have a 
less severe ASD presentation.  
Hypothesis 2.1.b: Parental BAP will be associated with subgroups of ASD in children that are 
qualitatively similar to those defining the parent BAP domain. 
Aim 2.2: Evaluate whether mother, father, or both parents having BAP are differentially 
associated with child ASD phenotype subgroups  
Hypothesis 2.2: Fathers with BAP will be more strongly associated with less severe child ASD 
subgroups compared to mothers with BAP.  
Aim 2.3: Examine whether child sex modifies the relationship between child ASD 
phenotype subgroup and any parent having BAP  
Hypothesis 2.3: Associations between parental BAP and child ASD will be stronger among boys 
than girls.  
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 Aim 2 is significant because we used well-defined ASD subgroups and a good proxy 
measure of ASD heritability to find association that can be a source of endophenotypes. 
Outcomes of this work enable us to examine specific characteristics that are present in both 
parent and child as endophenotypes. This can narrow the larger ASD genotype to individual 
genes, consequently enhancing the efficiency of etiologic research. In addition, understanding 
how child phenotype relates to parent BAP can improve success of current interventions by 
adapting the intervention strategy to tailor a specific child phenotype with parent’s with socio- 
communication ability.  
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CHAPTER 2. LITERATURE REVIEW 
2A. Autism Spectrum Disorder 
Improved understanding of autism spectrum disorder (ASD) is of vital public health 
importance because of increasing reported prevalence and the extensive financial and 
emotional burden that ASD places on individuals, families, and communities. The most recent 
Centers for Disease Control and Prevention (CDC) estimate of ASD prevalence in 8-year-old 
children in the United States is 14.6 per 1000, a 123% increase since 2002 (32). The National 
Survey of Children’s Health estimated ASD prevalence among children aged 6-17 years to be 
2.0% in 2011-2012, compared to 1.16% in 2007 (33).  
ASD is defined by two major features: impairment in social interaction / social 
communication and repetitive and restricted behaviors and interests (RRBI) that present early in 
development and impair daily life (1). Social interaction / communication impairment is 
characterized by deficits in social-emotional reciprocity (lack of back and forth communication, 
reduced sharing of interests or emotions), deficits in nonverbal communicative behaviors 
(abnormal use of eye contact, lack of facial expression), and deficits in developing, maintaining 
and understanding relationships (adjusting behavior to suit social context, making friends) (1). 
RRBI include stereotyped / repetitive motor movements or speech (hand flapping, echolalia, 
linking up toys), insistence on sameness / routine, restricted and fixated interests, and hyper- or 
hypo-reactivity to sensory input (1). ASD presents before the age of three years (1) and is 
diagnosed three to four times more in boys compared to girls (25). 
This is a broad framework for defining ASD, which results in considerable phenotypic 
heterogeneity among individuals with an ASD diagnosis. Associated features (which are not part 
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of the diagnostic criteria but are highly prevalent among those with the disorder) include 
intellectual disability, developmental regression, language disorder, motor deficits, and 
challenging behaviors (1). Specific co-occurring conditions are also highly prevalent among 
children with ASD. These include gastrointestinal issues, attention deficit hyperactivity disorder 
(ADHD), anxiety, depression, epilepsy, sleep problems, and developmental delays (1, 34). 
Etiology 
 The etiology of ASD is not fully understood. Twin studies show the disorder to have a 
heritable component; monozygotic twins have between 47%-96% concordance while dizygotic 
twins have between 0% and 61% concordance (35-39). Overall, an estimate by Gaugler et al. 
(26) has genetic components (additive genetics, non-additive genetics, rare inherited genes, 
and de novo mutations) explaining 59% of variance in ASD liability with the other 41% belonging 
to unaccounted environmental factors. Genome wide association studies have found more than 
100 genes and 40 gene regions related to ASD or ASD traits, but effects are weak (40) and 
have not been deemed causal (41). De-novo mutations may be associated with non-heritable 
ASD and are evident in ASD with fragile X syndrome or tuberous sclerosis (40). 
Public health impact 
Improved understanding of ASD is of vital public health importance because of 
increasing reported prevalence and the extensive financial and emotional burden that ASD 
places on individuals, families, and communities. The most recent estimate of age standardized 
disability adjusted life years has ASD accounting for 135.5 disability adjusted life years lost per 
100,000 life years; this is greater than pancreatic cancer, prostate cancer, brain and nervous 
system cancer, and endocrine, metabolic, blood, and immune disorders (42). Additionally, 
although we know little about ASD in adulthood, recent studies suggest an increased rate of 
suicide (43), overall poorer health due to co-occurring morbidities (43, 44), and lower quality of 
life (45) in adults with ASD compared to typically developing peers. Lifetime cost estimates for 
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an individual with the disorder range from $1.4 to $2.4 million and total annual US government 
expenditure to support children with ASD is $61 billion (3).  
Child outcomes 
 It is important to recognize ASD as early as possible; the younger a child is identified as 
having ASD and enrolled in intensive behavioral modification programs that focus on skill 
building and reaching developmental milestones, the better the long term outcomes (8, 11). 
Early intervention is defined as highly structured teaching methods where an instructor (usually 
a teacher or parent) works with a child one-on-one using discrete trial training techniques. 
Children are generally under the age of five and receive 20-40 hours a week of intervention 
(46). Early intervention has been shown to improve intelligence, social skill, communication, 
language, autism symptoms, and quality of life in children with ASD (8, 46). Additionally, by 
intervening at such a young age, risk of secondary symptoms (like aggression, depression, 
anxiety, self-injury) and parental stress can be reduced (11).  
Financial outcomes 
  It is important to continue to research ASD etiology and intervention because ASD is 
extremely costly for families, health systems, and research infrastructure. A study conducted in 
Australia found that the median yearly expense of having a child with ASD (over and beyond 
having any child) on a family was ~$25,000 US dollars, mainly due to loss in income from 
employment (47). In the US, mothers of children with ASD earn 56% of what mothers of 
typically developing children earn (48). A recent estimate of total economic impact found that a 
child with ASD leads to an additional $17,000 per year on health, school, and other 
expenditures as compared to a typically developing child for a family (49). The California 
Department of Developmental Services spends roughly $11,000 per year per child with ASD 
between the ages 3-17 and roughly $27,000 per year per adult with ASD (50). The national 
economic impact of ASD in the US is estimated at $66 billion per year for children and $175 
billion per year for adults (49). Forecasts estimate economic burden of ASD to be $461 billion by 
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2025 (5). Accurate diagnoses will directly lead to economic cost savings. Koegel et al. (11) 
estimated that lifetime savings for early identification leading to early intervention range between 
$187,000 and $203,000 for a child in the US. An estimate by Peters-Scheffer et al. (51) 
conducted in Denmark estimated savings of early intervention at €1,103,000 from age 3 to 65.  
Diagnostic process 
Diagnosis of ASD is a complex process. Because of the socio-communicative nature of 
the disorder and lack of established biomarkers (52) or genetic tests (53), the ASD diagnostic 
process should be multi-step with information provided from multiple sources (parents, 
caregivers, pediatricians, teachers, and / or psychologists) (10). Since many children are young 
when assessed for ASD, or when older have social impairments that may prevent accurate 
assessment, self-report is often unfeasible. Therefore screening and diagnosis of ASD in 
children is done through informant report and clinician observation (10, 25, 54). The informant is 
the primary caregiver for the child, usually the mother.  
Screening 
The first step in the ASD diagnostic process is often a brief screener (10, 25, 54, 55). 
This is a vital step because screening lowers the age at identification, increasing the likelihood 
of early intervention, which is key to better outcomes for children with ASD. Since universal 
screening of ASD is not mandatory for all children (56, 57), the American Academy of 
Pediatricians recommends developmental screening (which covers a wider range of 
developmental concern) at 9, 18, and 24 or 30 months and ASD specific screening at 18 and 24 
months or when concerns are raised by a parent, teacher, or other child health care provider 
(10, 55, 58). Screeners are often short with an informant responding to questions on their child’s 
social and communication skill and repetitive and restricted behavior (25). Common screeners 
include the Modified Checklist for Autism in Toddlers (59), Social Responsiveness Scale (60), 
and the Social Communication Questionnaire (61).  
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Comprehensive diagnostic evaluation 
The gold standard ASD diagnosis is conducted using information from multiple sources 
(observations and interviews) (10, 62-64). When diagnosing children, the most common sources 
for information on child behavior, social skills, and other concerns are parental report and 
clinician observation (10, 62).  
Caregiver Interview: When a child meets criteria on a screening instrument or a health-
care professional has enough concern, the child is given a full diagnostic evaluation (10). The 
caregiver interview (often completed by the mother) provides information on the child’s day-to-
day functioning in a wide range of situations, family history and expectations, resources 
available to the family, and other contextual factors (10). This caregiver is often times an expert 
in the child’s developmental and medical history and has spent the most time with the child. The 
interview is structured and conducted by trained professionals, usually taking between 1.5 to 4 
hours (25). The caregiver is asked about past and current child traits that indicate patterns of 
behavior and symptoms (10). Interview tools include the Diagnostic Interview for Social and 
Communication Disorders (65), the Developmental Dimensional and Diagnostic interview (66), 
and the most frequently used Autism Diagnostic Interview- Revised (67). 
  Clinician Observation: A clinician observation allows for a child’s behavior to be put in 
the context of typically developing children and children with ASD (10). The clinician, often a 
trained psychologist, observes the child’s social communication behavior in a play setting or 
with peers (10). The observation is specific to a child’s expressive language and chronologic 
age (25). Common observation instruments are the Childhood Autism Rating Scale (68) and the 
Autism Diagnostic Observation Schedule (69). 
Final diagnosis: A final diagnosis is achieved by a clinician (or team of clinicians) 
synthesizing information from the caregiver interview, child observation, and any other 
information available to determine whether a child meets the DSM5 definition of ASD (10).  
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Challenges when diagnosing ASD 
Challenges in diagnosis arise due to the heterogeneity of the ASD phenotype and 
complications of other co-occurring disorders (70, 71). A clinician needs to be cognizant of 
child’s age and intellectual ability, since some behaviors and socio-communication abilities are 
greatly impacted by those two factors (10). If a clinician does not take those factors into 
account, a diagnosis may be incorrect due to inappropriate developmental expectations. 
Further, observation of the child’s behaviors and social ability are limited by time and the likely 
unfamiliar setting in which the assessment takes place (10).  
 Informant reports, like the caregiver interview, are tricky. The order in which questions 
are asked to the informant can affect response (72). Often, a child’s current behavior affects the 
mother’s reporting of past behavior and demographics are associated with differential reporting 
on child characteristics (73). Informant language ability may also affect response, particularly for 
non-native English speakers (10, 74). 
 Based on other child psychiatric disorders, mother psychiatric profile may be associated 
with discordance between maternal-reported and clinician-observed instruments. When 
reporting on specific psychiatric disorders in children, a mother who has the same disorder often 
report that the child has more symptoms than the child reports or a clinician observes (75, 76). 
These results are seen for depression (12, 13, 15, 75-80) as well as anxiety (14, 15, 81, 82), 
ADHD (13), and stress (83). A full review of these studies is presented in Table 1. Child traits of 
these disorders may be reported more because mothers with psychiatric conditions could view 
other’s behavior more negatively (84), or, children of parents with psychiatric conditions have 
traits of that psychiatric condition and the parent has lower tolerance or a better recognition for 
said traits, which influences reporting (75, 85). Learning more about reporting discordance in 
these other disorders has provided insight into child psychosocial adjustment (86), family 
dynamics (87), and intervention efficacy (88-90). Aim 1 will assess maternal autistic like traits as 
a potential source of this discordance.  
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 Table 1 Literature summary of informant bias in research of psychological disorders in children 
Author (year) Child disorder/ Traits Design (n) Result 
Noterdaeme et al. 
(2002) (91) ASD 
Compared maternal report measure to 
clinician observation in a cross 
sectional clinical sample (n=27 children) 
 
Ten out of 11 children with autism were 
correctly classified on the maternal report 
and the clinician observation. One false 
positive on the maternal report.  
 
De la Marche et al. 
(2014) (92) ASD 
Phenotypic data from families with at 
least one child with ASD. Parent 
reported on ASD traits in spouses, and 
children (n=24 families).  
ASD score in child differs by informant 
type with significant interaction between 
informant type and past ASD diagnosis. 
Significant disagreement between all 
informants in children with ASD but not in 
unaffected siblings.  
Rothen et al. 
(2009)( 13) 
Depression, 
anxiety, attention 
deficit 
hyperactivity 
disorder (ADHD) 
Nested case-control study. Parents 
either had psychiatric disorder or a 
control. Psychiatrists interviewed parent 
and child, and parent was given a 
family history interview disorders. 
(n=296 pairs) 
Lifetime history of depression or ADHD in 
parent was associated with poorer 
agreement (over-reporting) between child 
and parents.  
Chapman et al. 
(1994)( 93) 
Depression, 
alcoholism, 
panic disorder, 
any psychiatric 
disorder 
Case control study of probands from 
anxiety clinics with friend controls. Each 
member of the pair was given an 
interview on their own health history 
and their partner's. (n=2193) 
Informants with same diagnosis as 
subjects had lower specificity and higher 
sensitivity than other informants subject 
pairs. There was no difference if the pair 
had different disorders, except for 
alcoholism. 
Collishaw et al. 
(2009)( 94) 
Strength and 
difficulties 
questionnaire 
 
Scottish survey of mental health in 
children and adolescents aged 5-15, 
with parent, teacher, and self report 
(n=4525) 
 
 
Parent teacher and parent child 
correlations were significantly greater than 
teacher child correlations. Some other 
correlates (family functioning, child 
physical health) may be more associated 
with parent rating. 
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Author (year) Child disorder/ Traits Design (n) Result 
De los Reyes 
(2005)( 15) 
Depression, 
anxiety 
Review of current state of knowledge of 
informant discrepancies on ratings of 
child psychopathology in clinical 
research.  
 
Informant discrepancies may have a 
significant impact on assessment, 
classification and treatment of child 
psychopathology. Parental levels of 
psychopathology are related to informant 
discrepancies.  
 
 
 
Verweij et al. 
(2011)( 77) 
Diabetes, 
psychiatric 
disorders 
 
Subjects were between 18 and 50 with 
no psychotic disorder, and no first or 
second-degree relatives with psychosis 
and their mothers were given family 
history interviews (n=33 pairs) 
Mothers with depression indicated 
significantly more depression in family 
members (12.4% to 5.8%). There were no 
reporting issues for diabetes 
Vandeleur et al. 
(2015)( 12) 
Bipolar disorder, 
schizophrenia, 
major 
depressive 
disorder, drug 
dependence 
Case control study with cases being 
recruited from hospital psych 
departments. Controls recruited from 
orthopedic departments. Interviewed 
and asked about parents siblings 
offspring and spouses. (n=1621 pairs) 
 
Individuals who had a history of 
depression themselves were more likely to 
report depression in their relatives. 
Mueller et al. 
(2011)( 95) 
Internalizing 
behavior, 
externalizing 
behavior, total 
problems 
Cross sectional study of children 
selected from a psychiatric hospital and 
their parents. Their mothers, 
kindergarten teachers and therapists 
rated Child behavior. Maternal 
psychopathology was assessed by self-
rating (n=124 pairs) 
Overall, mothers gave higher ratings for all 
behaviors than teachers, who gave higher 
ratings than therapist. Structural equation 
models suggested favoring the distortion 
model, which obtained the best model-fit 
and parsimony indices. The distortion 
model postulates exaggerated ratings of 
highly distressed mothers 
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Author (year) Child disorder/ Traits Design (n) Result 
 
De los Reyes et al. 
(2011)( 96) 
 
Mood 
syndromes 
 
Secondary analysis of study on bipolar 
disorder in youths. Parents reported on 
child characteristics and older children 
offered self-reports. (n=420 pairs)  
 
Caregiver mood symptoms and family 
functioning were not significantly 
associated with reporting discrepancy. 
Hughes et al. 
(2010)( 76) 
Internalizing 
behavior 
Self reported internalizing symptom 
levels were completed by adolescents 
aged 13 to 18 years and a parent. 
Parents also completed instruments of 
their own depression, anxiety, and 
stress symptoms (n=219 families) 
Mothers’ depressive and stress symptoms 
each explained additional variance in the 
discrepancy between mother and son 
reports and in the discrepancy between 
mother and father reports of sons’ 
symptoms. 
 
Heun et al. (1998)( 
79) 
Dementia, 
depression 
Case control comparison of family 
history information for dementia and 
depression (n=75 pairs) 
Any psychiatric disorder in a subject 
raises the likelihood that informants 
indicate a diagnosis of depression in the 
subjects  
Randazzo et al. 
(2003)( 97) 
Internalizing / 
externalizing 
behaviors 
 
Parents, foster parents, and teachers 
reported on behaviors of foster children. 
Depression was assessed in biological 
parents (n=95 groups) 
 
Depressive symptoms are related to the 
difference between the biological parent 
report and the other two informants' report 
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Author (year) Child disorder/ Traits Design (n) Result 
Chilcoat et al. 
(1997)( 75) 
Internalizing / 
externalizing 
behaviors 
Behavioral reports by mothers and 
teachers on six-year-old children. 
Mother's history of major depression, 
anxiety disorders, and substance use 
disorder was assessed (n=801 trios) 
Mothers with history of any psychiatric 
disorder reported more externalizing 
problems in their children than expected.  
Boyle et al. (1997)( 
98) 
Internalizing / 
externalizing 
behaviors 
Cross sectional community survey of 
childhood psychiatric disorders and 
maternal interview for her depression 
(n= 1151 pairs) 
None of the associations between 
maternal depression and mother reporting 
errors were significant 
Gartstein et al. 
(2009)( 80) 
Internalizing / 
externalizing 
behaviors 
Cross sectional survey of parents on 
child behaviors, maternal report of her 
own depression (n=219 groups) 
There was a modest effect of maternal 
depression, which leads to the inflation of 
reported son externalizing and daughter 
internalizing problems.  
Zablotsky et al. 
(2015) (99) ASD 
Data came from the 2011 Survey of 
Pathways to Diagnosis and Services 
(n=967 parent respondents)  
Children with higher family impact factor 
scores were more likely to have parents 
who rated their child's ASD as the most 
severe.  
Ringoot et al. 
(2015) (78) 
Internalizing / 
externalizing 
behaviors 
 
Population-based cohort, parents 
reported lifetime depression and 
depressive symptoms. Child emotional 
and behavioral problems were 
assessed by child self-report and parent 
report 
Depression of mothers and fathers affects 
young children's well-being. However, if 
parents had reported depression and child 
had behavioral problems, associations 
were inflated. 
Pereira et al. 
(2014) (14) Anxiety 
 
Portuguese children aged 7-14 years 
and their mothers completed an anxiety 
symptoms scale. For a subsample, 
maternal anxiety and depression 
symptoms were collected (n=135 
children). 
Maternal anxiety was positively associated 
with the discrepancy between mother and 
child reports of anxiety symptoms. 
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Author (year) Child disorder/ Traits Design (n) Result 
Lerner et al. (2012) 
(88) 
High functioning 
ASD 
 
Community sample of children with high 
functioning ASD and their parents, 
recruited form skill training programs 
(n=15) 
Parents who have lower self-efficacy 
report lower social skills in their children 
as compared to child self report 
 
Daryanani et al. 
(2015) (83) 
 
Stress 
 
 
Mother’s reported on their own 
depression, child stress. Child reported 
on own stress and depression (n=300 
dyads)  
 
Mothers with a history of depression were 
more likely than non-depressed mothers 
to report more familial, social, and youth-
dependent stressors relative to their 
children; non-depressed mothers were 
more likely to report less independent 
stressors than their children. 
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Reducing heterogeneity when studying ASD 
 ASD research is often hampered due to the heterogeneity in phenotype and variety and 
uncertainty in etiological mechanisms. A current well-supported hypothesis is that ASD is really 
a series of ‘autisms’ with different presentations and etiologic origins, and by studying certain 
‘autisms’ rather than the ‘whole’ ASD we could more efficiently study the disorder (28, 29, 100).  
 A strategy to reduce phenotypic heterogeneity when conducting ASD research is to 
create more similar phenotypic subgroups. Past studies have used cluster analysis and latent 
class analysis (LCA) to analytically create these subgroups based on phenotypic variables 
(Wiggins in press)(27, 28, 101-103). These subgroups have been used to assess differences in 
child problem behaviors and create severity gradients (28), association between child IQ and 
phenotype (101), associations with specific genes (27), and possible treatment trajectories 
(102). 
Additionally, grouping children with ASD based on hereditary predisposition to ASD can 
improve efficiency in etiologic research (27, 29). Looking at a subset of children who likely do 
not have ASD through hereditary or genetic means may create a group more likely to be 
affected by environmental risk factors (29). Focusing on this group could lead to greater 
success in evaluating these environmental factors. Identifying children with likely genetic origins 
for ASD can help find specific genes and mechanisms that may cause ASD or ASD specific 
traits; past approaches have looked at families with multiple children with ASD or with ASD like 
traits in family members (104-107).  
With this more homogenous subset of children with likely hereditary ASD, 
endophenotypes can be identified. An endophenotype is a measurable, more homogenous 
subset of a psychiatric disorder’s clinical phenotype. Endophenotypes can be 
neurophysiological, biochemical, cognitive, or neuropsychological, but must be associated with 
the disorder in the population, be heritable, state independent (apparent in an individual whether 
they have the disorder or not), co-segregate in families, and be found in higher rates in 
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unaffected relatives of probands than in the general population (30, 31). Using these guidelines, 
studies have been able to trace traits associated with ASD to genetic origins (108-114).  
2B. Broader autism phenotype  
 Since ASD was formally identified by Kanner in 1943 (115), it has consistently been 
observed that parents of children diagnosed with ASD often exhibit social tendencies that are 
similar to ASD, but do not impair functioning or otherwise reach the same level of clinical 
significance (116-121). The constellation of sub-threshold diagnostic ASD traits in families of 
people with ASD is referred to as the broader autism phenotype (BAP)(121). The range of these 
traits in a population is often referred to as quantitative autism traits (QAT) (107). Specific traits 
of BAP include pragmatic difficulties, broadly defined communication difficulties, poor social 
skills, rigidity, broadly defined stereotyped behaviors, impaired emotional recognition, and 
aloofness (10-17, 9). 
A proposed distribution of BAP in the general population is presented in Figure 1. BAP is 
found to be continuously distributed in the general population (23, 122-126) and heritable (123, 
127). Non-ASD psychiatric conditions are also highly associated with BAP; these include 
anxiety, depression, and obsessive-compulsive disorder (16, 24). BAP in adults is also marked 
by cognitive traits like weak central coherence, and diminished executive functioning and 
neurological processing (16, 24). BAP has neurological components and genetic origins, which 
makes it a promising area for etiologic ASD research. 
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Figure 1. Hypothesized distribution of autism traits in the general population
Autism traits 
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BAP instruments 
Several tools have been developed to measure BAP (24). Table 2 presents an overview 
of the most commonly used tools we identified in the adult BAP literature. Many of these tools 
are adapted from tools that had been used in the past, specifically from the Pragmatic Rating 
Scale (PRS) and the Family History Interview (FHI) developed by Bolton et al. (121). Data are 
collected in a variety of ways. The first method used was a family history interview where one or 
more subjects would provide health and personality information on themselves and their 
relatives. Most common reports now include informant report (through questionnaire or 
interview) (Social Responsiveness Scale-Adult (SRS-A), Social Responsiveness Scale- 2nd 
edition (SRS-2), Broader Autism Phenotype Questionnaire (BAPQ), Modified Personality 
Assessment Schedule-Revised (MPAS-R), FHI-Informant (FHI-I)), self-report (through 
questionnaire or interview) (BAPQ-self report, Autism Quotient (AQ), FHI-subject (FHI-S), SRS-
2) or clinician observation (Broader Phenotype Autism Symptom Scale (BPASS), FHI-
Impression of Interviewer (IOI), MPAS-R). Some instruments (PRS, MPAS-R, BPASS, FHI) 
collect data from multiple sources (self report, informant report, clinician observation) and 
synthesize the results. We refer to this method as ‘best estimate’ because they combine various 
data sources and result in a more comprehensive measure of BAP. The instruments tend to be 
short, usually taking under an hour to complete. For more information on these instruments, 
specifically psychometric properties, see Gerdts et al (24).  
All tools provide a continuous measure of BAP in adults. Additionally, the tools measure 
two (FHI), three (MPAS-R, BAPQ), four (BPASS), or five (SRS-A, SRS-2, AQ) subsets of BAP 
traits, called domains, factors, or scales. These subsets can better measure groups of traits like 
autistic mannerisms, attention, communication, rigidity, and social skills (23, 123, 126).  
Many case-control studies use a continuous measure of BAP to assess BAP as a risk 
factor for ASD. These studies find a clear pattern of higher mean scores on BAP instruments in 
parents of children with ASD as compared to controls (20, 22, 92, 107, 128-146). There is value 
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to looking at BAP continuously, but cutoffs allow for dichotomization into BAP+ and BAP- 
groups that may be useful for etiologic research and creation of more homogenous familial 
subgroups.  
Previous studies have examined correlations between these tools. The SRS-A total 
score and BAPQ total score were significantly inter-correlated (r=0.32) as were their subdomain 
scores in a study by Hurley et al. (147). Although, correlation coefficients were modest (r=0.11 
to .29) in a similar analysis conducted by Davidson et al. (148). That study also found weak but 
significant correlation between the clinician rated FHI and the SRS-A and BAPQ (148). Ingersoll 
et al. (122) examined the BAPQ, SRS-A, and AQ in a non-clinical sample of college students. 
They found a total score correlation of 0.66 between the BAPQ and SRS-A, 0.55 between the 
AQ and SRS-A, and 0.65 between the AQ and BAPQ (122). Results were similar in a study 
conducted in Japan (149). These properties illustrate the variability in BAP measurement but the 
overall fact that the instruments are measuring the same concept.  
 All of these tools have different strengths and weakness. The BAPQ and BPASS were 
specifically designed to measure BAP and used samples of people with BAP to create the 
instrument (21, 147). The FHI-IOI and BPASS include clinician observations (150), which may 
remove the variance in the informant’s ability but also limit the utility of the instrument in large 
studies. The SRS-A and AQ have both been shown to effectively measure BAP in non-clinical 
populations (151, 152). Informant reports may reduce biases by getting an outside opinion on a 
person’s BAP traits. Self-report questionnaire instruments can be completed quickly, do not 
need the participant to find someone to report on them, and do not require a trained 
professional. Collecting data from more than one source can reduce some reporter related bias. 
The optimal tool is related to the research question; a study with a large non-clinic based 
sample may select a instrument that is self-report and easy to complete, while a study that 
wants to maximize precision would use a clinician observation and a best estimate approach.
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Table 2 Overview of adult BAP instruments 
Instrument Author, year Reporter Description Scoring 
Autism 
Spectrum 
Quotient 
(AQ) 
Baron-Cohen, 
2001(126) 
Self -50 question self-administered 
instrument 
-Answers range from strongly 
agree to strongly disagree 
-Five domains: attention 
switching, social skill, attention to 
detail, communication, and 
imagination 
-Intended for individuals with 
normal / high IQ (126) 
 
-1 point for definitely or slightly 
agree / disagree depending on 
question  
-1 to 2 standard deviations above 
mean (145) 
 
 
Social 
Responsiveness 
Scale- Adult 
(SRS-A), SRS-2 
 
 
 
Constantino, 
2005 (123, 153) 
 
 
Informant/ 
Self (SRS-
2) 
-65-item likert scale 
questionnaire  
-The questionnaire takes 15-20 
minutes to complete  
-Measures five domains: social 
awareness, social cognition, 
social communication, social 
motivation, and autistic 
mannerisms  
-SRS-2 has informant and self-
report versions 
 
-Items scored 0-3 
BAP cutoffs: 
- A T-score ≥ 60 (60) 
-A T-score >70 (154) 
-Top 20% of scores in a 
population based sample has 
been used to indicate BAP (17)  
-Top 25% of a sample of 
Hispanic parents (154) 
 
 
Broader Autism 
Phenotype 
Questionnaire  
(BAPQ) 
Hurley, 2007 
(147) 
Self / 
Informant 
-36 Items derived from previous 
direct assessments of autistic 
traits (MPAS-R) 
-Scales corresponding to three 
components: aloofness, rigid 
personality, pragmatic language 
problems 
- Item scoring range: 1-6(147) 
-‘Best estimate’ is the mean of a 
self- and informant report score 
-Sex specific BAP cutoffs defined  
  Males:   3.55 self 
          3.65 informant 
  Females: 3.17 self 
          3.46 informant(23) 
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Instrument Author, year Reporter Description Scoring 
Broader 
Phenotype 
Autism 
Symptom Scale 
(BPASS) 
Dawson, 2007 
(21) 
Interview / 
direct 
observation 
-Interview with trained clinician 
who rates subjects socio-
communication ability  
-Four domains: social motivation, 
social expressiveness, 
communication, and flexibility  
- 1 to 4 or 5 point scales ranging 
from highly atypical to above 
average 
-Mean score above 2 indicates 
BAP (21) 
 
Family History 
Interview 
Bolton, 1994 
(121), Piven, 
1997(140), 
IMGSAC, 
2000(150, 155, 
156) 
Interview, 
self, 
informant, 
direct 
observation 
-Older version (121, 140) is a 
structured interview where a 
responder answers questions on 
their own and family’s health 
history and personality traits. 
-77 Items, 30 to 60 minutes in 
length 
--Factor analysis suggests two 
factor solution: social 
communication and rigidity, 
reading and spelling impairments  
(150) 
 
-Rating from 0-not reaching 
scoring threshold to 2-associatedi 
impairment 
-Clinical significance determined 
by summing results with scoring 
algorithm, if score ≥ 1 than 
evidence of BAP (150, 155, 156)  
 
Modified 
Personality 
Assessment 
Schedule 
Piven, 1994, 
1997 (119, 140) 
Interview, 
informant 
-Trained professional conducted 
semi-structured interview of ASD 
traits 
-Focuses on six traits (aloof, 
anxious, hypersensitive, overly 
conscientious, rigid, and 
untactful)(136) 
 
-Characteristics rated 2=present, 
1=unknown, 0=absent (157) 
-Results synthesized to a ‘best 
estimate’ 
-Algorithm of sum of traits ≥ 2 = 
BAP (158) 
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Instrument Author, year Reporter Description Scoring 
Pragmatic 
Rating Scale 
Landa, 1992 
(118) 
Interview, 
direct 
observation 
 -Subscales: disinhibited social 
communication, awkward / 
inadequate expression, odd 
verbal interaction(24) 
 
-25 behaviors rated by clinician 
on three point scale: 0- normal, 1- 
moderately abnormal, 2-strikingly 
abnormal 
-Summed and averaged by 
subscale (158) 
Communication 
Checklist-Adult 
Whitehouse, 
2010 (159) 
Informant -Questionnaire 
-70 behavioral statements that 
the informant judges on 
frequency: less than once a week 
or never (0), at least once a week 
but not every day (1), once or 
twice a day (2), or several times 
a day or always (3).  
-Three subscales: language 
structure, pragmatic skills, social 
engagement (160) 
-All questions summed 
-BAP is identified as 2 SD below 
the mean (by sex)(160) 
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Percentage of parents with BAP 
We conducted a systematic review and identified 40 studies that assessed percentage 
of parents of children with ASD who have BAP; these studies are presented in Table 3. All 
studies present crude percentages as no studies estimated BAP prevalence by means of 
statistical analyses. The earliest identified used data collected in 1994 (161) with the most 
recent study being published in 2016 (162).  
Specific samples 
We also present BAP percentage if a control group was used; 16 studies provided 
percentage for controls (either parents of typical developing children, parents of children with 
Down Syndrome or non-biological relatives of children with ASD)(17, 19, 23, 128, 129, 139, 
141, 144, 145, 154, 156, 159, 163-166). Uniformly, parents in the control group had lower 
percentage of BAP. Some studies looked at specific subgroups of ASD parents, including 
multiplex or simplex families (106, 156, 166), high functioning autism or Asperger’s syndrome 
(167), specifically Hispanic samples (154), samples with and without regression (22), and by 
parents usage of anti-depressants (168). By subgroup, the percentage of parents with BAP was 
higher in multiplex families as compared to simplex families (106, 136, 166). Other subgroups 
were not assessed in more than one study.  
By sample size 
Our range was from 4 (168) to 3299 (148). Figure 2 presents sample size after 
stratification by instrument. There is some indication that there are a larger percentage of 
parents with BAP when sample size was smaller. This may be a result of sample type 
(population sample or clinical) or desire to have statistical power by lowering cut-offs.  
By parent type 
Of 40 studies identified, 25 reported percentages in all parents who completed the 
assessment (i.e. not stratified by sex). Twenty-two reported percentage in fathers of children 
with ASD and 23 reported percentage in mothers of children with ASD (see Table 3). These 
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results are visually presented in Figure 2 after stratification by instrument. Overall, fathers had a 
slightly higher percentage of BAP, which is in concordance with the male: female sex ratio in 
ASD and may signify a male predisposition to the disorder (169). However father BAP was not 
consistently higher in all studies that measured both mother and father. Mother results were 
similar to results for any parent.  
By informant type / instrument 
Figure 2 presents results by instruments. The FHI had the highest estimates, but also 
had a large range. This may be a result of the different informant styles for the FHI (FHI-S, FHI-
I, IOI), change in the tool over time, and differences in sample type. AQ, BAPQ, and SRS-A had 
similar distributions to one another. Informant type did not vary greatly between methods. 
Relationship between BAP and child ASD characteristics 
 Fourteen studies assessed the association between parental BAP and child ASD 
phenotype and they are presented in Table 4. These studies used a variety of the BAP 
measures and most were conducted in the US. The majority of studies assessed children aged 
3-18 years, but some restricted to younger children or expanded to adult children. Most studies 
were conducted in clinical settings. Samples ranged in size from 50 (170) to 711 probands 
(165). Most common analytic approaches were analysis of variance tests (20, 162, 163, 165, 
171, 172). Other analytic approaches included predictive modeling (132, 173), controlling for 
covariates like parent age and sex in models (168, 170), and mixed models (92, 171). 
 Positive associations were found between child scores on ASD screeners and parent 
scores on BAP measures (19, 20, 132, 165). Additional significant associations were found 
between child intense preoccupation and father rigidity domain (170), autistic like social 
functioning in parents and child daily functioning level (174), and parent and child RRBI score 
(162). Levin-Decanini et al. (168) stratified their results by anti-depressant status and found that 
there was a relationship between parent BAP and child RRBI among parents not taking anti-
depressants (23). Father’s BAP tended to have a stronger association with child phenotype as 
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compared to maternal BAP (19, 20, 170). Two studies found no associations between maternal 
BAP and child phenotype (20, 157), whereas Hasegawa et al. (132) found associations between 
maternal BAP and four of five child SRS domains with no associations between father BAP and 
child phenotype. Two studies had null results. Bishop et al. (129) found no association between 
BAP and child IQ and no difference between children having ‘autism’ or ‘pervasive 
developmental disorder’ by parental BAP status. Taylor et al (172) found no association 
between parental BAP and child ADOS severity. 
  
28
Table 3 Studies that present percentage with BAP in parents of children with ASD 
Author Yeara Instrument Informant Parent N 
Parent group 
assessed / 
domain 
Percent 
of 
parents 
Fombonne et al. (161) 1994 FHI Interview F/M 160 ASD 10.0 
Szatmari et al. (166) 1998 FHI Interview F 681 
 
ASD / ≥1 domain 28.3 
 
 ASD / ≥2 domain 9.5 
 
 M 681 ASD / ≥1 domain 16.7 
 
 ASD / ≥2 domain 4.0 
 
 F/M 1362 ASD / ≥1 domain 22.5 
 
 ASD / ≥2 domain 10.4 
 
 
ASD simplex / ≥1 
domain 19.0 
 
 
ASD simplex / ≥2 
domain 5.3 
 
 
ASD multiplex / 
≥1 domain 26.4 
 
 
ASD multiplex / 
≥2 domain 8.3 
 
Informant 337 
Non bio relative / 
≥1 domain 6.8 
 
 
Non bio relative 
/≥2 domains 2.4 
Pickles et al. (139) 1994 FHI Interview F/M 92 
 
ASD 12.1 
 72 DS  9.8 
Starr et al. (143) 2001 FHI Interview F/M 86 
 
ASD 15.0 
Lainhart et al. (22) 2002 
MPAS-R, 
PRS Best estimate F/M 18 ASD w regression 27.8 
 70 
ASD w no 
regression 32.9 
Bishop et al. (129) 2004 AQ Self F 52 ASD 36.9 
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Author Yeara Instrument Informant Parent N 
Parent group 
assessed / 
domain 
Percent 
of 
parents 
 37 TD 13.5 
 M 69 ASD 15.4 
 52 TD 3.5 
Bishop et al. (163) 2004 AQ Self F/M 114 ASD 21.3 
 87 TD 3.4 
Klin et al. (175)* 2005 FHI Interview F - ASD 21.0 
 M - ASD 3.0 
 F/M 220 ASD 12.0 
Ghaziuddin et al. (167) 2005 FHI Interview F/M 58 Asperger's 29.0 
 39 HFA 20.5 
Dawson et al. (21) 2007 BPASS Best estimate F 172 
ASD / 
expressiveness 16.0 
 
ASD/ 
communication 13.5 
 M 151 
ASD / 
expressiveness 6.0 
 
ASD / 
communication 5.0 
FHI Interview F/M 299 
ASD / ≥1 BAP 
domain 50.3 
 ASD /≥ 2 domain 11.4 
Hurley et al. (147) 2007 BAPQ Best estimate F 35 ASD  40.0 
 M 43 ASD  9.3 
 F/M 86 ASD  31.4 
Self  ASD  25.0 
Informant ASD  25.0 
Losh et al. (109) 2007 
MPAS-R, 
PRS,  Best estimate F/M 48 ASD / ≥1 domain 50.0 
Ruser et al. (176) 2007 PRS Best estimate F/M 47 ASD 15.0 
Whitehouse et al. (177) 2007 AQ Self F 10 ASD 10.0 
 M 20 ASD 25.0 
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Author Yeara Instrument Informant Parent N 
Parent group 
assessed / 
domain 
Percent 
of 
parents 
Losh et al. (136) 2008 
MPAS-R, 
PRS,  Best estimate F/M 78 
SX ASD / ≥2 
domains 33.0 
     48 
MX ASD / ≥2 
domains 56.0 
     60 
DS control/ ≥2 
domains 10.0 
Losh et al. (109) 2009 MPAS-R Best estimate F/M 83 
ASD / social 
domain 26.5 
Whitehouse et al. (159 2010 CC-A Informant F/M 238 ASD 25.6 
 187 TD  16.0 
Wheelwright et al. (145 2010 AQ Self F 571 ASD 33.0 
 349 TD 22.0 
 M 1429 ASD 23.0 
 658 TD  9.0 
Coon et al. b(178) 2010 SRS-A Informant F/M 518 ASD pedigreesb 12.1 
Ingersoll et al. (179) 2011 AQ Self F/M 149 ASD 10.0 
Ruta et al. (141) 2012 AQ Self F 115 ASD 43.5 
 150 TD  20 
 M 130 ASD 26.2 
 150 TD  11.3 
Seidman et al. (18) 2012 BAPQ Best estimate F 38 ASD  2.6 
Self ASD  10.5 
   Informant   ASD 7.9 
Best estimate M 38 ASD  13.1 
Self ASD  21.0 
   Informant   ASD 15.8 
Mohammadi et al. 
(138)  2012 AQ Self F 96 ASD 50.0 
      TD  11.0 
    M  ASD 37.0 
      TD  11.8 
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Author Yeara Instrument Informant Parent N 
Parent group 
assessed / 
domain 
Percent 
of 
parents 
Levin-Decanini et al.( 
168) 2013 BAPQ Self F 115 
ASD w no SSRI 
use 17.4 
 4 ASD w SSRI use 20.0 
 M 136 
ASD w no SSRI 
use 11.8 
 19 ASD w SSRI use 36.8 
Taylor et al. (172) 2013 AQ Self F 82 ASD 26.8 
 M 82 ASD 25.6 
 
Berthoz et al. (128) 
 
2013 
 
AQ Self 
 
F/M 
 
87 
 
ASD 
 
13.8 
 47 TD  8.2 
Maxwell et al. (19) 2013 BAPQ Best estimate F 245 ASD 21.0 
 129 TD 7.0 
 M 245 ASD 10.0 
 129 TD  1.0 
 F/M 490 ASD 26.0 
 258 TD 8.0 
Sasson et al. (23) 2013 BAPQ Best estimate F 359 ASD 19.0 
 490 TD  8.9 
 M 352 ASD 23.2 
 491 TD  8.1 
Sasson et al. (165) 2013 BAPQ Best estimate F/M 711 ASD 36.0 
 981 TD  14.1 
Gerdts et al. (106) 
1998-
2011 BPASS Best estimate F 71 Mx ASD / social 66.0 
 40 Sx ASD / social 33.0 
 M 84 Mx ASD / social 44.0 
 41 Sx ASD / social 32.0 
Sasson et al. (180) 2014 BAPQ Informant F 222 ASD  17.6 
Self ASD  9.5 
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Author Yeara Instrument Informant Parent N 
Parent group 
assessed / 
domain 
Percent 
of 
parents 
Informant M 222 ASD  19.8 
Self ASD  20.3 
Davidson et al. (148) 2014 BAPQ Best estimate F 1582 ASD 14.5 
 M 1596 ASD 8.5 
 F/M 3178 ASD 11.5 
 
SRS-A 
 
Informant 
 
F 
 
1647 
 
ASD 
 
7.3 
 M 1652 ASD 5.3 
 F/M 3299 ASD 6.3 
Lyall et al. (17) 2014 SRS-A Informant F/M 2365 ASD 27.5 
 482 TD  14.7 
 F 1372 ASD 32.6 
 242 TD 18.1 
 M 993 ASD 22.5 
 240 TD  20.0 
Shi et al. (144)  
2012-
2015 BAPQ Best estimate F 299 ASD  13.0 
Self ASD 9.0 
Informant ASD  11.0 
Best estimate TD  2.9 
Self TD  3.6 
Informant TD  4.7 
Best estimate M 274 ASD  30.8 
Self ASD 29.1 
Informant ASD 21.4 
Best estimate TD  20.8 
Self TD  17.5 
Informant TD  10.2 
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a Year is year data collected if indicated, otherwise year of publication 
b Includes pedigrees 
DS Down Syndrome 
Mx Multiplex 
Author Yeara Instrument Informant Parent N 
Parent group 
assessed / 
domain 
Percent 
of 
parents 
 
de Jonge et al. (156) 2015 FHI-I Informant F 26 Mx ASD  80.0 
FHI-S Interview Mx ASD 73.0 
IOI Best estimate Mx ASD 55.0 
FHI-I Informant 29 DS 7.0 
FHI-S Self DS 28.0 
IOI Best estimate DS 28.0 
FHI-I Informant M 27 Mx ASD  48.0 
FHI-S Self Mx ASD 52.0 
IOI Best estimate Mx ASD 52.0 
FHI-I Informant 30 DS 6.0 
FHI-S Self DS 3.0 
IOI Best estimate DS 3.0 
Duvekot et al. (181) 2016 SRS-2 Self F 224 ASD 37.4 
Informant ASD  38.4 
Self M 182 ASD 33.7 
Informant ASD 29.0 
Yucel et al. (182) 2015 BAPQ Best estimate F 20 ASD 40.0 
 M 20 ASD 35.0 
 F/M 40 ASD 37.5 
Parr et al. (183) 2015 FHI-S Interview M 18 ASD 35.7 
Bora et al. (164) 2016 AQ Self F/M 673 ASD 21.1 
 146 TD  7.5 
Page et al. (154) 2016 SRS-2 Informant/ Self F/M 140 ASD 15.0 
     125 TD 4.0 
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Sx Simplex 
TD typically developing 
F Father 
M Mother 
F/M Either parent 
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Figure 2. Scatter plot of percentage of parents with BAP, by instrument, sample size, and parent type 
 
 
 
 
 
 
 
 
 
 
 
 
 
Control percentages excluded from graph 
AQ= Autism Quotient, BAPQ= Broader Autism Phenotype Questionnaire, BPASS= Broader Phenotype Autism Screening Scale, FHI- 
Family History Interview, MPAS-R= Modified Personality Assessment-Revised, PRS= Pragmatic Rating Scale, SRS-A= Social 
Responsiveness Scale Adult 
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Table 4 Studies that assess traits in children with ASD that are associated with parent BAP and their results 
Author, year Instrument Probands Parent Country Child age (years) Results 
Bishop et al., 
2004 (129) AQ 65  
M (65) 
F (42) Australia - 
-Neither Mother nor father BAP was 
associated with proband IQ or whether 
proband had ASD or pervasive 
developmental disorder diagnosis  
Mazefsky et al., 
2008 (184) FHI 77  F/M (77) US 8-39  
 
-Parental BAP did not predict Vineland 
adaptive behavior score in socialization, 
communication, and daily living skills. 
-Autistic like social function in relatives 
did predict whether a child would be in a 
high functioning or lower functioning 
cluster 
 
Smith et al., 
2009 (170) MPAS 50  
M (50) 
F (50) US 5-22  
-Child intense preoccupation was 
associated with fathers aloof and rigid 
BAP domains 
-No association between parental BAP 
domains and insistence on sameness 
factor 
Schwichtenberg 
et al., 2010 (20) SRS-A 
115 Sx  
10 Mx  
 
Sx F/M 
(124)  
Mx F/M 
(11) 
 
US - -Father SRS-A but not mother SRS-A predicted proband SRS score  
Losh et al, 2012 
(185) MPAS 89 M (89) US - 
 
-No association between mother BAP 
and child SRS score 
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Author, year Instrument Probands Parent Country Child age (years) Results 
Levin-Decanini 
et al., 2013 
(168) 
BAPQ 197 M (196) F (161) US 3-50  
 
-Fathers not on anti-depressants total 
and aloof domain scores significantly 
correlated with child RRBI subscales and 
childhood routines and inventory score 
and father aloof domain score was 
associated with child compulsive score 
-If mother took antidepressants, a 
significant partial correlation was found 
between maternal aloof scores and 
proband ADOS RRBI total. 
 
Taylor et al., 
2013 (172) AQ 82  F/M (82) Australia 4-17  
 
-No association between parental BAP 
status and child ASD severity. 
 
Maxwell et al., 
2013 (19) BAPQ 245  
F/M 
(245) US 6-18  
 
-When at least one parent met criteria for 
total BAPQ or exceeded threshold in any 
subdomain, child SRS scores were 
higher. 
-Stronger association between father 
BAP and child SRS score than mothers-
child association 
 
Sasson et al., 
2013 (165) BAPQ 711 
F/M 
(711) US - 
-Total BAPQ and aloof BAPQ in parent 
associated with child total and social 
scores on ASD screener 
-Parent pragmatic language domain 
score were associated with child social 
score 
-No association between parental BAPQ 
rigidity domain and child score 
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Author, year Instrument Probands Parent Country Child age (years) Results 
       
Hasegawa et al, 
2014 (132) AQ 44  F/M (44) Japan 
37-95 
months 
-Maternal AQ total associated with all 
child SRS domains excluding awareness 
and mannerism.  
-Maternal attention switching and 
communication scores associated with 
child SRS total score 
-No association between father AQ score 
and child SRS total score 
 
Rocnoni et al., 
2014 (186) AQ 26 F/M (26) Italy 8 months 
-Higher AQ attention to detail score was 
associated with a longer time for child to 
look away from a previous cue and 
worse alerting skills of the child 
-Negative correlation between parental 
AQ communication score and child rapid 
orienting index 
- Results were not significant between 
mother and child 
       
       
  
39
Author, year Instrument Probands Parent Country Child age (years) Results 
 
 
 
Klusek et al., 
2014 (171) 
 
 
 
MPAS 
 
 
 
52  
 
 
 
M (50) 
F (42) 
 
 
 
US 
 
 
 
7-36  
-No association between mother BAP 
and child ASD traits when child was 4-5 
years  
-Untactful personality in fathers was 
associated with child’s total severity, 
degree of social impairment, and deficits 
in communication at 4-5 years 
-Father aloof traits were positively 
associated with child severity of RRBI at 
4-5 years  
-Father overly conscientious trait was 
negatively associated with child severity 
of RRBI at 4-5 years 
-Parent pragmatic language total score 
and dominating subscale associated with 
child’s current communication 
impairment 
-Aloof trait in fathers was positively 
associated with child current overall 
symptom and RRBI severity.  
-Overly conscientious in fathers was 
negatively associated with a current 
overall severity and degree of social 
impairment 
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F Female 
M Male  
RRBI Repetitive and restricted behaviors and interests 
SRS Social Responsiveness Scale  
SRS-A Social Responsiveness Scale- Adult 
AQ Autism Quotient 
BAPQ Broader Autism Phenotype Questionnaire 
MPAS Modified Personality Assessment Schedule
Author, year Instrument Probands Parent Country Child age (years) Results 
Duvekot et al., 
2015 (181) SRS-2 231 
M (224) 
F (182) US 2.5-18  
 
-Paternal BAP significantly predicted 
child's ASD symptoms  
- Maternal BAP was associated with 
child anxiety symptoms.  
-No cross-symptom associations 
between paternal BAP and children’s 
anxiety symptoms when correcting for 
paternal anxiety symptoms. 
 
De la Marche et 
al., 2015 (92) SRS-A 310 
 
M (296) 
F (256) 
Belgium 4-17  
 
-Paternal BAP had a significant effect on 
child SRS while maternal BAP had no 
effect on child SRS 
-No difference by child gender or 
whether family was simplex or multiplex 
 
Uljarevic et al., 
2016 (162) AQ RRBI 169  
F/M 
(169) Australia 2-18 
 
 -Having both parents within the top 20% 
of RRBI scores was associated with an 
increase of RRBI scores in their children 
-No parent of origin effect for RRBI effect 
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BAP as a source of reporting discrepancy during diagnosis 
To date, autism-like traits in a mother have not been reported as a factor in discordance 
between ASD screening, interview, and observation instruments. The presence of BAP among 
mothers may be a source of differential reporting, similar to what has been reported in the 
depression literature. Studies have shown that individuals with BAP may have more impairment 
in communication, emotional understanding, ability to understand non-verbal cues, narrative 
ability, and have decreased empathy, higher attachment anxiety, and increased avoidance 
compared to people without BAP (16, 117, 128, 187). Inhibition in these socio-communicative 
traits may impact informant ability (188, 189). Additionally, maternal BAP may affect how a 
mother reports on her child’s characteristics; maternal BAP is a predictor of increased parental 
stress (179, 190) and anxiety (191), which both may impact informant ability (95). We have 
identified no published work has assessed how BAP in mothers’ may affect reporting of child 
ASD during the ASD evaluation process. 
BAP as a tool to improve efficiency in ASD research 
As discussed earlier, subgrouping approaches may be an efficient way to better 
research ASD. Efficiently finding children with genetic predisposition can be difficult. Genetic 
testing is not yet universal among children with ASD, let alone family members, and families are 
concerned about costs and relevance (192). Comparing multiplex and simplex families is biased 
by reproductive stoppage (defined as changes in reproductive behavior after the birth of a child 
with serious health needs) among families with children with ASD (193-195). Using parental 
BAP may be an ideal way to subset child ASD by hereditary origin since BAP is a risk factor for 
ASD and heritable.  
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CHAPTER 3. METHODS 
3A. Study to Explore Early Development 
Our study is a secondary analysis using data from the Study to Explore Early 
Development. SEED is a multi-site, community based, case-control study. The purpose of this 
study was to 1) characterize the autism behavioral phenotype and associated behavioral, 
medical, and developmental conditions and 2) investigate genetic and environmental risk factors 
for ASD (196).  
SEED includes six sites (California, Colorado, Georgia, Maryland, North Carolina, and 
Pennsylvania) with a target population of between 33,000 and 52,000 births for each site in 
each study year. Data on children born between 2003 and 2006 were collected between 2007 
and 2012. Eligible children were between 30 and 68 months at time of developmental 
assessment, were born and resided in the study catchment area at the time of first study 
contact, and lived with a knowledgeable caregiver who was able to communicate the child’s 
developmental history in English (or Spanish in Colorado and California) (196).  
Children that were likely to have ASD or DD were identified through health clinics, early 
intervention programs, special education programs, or self-referral. Population controls were 
randomly selected from birth certificates. Sixty-four percent of participants identified from ASD 
or DD service providers and 68% from the population sample did not respond (196). After study 
entry, case status was confirmed (see section 3B) which created four groups: children with 
SEED confirmed ASD, population controls without ASD (POP), children referred to the study 
from DD service providers without SEED determined ASD (DD), and children who were unable 
to be accurately classified due to refusal or inability to receive the full ASD evaluation (PC). The 
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final SEED sample included 3899 children of whom 722 were in the ASD group, 1304 in the DD 
group, 1289 in the POP group, and 584 in the PC group. 
 Upon agreeing to participate, a telephone interview was conducted in which the Social 
Communication Questionnaire (SCQ) (61) was administered as an instrument to screen for 
ASD. All families were invited to a clinic to complete a standard developmental evaluation and 
bio-specimen collection. If the child had a past history of ASD, screened positive, or a clinician 
suspected ASD at the standard developmental evaluation, the child received a full ASD 
evaluation. ASD evaluations were done for research purposes and children were not formally 
diagnosed. All caregivers completed a series of questionnaires and provided medical records on 
pregnancy history and child development. A full list of data collection tools and SEED data 
collection procedure are presented in appendix 1 and 2.  
3B. Final classification 
 Study ASD classification was determined using a diagnostic algorithm which 
incorporated ASD specific instruments (197).  
Autism Diagnostic Observation Schedule (ADOS) (198) 
 The ADOS (version 2) was used in SEED as the clinician observation instrument. SEED 
clinicians had advanced degrees in developmental pediatrics, developmental psychology, 
clinical psychology, and related fields. All had extensive experience with the assessment and 
diagnosis of children with ASD (197). Clinicians observed children for over 40 minutes while 
creating settings that measured social affect and RRBI. The ADOS has specific modules based 
on age and verbal ability (69); our sample used modules 1 for children with no or limited verbal 
ability, module 2 for children with some verbal ability but no phrase speech, and module 3 for 
verbally fluent children (197). To meet SEED ASD criteria, the child had to score > 11 if they 
received module one and had no words, a score ≥ 8 if they received module one and had some 
words, a score ≥ 7 on if they were younger than 59 months and received module two, score ≥ 8 
  
44
they were older than 59 months and received module two, and a score ≥ 7 if they received 
module three (197). Inter-site reliability was 99% and intra-site reliability was 99% (197).  
Autism Diagnostic Interview- Revised (ADI-R) (199) 
 Along with the ADOS, the ADI-R was administered at the comprehensive evaluation. 
The ADI-R is a 93-item, 150 minute structured interview with the child’s caregiver that is 
administered by the clinician. The ADI-R measures the child’s social communication, RRBI, and 
developmental delays or deficits (67, 199). ADI-R cutoff scores for ASD were a social score ≥ 
10, communication score ≥ 8 for children with some words or ≥ 7 for non-verbal children, and a 
RRBI score ≥ 3 (197). In SEED, inter-site reliability was 99% and intra-site reliability was 87% 
(197).  
The Ohio State University Autism Rating Scale (OARS) (200) 
 The OARS is a tool filled out by a clinician and was used to measure symptom severity, 
degree of impairment, and clinician certainty in child’s ASD diagnosis. SEED investigators 
specifically modified this tool. The OARS was calibrated to a five-point Likert rating of clinician 
degree of certainty that the child had ASD dichotomized into ‘‘uncertain’’ (scores of 1–3 or note 
that ASD symptoms better accounted for by another disorder) and ‘‘certain’’ (scores of 4–5).  
3C. Broader autism phenotype  
 BAP was assessed using the Social Responsiveness Scale-Adult (SRS-A). Although 
designed to measure autistic traits in the general population, the SRS-A has shown good 
consistency with other BAP and qualitative autism trait instruments (122, 149). The SRS-A is 
65-item likert scale questionnaire that a friend, spouse, or relative completes was asked to 
complete on the parent. The questionnaire takes 15-20 minutes to complete and is filled out 
before the clinic evaluation. The full questionnaire is presented in appendix 3. Examples of 
question’s asked are “[Parent] seems too dependent on others for help with meeting basic 
needs” and “[Parent] does extremely well at a few intellectual or computational tasks, but does 
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not do as well at most other tasks.” Another strength of the SRS-A is its ability to measure five 
distinct domains to define ASD and ASD-like traits; domains are social awareness, social 
cognition, social communication, social motivation, and autistic mannerisms (60). These 
domains are derived through sub-setting specific questions of the SRS-A that relates to these 
topics. The SRS-A has strong internal validity, exhibiting a Cronbach’s alpha internal 
consistency coefficient of 0.95 (122, 123). SRS-A scores have been shown to be independent of 
IQ and age (60, 201). The child version of the SRS has been seen to be independent of race 
(123) and the SRS-2 (which incorporates a self-report version of the SRS-A) shows minimal 
effect of race and ethnicity in adults (153). Informant type showed strong inter-rater agreement 
(r> .84 comparing two different informers). However, using the self-report version (added in the 
SRS-2) had lower inter-rater agreement (r was between 0.61 and 0.66)(153). This is similar to 
scoring discrepancies between self- and informant-report from other instruments (147, 202-
204). Ultimately, the SRS-2 standardized both the self- and informant version on the same 
scale, which suggests minimal informant effects (153).   
 Raw SRS-A scores were adjusted to create T-scores, which have a mean of 50 and a 
standard deviation of 10. The cutoff point for BAP on these instruments is often variable. Past 
studies have used various cut points to indicate BAP: a score greater than or equal to an 
adjusted T-score of 60 on the SRS-A (60), participants in the top 20% of scores for the SRS-A 
(17), participants with scores in the top half on the Family History Interview (183), or one to two 
standard deviations above the population mean in the Autism Spectrum Quotient (145). We 
made BAP a binary variable using a score of greater than or equal to 60 as our cutoff based on 
past work using the SRS-A (60), but will also conducted analyses using a score ≥58 which 
represents 20% of our sample). The same scoring procedure was used for the five domains. 
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3D. Human subjects protection / Data security 
 All sites that participated in SEED received Institutional Review Board approval, as did 
this dissertation as a secondary data analysis. Personal identifying information was not included 
in any analyses. The SEED data coordinating committee located at Michigan State University 
oversaw the data, which could only be accessed through a secure remote data access 
connection.  
3E. Aim 1 specific methods 
Sample 
 For this study, we included all children in SEED identified from educational or medical 
providers that serve children with DDs, excluding siblings (which would violate independence), 
children without a completed SCQ, ASD evaluation, or maternal SRS-A; and children whose 
mother did not act as the sole informant on the ADI-R or SCQ. Although some children with 
history of DD did not receive the full evaluation, we elected to include those who did in our 
sample. DD is a broad category and many children who did not receive the full evaluation had 
no ASD symptoms (205). Additionally, children with DD who did not meet SCQ thresholds were 
still eligible to receive a full ASD evaluation if a clinician suspected ASD during the clinic visit 
 Approximately 20% of mothers did not have completed SRS-As. Based on a logistic 
regression of collected maternal demographics, mothers without SRS-As were more likely to 
have some college, less likely to have a college degree or higher, and were more likely to be 
from the Georgia site compared to mothers with SRS-As. We explored this missingness, by 
running sensitivity analyses that weighted mothers to approximate the demographics of the total 
sample. We chose not to impute values because the SRS-A is designed to be independent with 
race, age, or IQ or other variables that could be used in an imputation model (123). We also 
have no reason to believe that the SRS-A was differentially completed based on BAP status. 
Further, we explored this missingness as a sensitivity analysis (rather than main analysis) since 
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the SEED sample (which is overly white, educated, and non-Hispanic (206)) is not a very 
generalizable sample even without missingness. To apriori choose to weight our results to this 
sample was not vital.  
Exposure 
 We used the SRS-A as described in section 3C. Unfortunately, the informant (who filled 
out the SRS-A on the mother) is missing for approximately 75% of mothers. This prevents us 
from accounting for potential informant effects. We address this as a limitation in our discussion. 
Outcome  
 We created variables to indicate discordance between a maternal screener (SCQ) or 
maternal interview (ADI-R) and clinician observation (ADOS) or clinician best estimate (OARS) 
using the cut-off scores used in SEED. We compared difference in whether the child did or did 
not meet thresholds for being at high risk for ASD (SCQ) or for having ASD (ADOS, ADI-R, and 
OARS) between the maternal and clinician instruments. Our four comparisons were the SCQ 
versus the ADOS, the SCQ versus the OARS, the ADI-R versus the ADOS, and the ADI-R 
versus the OARS. If the two instruments were in agreement about whether the child met ASD 
criteria (whether both positive or both negative), they were considered ‘not discordant’. Since 
the ASD evaluation is a complex process that takes place over a limited amount of time, we do 
not want to imply that a mother’s report or clinician observation on child ASD is ‘right’; however, 
since we are more concerned about influence of maternal characteristics on reporting, we used 
the clinician completed instruments as our ‘gold-standard’ when presenting our results. 
Therefore, we define ‘over-reporting’ as the maternal report instrument meeting ASD thresholds 
when the clinician instrument does not and ‘under-reporting’ when the maternal report 
instrument does not meet ASD thresholds while the clinician instrument does. Outcomes are 
listed in Table 5. 
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Covariates / confounding 
 For aim 1.3, we assessed maternal self-reported history of depression or anxiety 
disorder diagnosis. Those data were taken from the maternal health history interview, where the 
mother reported on her past diagnosed health conditions.  
Based on BAP being a well validated construct (24) and the SRS-A being designed to be 
independent of age and IQ (123) and minimal association with race (153), we do not believe 
there is any confounding to adjust for in our primary analysis (Figure 3).  
Race, ethnicity, age, and education variables for mothers, children, and families were 
collected using child’s birth records and a SEED specific Caregiver Interview (CGI). The CGI is 
a 60 minute telephone interview administered by SEED staff to the child’s caregiver to assess 
family demographics, maternal reproductive and pregnancy history, diagnosed developmental 
outcomes in all children in the household, and medical, therapeutic, obstetric, and lifestyle 
complications of pregnancy with index child (196). We were able to use multiple sources 
collected by SEED to first use the caregiver interview for demographic variables, and then fill in 
missing values with the child’s birth record. Exploratory analyses show that these variables are 
sufficiently concordant.  
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Figure 3. Directed acyclic graph for aim 1 analyses 
 
 
 
 
 
 
 
SES: Socioeconomic status
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Table 5.B Outcomes for aim 1. 
 
 
 
 
 
 
 
 
 
 
SCQ Social Communication Questionnaire 
ADOS Autism Diagnostic Observation Schedule 
ADI-R Autism Diagnostic Interview Revised 
OARS The Ohio State Autism Rating Scale 
 
Table 5. Outcome instrument for aim 1.  
Maternal report 
instrument 
Instrument 
type 
Clinician 
Instrument 
Instrument 
type 
Direction of 
discordance 
SCQ Screener ADOS Observation None, ‘over’, ‘under’ 
SCQ Screener OARS Best estimate None, ‘over’, ‘under’ 
ADI-R Interview ADOS Observation None, ‘over’, ‘under’ 
ADI-R Interview OARS Best estimate None, ‘over’, ‘under’ 
Maternal report (SCQ or ADI-R) Clinician (ADOS or OARS) 
 + - 
+ None ‘Over-reporting' 
- ‘Under-reporting’ None 
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Primary analysis 
 We ran log-binomial regression models to estimate risk ratios (RR) and 95% confidence 
intervals for the relationship between a binary maternal BAP variable and discordance outcome 
variables. Based on our approach outlined in the confounding / covariate section, we had no 
covariates or other type of adjustment in this primary analysis. All analyses describe below were 
run for all out outcomes in Table 5.  
 Next, we assessed correlation between maternal BAP and BAP domains (aim 1.2). 
Since our desire was to assess whether a BAP domain was associated with discordance 
independent of other domains, we reran our models with five binary indicators for each BAP 
domain (the intercept being no BAP in any domain). Since there was some correlation between 
domains, not adjusting for the other domains would muddy the interpretation of our results. 
For aim 1.3, we addressed maternal self-reported past history of depression or anxiety 
disorder diagnosis to better understand whether discordance is particular to BAP or more 
general to other psychiatric conditions. First, we assessed correlation between BAP, reported 
past history of diagnosed depression, and reported past history of a diagnosed anxiety disorder. 
We did not control for maternal BAP in these analyses because correlation in our data were low 
between maternal BAP, self-reported depression, and self-reported anxiety diagnosis. 
Additionally, since the literature is limited on whether BAP confounds the relationship between 
depression or anxiety and reporting on ASD instruments and this analysis is more exploratory in 
nature, we do not condition our estimates on maternal BAP status. We qualitatively examined 
whether effect estimates differed from the BAP estimates.  
Additional analysis 
 We ran a series of additional analyses to better understand our data and to explore the 
relationship between maternal BAP and discordance in ASD instruments. First, we evaluated 
psychometric properties comparing both maternal report instruments (SCQ, ADI-R) to clinician 
reported instruments (ADOS, OARS)(used as gold standard). We calculated sensitivity 
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(probability of maternal report reaching ASD criteria | clinician report reaching ASD criteria), 
specificity (probability of maternal report not reaching ASD criteria | clinician report not reaching 
ASD criteria), positive predictive value (PPV) (probability of clinician report reaching ASD criteria 
| maternal report reaching ASD criteria), negative predictive probability (NPV) (probability of 
clinician report not reaching ASD criteria | maternal report not reaching ASD criteria) four our 
overall sample and by maternal BAP status.  
 Additionally, we reran all aim 1.1 and 1.2 analyses using linear-risk regression to 
calculate risk differences. We chose this to be additional analyses rather than primary because 
using risk ratios is the standard measure of effect in the ASD literature.  
 To evaluate the effect of language preference we also reran primary analyses restricting 
to mothers whose preferred language was English. Similar to exploring language preference, 
we examined differences by site by running models that weighed for differences in site using 
inverse probability weighting. We did this because two sites administered evaluations in 
Spanish and site may be considered a design variable in the SEED study; however, because of 
SEED’s strong internal and external validity and lack of difference in site between discordant 
and non-discordant mothers, consider it a sensitivity analysis. Other sensitivity analyses 
included using the standard SCQ score of ≥ 15 as our ASD threshold and weighting for missing 
SRS-As.  
 Lastly, we examined race/ethnicity as a potential effect measure modifier. We reran 
analyses stratified by race (white, black, other) and ethnicity (non-Hispanic or Hispanic). Our 
goal was to determine if there were differences by these demographic variables.  All analyses 
were conducted in SAS 9.3 (SAS Institute, Cary NC) 
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3F. Aim 2 specific methods 
Sample 
 For aim 2, we include all children with SEED determined ASD and an SRS-A completed 
for both parents. If a family had multiple children in the study who had ASD (n=7), we excluded 
the second child (who was brought into the study after their sibling) to be in line with past latent 
class analysis (LCA) work done in SEED, and to ensure statistical independence. In the future, 
it may be worthwhile to include multiplex families.  
 There was missing data in our sample due to incomplete SRS-A data. We explored this 
using inverse probability weights to make our restricted sample look more like our total sample. 
We ran a logistic model predicting SRS-A completion for both parents by site, maternal race, 
maternal ethnicity, and maternal age at childbirth. Probabilities were calculated and if both 
parents had a completed SRS-A then the weight was 1/(probability of not missing). If one or 
both parent were missing an SRS-A, then the weight was 1/(1-probability of not missing). These 
weights were used in sensitivity analyses. 
Exposure 
 We used BAP cutoffs as described in section 3c. We included paternal BAP scores and 
created variables to signify whether father only, mother only, or both meet BAP cutoffs. 
Creating latent classes  
 Our outcome was latent classes derived using an analytical approach first used by 
Wiggins et al (under review). They identified 27 variables that would characterize the ASD 
phenotype and differentiate between those with ASD, rather than those with and without. 
Variables come from multiple measures that use multiple modes of data collection. This is an 
improvement on other LCA approaches that derived classes from only one measure. Three 
sources of indicators, the ADOS, ADI-R, and SCQ are described in section 3E. Four other data 
sources were used: 
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 The Child Behavior Checklist (CBCL): The CBCL is a fifteen-minute questionnaire filled 
out by a parent to assess the child’s behavior problems and social competencies (207).  
 Mullen Scale of Early Learning (MSEL): The MSEL is a 45 minute clinician administered 
measure to assess cognitive ability and motor development in children from birth to 68 months 
(208).  
 Gastrointestinal Questionnaire (GIQ): SEED constructed the GIQ, a ten-minute parent-
completed questionnaire to assess the child’s past and current gastrointestinal distress (196).  
Indicator variables to create these classes are listed in Table 6.  
 Early Developmental Questionnaire (EDQ): Brief questionnaire filled out by a parent to 
assess child’s regression of language and social skills and functional behavior (209.) 
Covariates 
 Covariates were used to describe our sample, weight for possible selection bias, and 
were used as an effect measure modifier (child sex). These variables were collected in maternal 
interviews, the child’s birth certificate, and other medical records. 
Confounding 
 Since our exposure in aim 2 is the same as in aim 1, our confounding model is similar. 
We know that BAP is theorized and BAP measures are designed to be independent of IQ, age, 
and race (123). Since we consider BAP to be an underlying genetic trait, there are not 
characteristics that can precede BAP. Factors like SES, parental education, parental age, child 
age at diagnosis, and child service usage are potential mediators. In aim 1 we ran sensitivity 
analyses to examine the effect of ethnicity, but for this aim there were no associations between 
child ethnicity and ASD phenotypic classes (Wiggins under review). Our decision making 
process is presented as a DAG (Figure 4). Further, all but two studies presented in Table 4 
(review of studies that assessed associations between parent autism-traits and child ASD 
phenotype) did not adjusted for any demographic covariates or proposed confounders. One 
study controlled for sex (which we explored by categorizing BAP by parent type) (170) and the 
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other controlled for age and sex, but their research question was specific to interactions with 
anti-depressant use (168). 
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Table 6 Latent class variables for children with autism spectrum disorder enrolled in the Study to Explore Early 
Development (SEED) 
SEED data source Latent class variables  Scores used in latent class analysis Scores indicating 
impairment  
Autism Diagnostic 
Observation Schedule 
Autism symptom severity Total severity scores from 1-10 
 
Higher 
Autism Diagnostic 
Interview – Revised 
Age at verbal language development 
Age at walking 
History of regression 
 
 
Insistence on sameness 
 
 
Repetitive behavior with objects 
 
Repetitive motor mannerisms 
 
 
Restricted interests 
 
Item scores from 4-62 months 
 
Item scores from 7-43 months 
 
Item score dichotomized into yes 
(regression in either language or social 
domains reported) or no (regression in 
language or social domains not reported) 
 
Item scores representing 
compulsions/rituals, difficulties with minor 
changes in routines, and resistance to 
trivial changes in the environment 
dichotomized into yes (any reported) and 
no (not reported)  
 
Item score dichotomized into yes 
(reported) and no (not reported) 
 
Item scores representing hand and finger 
mannerisms and other complex 
mannerisms dichotomized into yes (any 
reported) and no (not reported)  
 
Item scores representing unusual 
preoccupations, circumscribed interests, 
and unusual attachment to objects 
dichotomized into yes (any reported) and 
no (not reported)  
 
Higher 
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SEED data source Latent class variables  Scores used in latent class analysis Scores indicating 
impairment    
Self-injurious behaviors 
 
 
Unusual sensory response  
Item score dichotomized into yes (self-
injurious behavior reported) and no (no 
self-injurious behavior reported) 
 
 
Item scores representing unusual sensory 
interests, undue sensitivity to noise, and 
negative response to specific sensory 
stimuli dichotomized into yes (any 
reported) and no (not reported)   
 
Caregiver Interview Early recognition of epilepsy/seizure 
disorder 
Item score dichotomized into yes (parent 
report of epilepsy/seizure disorder) or no 
(no parent report of epilepsy/seizure 
disorder) 
 
Higher 
Child Behavior 
Checklist 
Aggressive behaviors, 
anxiety/depression, attention 
problems, emotional reactivity, 
somatic complaints, withdrawn 
behaviors 
Domain t-scores from 50-100  Higher  
 
Child Sleep Habits 
Questionnaire 
 
Sleep problems Total problems scores from 0-91  Higher 
 
Early Development 
Questionnaire 
Problems with age at first social smile Item scores dichotomized into yes 
(delayed social smile) and no (typical 
social smile) 
 
Higher 
Gastrointestinal 
Questionnaire 
Current diet restrictions Item score dichotomized into yes (diet 
restrictions) or no (no diet restrictions) 
 
Higher 
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SEED data source Latent class variables  Scores used in latent class analysis Scores indicating 
impairment  
Mullen Scales of Early 
Learning  
Expressive language skills 
 
Fine motor skills 
 
Receptive language skills 
 
Visual reception skills 
Age equivalent scores from 2-70  
 
Age equivalent scores from 4-68 
 
Age equivalent from 1-69 
 
Age equivalent scores from 5-69 
 
Lower  
 
Social Communication 
Questionnaire  
 
Social communication abilities Total scores from 1-35 Higher 
    
 
 
*Table adapted from Wiggins et al (under review)
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Figure 4. Directed acyclic graph for aim 2 analyses 
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Analysis 
 For our analysis, we created latent classes by replicating the approach used by Wiggins 
et al. (under review). We used an LCA approach because we believe that there is an underlying 
latent variable that explains the observed ASD phenotype. An extended LCA allows for use of 
continuous, dichotomous, and categorical variables. Response probabilities and patterns of 
observed data are used to create subgroups. Each individual has a probability of being in each 
class based on response patterns seen in the larger sample. In the past classes were assigned 
by highest probability, pseudo random draws, or maximum likelihood; but, the current 
consensus is that that approach leads to biased estimates because it does not account for 
classification error (210, 211). 
 We evaluated number of classes by running models up to 5 classes. Fit was evaluated 
using Bayesian Information Criterion (BIC) and Lo-Mendel-Rubin Likelihood Ratio Tests (LMR-
LRT). Lower BIC values indicate better fit.  A LMR-LRT p-value <0.05 improved fit over the 
model with one less class. Entropy ranges from 0 to 1 and higher entropy indicates greater 
classification precision. Low quality items (response probabilities close to 0.5) were dropped. 
These were gestational age and gastrointestinal issues. Tables from the Wiggins paper detailing 
model selection and response probabilities are presented in the appendix.  
 When adding covariates to assess associations with latent classes, there are multiple 
methods, each with strengths and weaknesses. Table 7 presents these three methods. Based 
on the literature and our research question, we used the inclusive LCA for our primary analyses. 
A three-step approach was used as additional analyses and is further expanded on below.
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Table 7 Approaches for latent class analysis with covariates for aim 2 analysis  
Approach Citation Overview Positives Negatives 
Inclusive LCA (211) 
An LCA is run with just the indicators 
to determine class numbers and 
profiles. Then classes are re-ran with 
a covariate(s) and posterior 
probabilities are calculated (either 
through pseudo random sampling of 
maximum likelihood) and used in 
multinomial regression 
Does not attenuate effect estimates 
due to omission of classification 
error, does not attenuate effect 
estimates due to not incorporating 
covariate into the LCA model, 
accounts for the fact that latent 
classes are a case of missing data 
May be impractical 
with large number of 
covariates, may 
slightly affect class 
makeup 
Three-step  (212) 
LCA is run to create classes and 
classification errors are saved in a 
matrix, observations are assigned to 
classes based on posterior 
probabilities (either through pseudo 
random sampling of maximum 
likelihood). Then, in a separate 
multinomial model covariates are 
regressed on the classes while using 
the covariance matrix to weight for 
classification error 
Classes remain the same 
independent of the covariates, 
easier model to fit, effects are not 
attenuated due to lack of 
classification error, more in line with 
how models are built 
Effects are still 
attenuated due to 
missing data theory 
that a variable in the 
imputation model 
should be in the 
analytic model 
Classify-
analyze (213) 
An LCA is run and observations are 
assigned to classes (whether 
through highest probability, pseudo-
random sampling, maximum 
likelihood). This classification is 
deterministic and does not allow for 
classification error. Analyses are run 
outside of the LCA framework and 
classes are treated like any other 
categorical variable 
Can be run outside of the LCA 
framework (do not need Mplus or 
other software), classes will always 
be the same, if LCA has high 
enough entropy, classification error 
will be minimal 
Attenuates effect 
estimates due to lack 
of classification error. 
Does not account for 
any differences in 
class if covariate 
variables are missing.  
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 As mentioned earlier, we had missing data on parental BAP for 183 children. In order to 
use data on all cases and ensure that our classes were appropriate, we included an indicator for 
missing SRS-As. Past work has shown that using an indicator is less biased than restricting the 
sample (214). Using an indicator for missingness allows us to model both our observed data 
and missing data mechanism within the latent class framework (214). Further, if we believe that 
the classes represent an underlying structure in our data, the classes derived from the total 
SEED case sample would be the ‘right’ answer. In the absence of confounding, a complete case 
analysis that restricts to those with BAP measured makes the same assumption that an 
indicator for missingness does; those who are missing look like those who are not. It is well 
known that a missing indicator is biased in epidemiological analyses because it removes the 
effects covariates have on one another, which prevents adequate control of confounding (215, 
216). However, in our analysis, we have no confounders and our exposure variables (whether 
dichotomous BAP or BAP by parent type) are independent. We believe that the cost of the extra 
missing parameter is made up for the ability to use data on all cases and used this approach in 
our primary analysis. For our third aim, we found no association between child sex and 
missingness, holding our assumption of no association between covariates and missingness. As 
sensitivity analyses, we used the complete case and weighting approaches. Strengths and 
weaknesses of these methods are described in Table 8.  
 We additionally explored inverse probability weights for missingness. These weights are 
calculated by using a logistic regression model to calculate probability of having complete BAP 
data. We used maternal race, age, ethnicity, and education as our covariates. If a child was not 
missing BAP data on parents, then their weight was 1/(probability of not missing) and 1/(1-
probaiblity of not missing) if the data were missing. Analyses were weighted using these values 
and correct standard errors were calculated using a sandwich estimator.  
 After accounting for this missingness, we calculated odds ratios using multinomial 
logistic regression using an inclusive LCA where the additional covariates help improve the 
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posterior probability of class membership (211). Our aim 2.1 analysis ran the LCA with BAP 
dichotomized as any one parent having BAP or neither parent having BAP as an added 
covariate with a missing indicator. For aim 2.2, we split our BAP classification by parent type 
(neither parent has BAP, father has BAP only, mother has BAP only, both have BAP) with an 
indicator for missingness. Lastly, we added child sex and a child sex by BAP interaction term to 
our aim 2.1 model to assess differences by child sex. Data cleaning and weight calculations 
were conducted in SAS 9.3 (217). Latent class creation and multinomial logistic regression were 
done in Mplus 7 (218).
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Table 8 Approaches for missing covariate data in latent class analysis for Aim 2 
Approach Description Positive  Negatives 
Indicator for missing 
SRS-As 
When using an inclusive LCA approach, a 
covariate with missing data will cause 
creation of classes that do not mirror the 
underlying structure in the total data. This 
approach adds a missing indicator for the 
covariate (basically creating a categorical 
variable) and then is used in the model 
(214)  
Allows use of all data, 
unbiased if there are no other 
covariates in the model: same 
assumptions as a complete 
case approach if no other 
confounders, can observe 
class pattern by missingness, 
easy to model 
Biased if multiple covariates 
because it does not 
adequately account for 
correlation between 
covariates. Assumes missing 
completely at random 
Complete case 
Restrict our sample to just those with 
complete data on the covariate, then 
create classes and run multinomial 
analysis on this sample 
Can handle multiple 
confounders without bias. 
Unbiased if missing completely 
at random 
Biased if not MCAR, does 
not use all available data 
and classes may not 
represent true underlying 
latent class 
Inverse probability of 
missingness weights 
Run logistic model to predict missingness, 
and then create inverse probability 
weights. Run the LCA model weighted for 
missingness. Past work has looked at 
survey sampling weights and LCA: we 
believe that using those techniques for 
missing data is a natural extension (219, 
220). 
Adequately controls for 
selection bias, can use 
multiple covariates in the 
model 
Does not use available data 
from those missing data to 
create classes  
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Additional analyses  
 As additionally analyses, we used the three-step approach and compared our estimates 
to the inclusive approach. We did this using two approaches for missing covariate data (missing 
indicator, inverse probability of missing weights). 
 The three-step approach starts with running the LCA as described by Wiggins et al. 
(under review). We then assigned classes based on posterior probabilities and ran our 
multinomial regressions weighting for classification error. Missingness was accounted for using 
our approaches detailed above (Table 8).  
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CHAPTER 4. RESULTS 
4A. Mothers with the broader autism phenotype may be more likely to be discordant with 
clinician observation when reporting on child autism spectrum disorder 
 
Overview 
 Diagnosis of autism spectrum disorder (ASD) relies on parent-reported and clinician-
observed instruments. At times results between these instruments are discordant. The broader 
autism phenotype (BAP) in a parent-reporter may be associated with discordance. We used 
data from the Study to Explore Early Development (N=712) to address whether BAP+ mothers 
of children with ASD or DD were more likely than BAP- mothers to ‘over-‘ or ‘under-report’ child 
ASD on ASD screeners or interviews compared with clinician observation or overall impression. 
Maternal BAP was associated with a child meeting thresholds on a maternal-reported screener 
or maternal-interview when clinician ASD instruments or impressions did not (risk ratios from 
1.30 to 2.85). Reporting discordances should be acknowledged and accounted for when 
diagnosing ASD. 
 
Introduction  
 The diagnostic criteria for autism spectrum disorder (ASD) are impairment in social 
communication and interaction and restricted and repetitive behaviors and interests (RRBI) (1). 
When diagnosing young children, the ASD diagnostic evaluation process relies on a caregiver 
(usually a parent) reporting on child behavioral and developmental traits as well as on a clinician 
observing the child’s social abilities and behavior. Generally, one or more clinicians synthesize 
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all available information to reach a diagnosis based on the Diagnostic and Statistical Manual 5th 
edition criteria for ASD (1, 10).  
ASD evaluation instruments, whether clinician observation or parent-report, have 
strengths and limitations. Clinicians are often experts in ASD evaluation and can compare a 
child to typically developing children or children with ASD. However, there is only a brief time to 
observe a child during an evaluation, they can only assess current behaviors at a single point in 
time, and they may be constrained by a clinical setting (e.g. cannot observe daily living skills, 
interacting with peers) (69, 91, 221). Parents (or other caregivers) are usually the most aware of 
the child’s development, health status, and current behaviors. Parents are often advocates and 
experienced reporters on the child’s health conditions (222, 223). But, ASD interview 
instruments based on parent report also have potential shortcomings. The order in which 
questions are asked can affect response (72) and responses about the child’s developmental 
history might be influenced by current child behavior, developmental level, and demographic 
characteristics (73). Informant language ability may also affect response, particularly for non-
native English speakers (10, 74). Using parent interviews in combination with clinician 
observation enables collection of a wider range of information while minimizing potential error of 
relying on only one clinical observation of child ASD or only on parental report (63, 64, 197, 224, 
225). Sometimes these two approaches produce discordant information. Past studies found 
discordance to be associated with a child’s age (224, 226) and RRBI (63, 197, 226). 
Reporting discordance between parents and clinicians or parent and child self-report in 
other psychiatric disorders may provide background into potential reasons for discordance 
between interview and observation instruments when evaluating ASD. Mothers with a 
psychiatric condition like depression (12, 13, 15, 75-80), anxiety (14, 15, 81, 82), ADHD (13) or 
high stress (83) were more likely to report traits of that condition in their child as compared to a 
clinician observation or child interview (75, 76). These traits may be reported more frequently 
because mothers with psychiatric conditions could view other’s behavior more negatively (84), 
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or, children of parents with psychiatric conditions have traits of that psychiatric condition and the 
parent is more finely attuned when reporting (75, 85). Learning more about reporting 
discordance in these other disorders has provided insight into child psychosocial adjustment 
(86), family dynamics (87), and intervention efficacy (88-90). 
Similarly, the presence of broader autism phenotype (BAP) among mothers may be a 
source of differential reporting. BAP is a sub-clinical collection of quantitative autism traits seen 
in families of children with ASD (17, 23, 24, 128, 138, 141, 144, 156, 163-166, 227). Traits of 
BAP most often include difficulties with pragmatic language, reciprocal social interaction, and 
social cognition, as well as behavioral and cognitive rigidity (16). Studies have shown that 
individuals with BAP may also have more problems with anxiety, articulation, empathy, 
language development, and social initiation and response, compared to people without BAP 
(16, 117, 128, 187). These socio-communicative traits may impact informant ability (188, 189). 
Additionally, maternal BAP is a predictor of increased parental stress (179, 190) and anxiety 
(191), which both may have an effect on an informant’s ability (95). Research is needed to 
examine if autism-like traits in a mother are a factor in discordance between child ASD 
evaluation instruments. 
Our objective was to evaluate whether maternal BAP is associated with discordance 
between a child being at risk for ASD on a maternal-reported screening instrument or meeting 
ASD criteria on an interview instrument as compared to a clinician observation instrument or a 
measure of clinician overall certainty that the child has ASD (‘best estimate’). We evaluated this 
discordance by examining whether the maternal report was more or less likely to meet these 
criteria than clinician observation or ‘best estimate’. Additionally, we evaluated each of five BAP-
related domains (social awareness, social motivation, social communication, social cognition, 
and autistic mannerisms) to see whether a particular area of BAP traits influence discordance. 
Lastly, we explored whether discordance is associated with maternal self-reported history of a 
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diagnosis of depression or anxiety disorders to better understand whether discordance is 
specific to BAP or to overall maternal psychiatric conditions more generally.  
Methods 
Study to Explore Early Development 
 
We used data collected in the first phase of the Study to Explore Early Development 
(SEED). SEED is a multi-site, community sampled, case-control study with the purpose of 
characterizing the autism behavioral phenotype and associated behavioral, medical, and 
developmental conditions and investigating genetic and environmental risk factors for ASD 
(196). SEED included six sites: California, Colorado, Georgia, Maryland, North Carolina, and 
Pennsylvania. Data on children born between 2003 and 2006 were collected between 2007 and 
2012. Eligible children were between 30 and 68 months at the time of developmental 
assessment, were born and resided in the study catchment area at the time of first study 
contact, and lived with a knowledgeable caregiver who was able to communicate the child’s 
developmental history in English (or in Spanish in California and Colorado) (196).  
Three groups of children were sampled in SEED. The first two groups were children with 
a past diagnosis or other indication of ASD or a non-ASD developmental disability or delay 
(DD). These children were identified from multiple education and health providers in the study 
areas that diagnose and serve children with a broad range of DDs including health clinics, early 
intervention programs, and special education programs. The third group of children was from 
the general population. They were randomly sampled from birth records at each study site. 
Identified families were sent a written invitation to participate and a follow-up invitation 
telephone call was conducted.  
ASD evaluation  
During the preliminary phone call with SEED staff, children's caregivers (99.0% 
biological mothers) completed the Social Communication Questionnaire (SCQ) (61), an autism 
screening instrument. The SCQ is comprised of 40 yes or no questions aimed at assessing a 
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child’s socio-communication ability. The recommended cut-off score that indicates ASD risk is 
15 points. Previous research suggests that a cut-off score of 11 points maximizes sensitivity and 
specificity in young children. Because of the young age of included children (3 to 5 years of 
age), a cut-off of ≥11 was used to define a positive autism screen in order to maximize case 
finding (228).  
After completing the SCQ, all children had a developmental assessment that included 
the Mullen Scales of Early Learning (MSEL). Children with a past diagnosis of ASD or a positive 
score on the SCQ received a full diagnostic evaluation. DD and POP children who scored 
negative on the SCQ were given a full evaluation if a clinician suspected ASD during the 
developmental assessment. Primary diagnostic instruments used were the Autism Diagnostic 
Observation Schedule (ADOS) and the Autism Diagnostic Interview-Revised (ADI-R) (10).  
Clinicians conducted the ADI-R (67) with the child’s caregiver during an in person visit. 
The ADI-R is a 93-item, 150-minute semi-structured interview that obtains comprehensive 
information from the caregiver in three domains of child development: social skills, 
communication skills, and RRBI. The ADI-R also obtains information on whether developmental 
delays or deficits were noted in the first three years of life (67, 199). SEED used the standard 
ADI-R algorithm to determine whether the child met ADI-R criteria for ASD. Inter-site reliability 
was 99% and intra-site reliability was 87% for the ADI-R (197).  
SEED used the ADOS (198) as the clinician observation instrument. During the ADOS, 
clinicians interact with and observe a child for over 40 minutes while creating social 
opportunities that elicit social communication and social interaction that allows the clinician to 
record RRBI. The ADOS has specific modules based on age and verbal ability (69); SEED used 
module 1 for children with no or few words and no phrase speech, module 2 for children with 
phrase speech who were not verbally fluent, and module 3 for verbally fluent children (197). 
Standard ADOS algorithms were used for each module to determine ASD classification. Inter-
site reliability was 99% and intra-site reliability was 99% (197).  
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The Ohio State University Autism Rating Scale (OARS) served as the global clinical 
judgment instrument. The OARS is a tool filled out by the clinician that uses all available 
information to measure symptom severity, degree of impairment, and clinician certainty in child’s 
ASD diagnosis (200). This tool was specifically modified to a five point Likert scale for SEED. 
We dichotomized this scale into ‘‘uncertain’’ (scores of 1–3 or note that ASD symptoms better 
accounted for by another disorder) and ‘‘certain’’ (scores of 4 or 5) (196, 197). For this study, a 
score of 4 or 5 indicated a case and the OARS served as our ‘best estimate’ of clinician 
certainty of ASD. Additionally, since it incorporates all available information and is similar to how 
diagnosis is derived in a clinical setting, the OARS acted as a diagnostic ‘gold standard’ in our 
analyses. Details of these instruments are presented in       Table 9. Further information on 
SEED procedure can be found in Schendel et al. (196) and Wiggins et al. (197).  
BAP instrument 
BAP was assessed using the Social Responsiveness Scale-Adult (SRS-A) (60). 
Although not originally designed to measure BAP, the SRS-A has shown good consistency with 
other BAP and qualitative autism trait instruments (122, 149). The SRS-A is a 65-item Likert 
scale questionnaire that takes 15-20 minutes to complete and assesses the caregiver’s social 
and communication traits. In SEED, the caregiver was asked to have a spouse (or friend or 
relative if no spouse) to complete the SRS-A on them, as recommended for this instrument. A 
strength of the SRS-A is its ability to measure five distinct domains of social responsiveness: 
social awareness, social cognition, social communication, social motivation, and autistic 
mannerisms (60). The SRS-A has strong internal validity, exhibiting a Cronbach’s alpha internal 
consistency coefficient of 0.95 (122, 123). SRS scores in children have been shown to be 
independent of IQ and age (60, 201) and psychometric properties are assumed to be the same 
in adults (122). Raw overall and domain SRS-A scores were standardized to T-scores, which 
have a mean of 50 and a standard deviation of 10. For this study we used the standard ‘mild 
range’ recommendation of ≥60 (59) to indicate BAP. We will refer to scores that meet or exceed 
  
72
this threshold as BAP positive (BAP+) and those that do not as BAP negative (BAP-). The 
domain scores use the same T score standardization but include only specific questions that fit 
the domain.  
Discordance 
We created variables to indicate discordance between the maternal screener (SCQ) or 
maternal interview (ADI-R) and the clinician observation (ADOS) or clinician ‘best estimate’ 
(OARS) using the SEED cut-off scores. Our four comparisons were the SCQ versus ADOS, 
SCQ versus OARS, ADI-R versus ADOS, and ADI-R versus OARS. If the two instruments were 
in agreement (both indicated ASD or ASD risk or both indicated no ASD or ASD risk) then they 
were considered ‘not discordant’. Since the ASD evaluation is a complex process that takes 
place over a limited amount of time, we do not want to imply that a mother’s report or clinician 
observation on child ASD is the ‘correct one’; however, since we are more concerned about 
influence of maternal characteristics on reporting, we use the clinician completed instruments as 
our reference group when presenting our results. Therefore, we define ‘over-reporting’ as the 
maternal report meeting the instrument’s threshold when the clinician did not and ‘under-
reporting’ when the maternal report did not meet the threshold while the clinician did.  
Study Sample 
For this study, we included all children in SEED identified from educational or medical 
providers that serve children with DDs (N=2,541), then excluded siblings (which would violate 
independence) (N=61); children without a completed Social Communication Questionnaire 
(SCQ) (N=26), ASD evaluation (N=1424) or maternal SRS-A (N=167); and children whose 
mother did not act as the sole informant on the ADI-R or SCQ (N=151). Our final analytic 
sample was 712 mother-child dyads. 
 Although some children with history of DD did not receive the full evaluation, we elected 
to include those who did in our sample. We chose to include these children because if a child 
screened negative on the SCQ and a clinician had suspicion of ASD at the clinic visit, the child 
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still received the full ASD evaluation (N=51). Additionally, DD is a broad category and many 
children with DD did not present any ASD symptoms (205). Our study is not designed to assess 
discordance among children without ASD symptoms.  
Analytic approach 
Demographic information and maternal-reported psychiatric history were collected in 
SEED using a maternal interview, self-completed questionnaires, and data abstraction from 
child’s birth and medical records. Maternal psychiatric history was collected using the maternal 
medical history form where a mother checked whether she had past physician diagnosis of 
certain conditions. We calculated means and percentages for these demographic characteristics 
by BAP status and by ADOS vs. ADI-R discordance as a representative outcome. 
We used log-binomial models to estimate percent discordance and evaluated whether 
discordance (‘over-reporting’ or ‘under-reporting’ compared to not discordant) differed by 
maternal BAP status (BAP+ or BAP-) using α=0.05 to indicate statistically significant 
differences. A model was run for ‘over-reporting’ which excluded those who ‘under-reported’ and 
a model was run for ‘under-reporting’ which excluded those who ‘over-reported’. 
Since 163 mothers were missing SRS-A (18.6% of mothers who met other eligibility 
criteria), we ran a sensitivity analysis to examine potential selection bias. We predicted missing 
SRS-A based on demographic variables then used individual probabilities to calculate inverse 
probability weights. We reran our analysis using these inverse probability weights to evaluate 
the impact of this missingness.  
Based on BAP being a well-validated construct that is not affected by demographics like 
age or education (24) and the SRS-A being designed to be independent of age and IQ (123), 
we do not believe that there are confounders for which to adjust in our main analyses. However, 
It is possible that language difficulties affected both completion of the SRS-A and the SCQ or 
ADI-R. We ran sensitivity analyses to evaluate how our estimates would change if we excluded 
those who indicated that their preferred language was Spanish (n=47).  
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For our secondary objectives, we ran models with all five SRS-A domains in one model 
rather than total BAP score to evaluate associations in each domain. Domains were 
dichotomized using a T score ≥60 as our cut-point. We include all domains in the same model to 
evaluate a single domain controlling for the others. To explore whether maternal self-reported 
history of a diagnosis of depression or an anxiety disorder (referred to as depression diagnosis 
or anxiety diagnosis) has an association with discordance, we ran models with these measures 
of depression diagnosis or anxiety diagnosis as an independent variable instead of BAP status. 
Being that this analysis is more exploratory in nature and the literature is limited on whether 
BAP confounds the relationship between depression or anxiety and reporting on ASD 
measures, we elected to calculate effect estimates that were not conditional on maternal BAP 
status. Further, there was negligible correlation in our data between maternal BAP and 
depression diagnosis (Φ=0.07), or with anxiety disorder diagnosis (Φ=0.03), supporting our 
decision not to control for maternal BAP. We qualitatively examined whether effect estimates 
differed from the BAP estimates. 
Results 
 In our analytic sample of 712 mother-child dyads that met all entry criteria, 67 mothers 
(9.4%) were BAP+ and 645 were BAP- (91.6%). Table 10presents demographic variables by 
overall BAP status and discordance status (using ADI-R vs. ADOS as a representative 
discordancy outcome). BAP+ mothers were 40.3% black, 23.9% Hispanic, and 19.4% had ≥16 
years of education. BAP- mothers were 19.8% black, 14.8% Hispanic, and 51.0% had ≥ 16 
years of education. Mothers who ‘over-reported’ were 68.6% white and 22.9% had <12 years of 
education. Mothers with no discordance were 60.9% white and 7.1% had <12 years education. 
 In our total sample, 624 children met the threshold for ASD risk on the SCQ (87.7%), 
456 met ADI-R criteria for ASD (64.0%), 544 met ADOS criteria (76.4%), and 466 had a 
clinician best estimate of ASD based on the OARS (65.4%). Table 11 presents counts and 
estimated discordances percentages between maternal report instruments and clinician 
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instruments stratified by BAP status. Discordance was common in our sample, as our 
comparison with the least discordance (ADI-R vs. ADOS in BAP- mothers) was 78.1% 
concordant. Most common discordance was ‘over-reporting’ between the SCQ and ADOS or 
SCQ and OARS in BAP+ mothers (32.8% and 40.3% respectively). Qualitatively, ‘over-
reporting’ was less common when the ADI-R was the maternal measure compared to the SCQ. 
Phi coefficients for correlation between discordance outcomes were moderate to low (ranging 
from φ =0.60 to φ =0.09). 
 Figure 1 graphically presents risk ratios for discordance comparing BAP+ mothers to 
BAP– mothers. Being BAP+ was significantly associated with ‘over-reporting’ compared to no 
discordance when comparing the SCQ to the ADOS (RR: 1.63, 95% CI: 1.12, 2.37), and the 
ADI-R to the ADOS (RR: 2.85, 95% CI: 1.35, 6.03) [Figure 1]. The effect estimate for the SCQ 
versus the OARS (RR 1.26, 95%CI: 0.95, 1.77) and ADI-R compared to the OARS (RR: 1.65, 
95% CI: 0.97, 2.81) were similarly elevated, but did not reach statistical significance. There were 
no significant differences when assessing ‘under-reporting’, but the effect estimates suggest 
less ‘under-reporting’ by BAP+ mothers when reporting on the SCQ (ADOS RR: 0.57, 95% CI: 
0.21, 1.50; OARS RR: 0.51, 95% CI: 0.16, 1.57).  
 We ran a series of sensitivity analyses for our overall estimates. Weighting to control for 
potential bias due to missing SRS-As showed minimal differences compared to un-weighted 
estimates (Table 12); therefore, we present un-weighted estimates. Excluding mothers whose 
preferred language was Spanish attenuated effect estimates for ‘over-reporting’ and slightly 
increased our effects for ‘under-reporting.’ Although there were some differences, restricting to 
English speakers did not change our interpretation of overall results so we present our full 
sample estimates (Table 13). Using a SCQ cut-off of 15 (instead of 11) increased our effect 
estimates for ‘over-reporting’ for comparisons between the SCQ and the ADOS and the SCQ 
and the ADI-R by approximately 10% (results not presented). Lastly, we restricted to just those 
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with a prior diagnosis of ASD. Effects were not meaningfully different, except confidence 
intervals were wider due to the restricted sample (results not presented). 
 We also evaluated the association between the five SRS-A domains and discordance. 
Of all mothers in our sample, 7.0% of mothers had a T score ≥60 in the social awareness 
domain, 13.8% in the social cognition domain, 9.3% in the social communication domain, 13.9% 
in the autistic mannerism domain, and 10.5% in the social motivation domain. Table 14 presents 
results for ‘over-reporting’ by SRS-A domain. Social cognition (RR: 1.94, 95% CI: 1.06, 3.55) 
and social awareness (RR: 2.1, 95% CI: 1.15, 3.82) were significantly associated with ‘over-
reporting’ on the ADI-R compared to the OARS. No other comparisons, including for ‘under-
reporting’ (not shown) met statistical significance.  
 In our sample, 36.5% of BAP+ mothers reported ever having a past diagnosis of 
depression whereas BAP- mothers reported 24.8%. Nevertheless, depression diagnosis was 
not associated with either ‘over-reporting’ or ‘under-reporting’ (Table 15). For anxiety disorders, 
17.7% of BAP+ mothers and 13.2% of BAP- mothers reported past diagnosis. Risk of ‘over-
reporting’ between the ADOS and the ADI-R by anxiety disorder diagnosis was elevated, but did 
not meet statistical significance (RR: 1,97, 95% CI: 0.92, 4.20). Compared to those without 
anxiety disorder diagnosis, those that did also had non-significant elevated risk of ‘over-
reporting’ on the SCQ compared to the ADOS (RR: 1.35, 95% CI: 0.95, 1.92) and to the OARS 
(RR: 1.27, 95% CI: 0.96, 1.77). 
Discussion 
 In a sample of children with past diagnosis of ASD or other non-ASD DDs, We found 
that discordance between maternal report instruments (a screening questionnaire or diagnostic 
interview) and clinician observation or clinician ‘best estimate’ of ASD was prevalent in our 
sample. For our purposes, we used clinician observation as our referent category and used 
‘over-reporting’ or ‘under-reporting’ as a way to characterize how maternal reporting relates to 
observations and opinions of clinicians.  
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 Mothers with BAP were significantly more likely than mothers without to ‘over-report’ on 
the SCQ versus both the ADOS and the OARS, and on the ADI-R versus the ADOS. These 
results are in agreement with literature for other psychiatric disorders that show that a mother 
with a psychiatric condition may report more characteristics of the condition in her child than 
child self-report or clinician observation (13, 75, 76, 80, 96). Qualitatively, effect estimates for 
‘over-reporting’ were slightly higher when using the ADI-R compared to the SCQ. This may be a 
result of the instruments delivery in SEED (in-person vs. telephone), length (150 minutes vs. 15-
20 minutes), or purpose (diagnostic interview vs. screening instrument). 
We found that BAP+ mothers were less likely than BAP- mothers to ‘under-report’ when 
reporting on the SCQ (compared to ADOS or OARS), but effect estimates were not statistically 
significant. ‘Under-reporting’ could be less likely because of the nature of the SCQ as a 
screening instrument, which we chose to have high sensitivity at the expense of specificity, and 
our exclusion of children with DD who scored negative and did not have ASD characteristics. 
Ultimately, we do not believe this sampling is differential by BAP status. When comparing the 
ADI-R to the ADOS or OARS, effect estimates for ‘under-reporting’ were near 1.0. This 
difference in point estimate for ‘under-reporting’ effects may be a function of the instruments 
purpose and administration in conjunction with BAP status. Based on BAP traits like aloofness, 
it could be postulated that a person with BAP would be more likely to ‘under-report’ another’s 
ASD symptoms because of differences in social understanding; however, our results did not 
support this belief.  
Although we found significant ‘over-reporting’ on the SCQ compared to both the ADOS 
and the OARS in BAP+ vs. BAP- mothers, none of the specific SRS-A domains were 
significantly associated with such ‘over-reporting’ after controlling for the other domains. It is 
possible that the overall construct identified by total SRS-A score is more important than any 
individual domain (which is made up from specific questions of the larger SRS-A) when 
assessing discordance on the SCQ. Our sample size may have limited our ability to precisely 
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estimate effects by domain. The autistic mannerisms domain was significantly associated with 
‘over-reporting’ on the ADI-R versus the ADOS and the social cognition domain was associated 
with ‘over-reporting’ on the ADI-R versus the OARS. It is possible that effects of traits that 
comprise those two domains are more pronounced in the longer, more intensive ADI-R 
interview process, but confidence intervals were wide. Further work should examine whether 
specific BAP traits in those domains, or domains from other BAP instruments, are associated 
with discordance.  
Even though mothers with depression may ‘over-report’ child depression 
symptomatology (13, 15, 85) and maternal depression is associated with BAP (133), we found 
no effect of maternal depression diagnosis on discordance between the instruments we 
evaluated. Our findings are restricted to those who reported a past diagnosis of depression, 
which may not capture the full extent of maternal depression; it may be of future interest to 
examine associations with dysphoria or trait based depression since depressive traits could 
mediate the relationship between BAP and discordance. As for maternal anxiety disorder 
diagnosis, we saw patterns suggesting ‘over-reporting’ when using the ADI-R compared to the 
ADOS or the OARS. It is possible that the ADI-R facilitates state anxiety in those with a reported 
history of an anxiety disorder diagnosis due to the in-depth nature of questioning and time 
required to complete the interview. It is also possible that trait anxiety (which we do not have 
measured) is exacerbated during the ADI-R and this effects reporting of ASD symptoms in the 
child. Future research should evaluate this question and associations with BAP using trait based 
anxiety measures.  
In the context of our results it should be noted that our sample was comprised primarily 
of children with past history of DD or ASD. Once concern is raised about a child’s development, 
a mother may be more likely to push for a diagnosis and report in such a way to receive 
maximum services, running counter to ‘under-reporting’ child traits (229, 230). It may be of 
future interest to evaluate discordance among mothers of children with ASD symptoms who 
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have never been through the ASD evaluation process to evaluate these patterns without the 
mother’s past experience. 
Potential causes of these BAP-related discordances in reporting ASD characteristics 
should also be examined in future work. We can hypothesize that the ‘over-reporting’ we see 
could be due to social desirability (231, 232), where mothers with BAP who know that their child 
has a history of DD may be more susceptible to giving answers that they think the clinician 
wants. Certain social traits like agreeableness and self-esteem are associated with more 
socially desirable responding (233). As yet, no empirical studies have evaluated the association 
between BAP and social desirability bias. We examined self-reported past history of diagnosis 
of psychiatric conditions, but state based emotional traits that are associated with BAP may play 
a role in how a mother completes an instrument. Further, mothers may notice or be less tolerant 
of traits they themselves have and this could lead to ‘over-reporting’ as has been seen when 
studying depression (84). Alternatively, this ‘over-reporting’ may be due to mothers with BAP 
having children who have a different ASD presentation that is more difficult to assess in the 
limited clinical observation setting. It is possible that mothers with BAP within SEED have 
children with different ASD profiles compared to children of mothers without BAP, which may be 
difficult to identify in the limited clinical observation setting. This question will be evaluated in 
future work. Along with different phenotypes, it is also possible that a mother with BAP is more 
finely attuned to the child’s presentation, being that they may have experienced similar socio-
communication difficulties, and are able to report on the finer details that a clinician does not 
have the time or opportunity to see or recognize.  
This study has some limitations. Our sample is restricted to children who were identified 
through ASD and DD education and health providers, which prevents us from making 
inferences about the larger SEED sample or the general population. Additionally, the SEED 
sample is more educated and less Hispanic than the general population, which limits our 
generalizability. In our study, mothers who are BAP+ versus BAP- differ in demographic 
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variables like education and age. However, based on our causal framework, which posits that 
BAP is independent of demographics like education and maternal age, we do not suspect 
confounding. Covariate differences may be because our effects are mediated through 
education, past child ASD diagnosis, or maternal age. When examining effects of culture, 
specifically language difference, our sensitivity analysis showed slight attenuation of effects 
when restricting to mothers whose preferred language was English. Next steps may be to 
examine cultural difference, measured as ethnicity or race, as an effect measure modifier of the 
BAP discordance relationship. Further, it is likely that the same clinician completed all 
instruments and this may lead to excessive correlation. Nevertheless, SEED’s thorough 
evaluation procedure and strong inter- and intra-rater reliability minimize this potential bias. We 
were missing data on the identity of the informant for the SRS-A for 18.8% of mothers. Mothers 
were asked to have a spouse or friend complete the SRS-A on her, but the relationship to the 
mother was often left blank on the form. If the SRS-A were completed through self-report, it 
could create misclassification. A past study has shown differential BAP scores between a self- 
and informant report using another BAP instrument (180). We ran sensitivity analyses defining 
BAP using various SRS-A T-score cutoffs and results did not show meaningful differences in 
risk of discordance between T scores of 58 and 62 (data not shown). We believe that are results 
are robust to minor misclassification in the SRS-A, but it would have been informative to know 
the effect of informant type on the SRS-A scores.  
This study also has major strengths and can inform future research and the ASD 
diagnostic processes. Our study sample was derived from multiple sites and from various types 
of education and health providers, not solely clinic-derived. Having a broader population 
sampling scheme allows for more diversity in included ASD phenotype and family 
demographics. Additionally, we have data on full diagnostic evaluations with data reported by 
informants and clinicians, regardless of screener score. This allows us to assess properties of 
the screener without risk of bias from evaluating only those who score positive. Moreover, data 
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were used on four separate instruments with different uses (screeners, interviews, observation, 
best estimate), allowing for us to assess discordance between instruments with different goals 
and methods. We believe that this is one of the first studies to assess BAP as a source of 
discordance between ASD evaluation instruments.  
Our study found that mothers with BAP were more likely to ‘over-report’ and indicate that 
a child meets an instruments criteria for ASD when a clinician does not meet those conclusions. 
This result was not seen when assessing maternal depression diagnosis and was evident only 
when comparing the ADI-R and the ADOS for maternal anxiety disorder diagnosis. Future work 
should address whether the phenotypic profile of children with ASD whose parents have BAP 
differs from that of children with ASD whose parents do not have BAP, which may explain some 
of this observed discordance. Additionally, much is still unknown on how people with BAP report 
on others, regardless of whether they are reporting on ASD; more work can be done to explore 
how people with BAP act as informants. Based on our results, clinicians may need to be 
cognizant of maternal socio-communicative ability when synthesizing available information and 
accounting for instrument discordance when deciding on a final diagnosis for child ASD. 
.
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      Table 9 Description of measures used to evaluate child autism spectrum disorder in the Study to Explore Early    
Development  
Instrument Instrument Type Respondent  Length Description 
Social Communication 
Questionnaire (SCQ) 
Screening 
questionnaire Mother  
40 yes or no questions 
that take approximately 
15 minutes to complete 
SEED staff administered 
the questionnaire about a 
child’s behavior and 
development over the 
phone during study 
enrollment call 
Autism Diagnostic 
Interview-Revised (ADI-
R) 
Interview Mother 
93 items that take 
approximately 150 
minutes to complete 
 
Structured interview about 
child’s past and current 
behavior and development 
that is led by a SEED 
clinician either at the 
mother’s home, SEED 
clinic, or over the phone 
 
Autism Diagnostic 
Observation Schedule 
 
Observation Clinician 40 minute observation and interaction period 
 
SEED clinician interacts 
and observes the child at 
the child’s home or SEED 
clinic. Different modules are 
administered based on 
child’s age and verbal 
language ability 
The Ohio State 
University Autism Rating 
Scale (OARS) 
Synthesis of 
available data Clinician 
Clinician completed 
Likert scale of certainty 
that the child has ASD, 
completed after all other 
data are collected 
 
SEED clinician or team of 
clinicians used all available 
data, specifically from the 
ADI-R and ADOS to give 
best clinical impression of 
whether the child has ASD 
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Table 10. Distribution of socio-demographic characteristics for families referred into the Study to Explore Early 
Development, by maternal broader autism phenotype status and ADI-R-ADOS discordance 
   
    BAP+ BAP-  Not discordant ‘Over-reporting’ ‘Under-reporting’ 
    N=67 N=645  N=553 N=35 N=124 
  N % N % 
 N % N % N % 
Child Case 
status         
             
  ASD 40 59.7 439 68.1  410 74.1 0 0.0 69 55.7 
  DD  25 37.3 174 27.0  122 22.1 29 83.9 48 38.7 
  Possible Case 2 3.0 32 5.0  21 3.8 6 17.1 7 5.7 
Child Sex                      
  Male 51 76.1 514 79.7  442 79.9 28 80.0 95 76.6 
  Female 16 23.9 131 20.3  111 20.1 7 20.0 29 23.4 
Maternal race                      
  White 33 49.3 462 62.3  385 60.9 24 68.6 75 60.5 
  Black 27 40.3 147 19.8  139 22.0 5 14.3 25 20.2 
  Asian 3 4.5 51 6.9  43 6.8 1 2.9 9 7.3 
  Other 3 4.5 46 6.2  39 6.2 3 8.6 8 6.5 
  Multi-racial 1 1.5 35 4.7  26 4.1 2 5.7 7 5.6 
Maternal 
ethnicity         
             
  Hispanic 16 23.9 95 14.8  86 17.4 8 22.9 17 13.7 
  Not-Hispanic 51 76.1 549 85.3  466 84.4 27 77.1 107 86.3 
  Missing     1    1           
Maternal education (years)                   
  <12  13 19.4 42 6.5  39 7.1 8 22.9 8 6.5 
  12 to <16 41 61.2 274 42.5  252 45.6 16 45.7 47 37.9 
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  >=16  13 19.4 329 51.0  262 47.4 12 34.3 69 55.6 
Maternal self-reported history of 
depression diagnosis   
             
  Yes 23 36.5 158 24.8  147 27.1 8 23.5 26 21.8 
  No 40 63.5 479 75.2  400 73.7 26 76.5 93 78.2 
  Missing 4   8    6   1  5   Maternal self-reported history of an 
anxiety disorder diagnosis   
             
  Yes 11 17.7 84 13.2  70 12.9 8 21.6 17 14.2 
  No 51 82.3 551 86.8  473 87.1 26 70.3 103 85.8 
  Missing 5   10    10   1   4   
Site                      
  California 15 22.4 95 14.7  80 14.5 11 31.4 19 15.3 
  Colorado 9 13.4 132 20.5  116 21.0 5 14.3 20 16.1 
  Georgia 10 14.9 130 20.2  115 20.8 4 11.4 21 16.9 
  Maryland 11 16.4 81 12.6  80 14.5 5 14.3 7 5.6 
  North Carolina 8 11.9 135 20.9  97 17.5 8 22.9 38 30.6 
  Pennsylvania 14 20.9 72 11.2  65 11.8 2 5.7 19 15.3 
Child age                      
  Mean, SD 60.3 6.0 59.5 6.6  59.7 6.4 61.6 5 58.4 7.4 
  Missing     3    2   1       
Maternal age                      
  Mean, SD 34.1 6.4 36.1 5.7  35.9 5.8 33.8 6.1 36.3 5.7 
  Missing     1    1           
Number of children in household                 
  Mean, SD 2.5 1.3 2.2 1.0  2.3 1 2.4 1.37 2.3 1.0 
  Missing 2   8    8   1   1   
Past child ASD diagnosis                    
  Yes 37 55.2 458 71.2  407 73.9 16 45.7 72 58.1 
  No 30 44.8 185 28.8  144 26.1 19 54.3 52 41.9 
  Missing     2    2           
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ASD: autism spectrum disorder; 
DD: developmental disability; 
SRS-A: social responsiveness scale adult; 
SD standard deviation 
Sample: referred into SEED, had completed SRS-A, SCQ, and full evaluation 
Excludes siblings 
 
a Not discordant is when SCQ or ADI-R has the same result as the ADOS or OARS 
b ‘Over reporting’ is when the SCQ or ADI-R meets ASD criteria while ADOS or OARS does not 
c ‘Under reporting’ is when the SCQ or ADI-R does not meet ASD criteria while ADOS or OARS does 
d Possible Cases are children whose final case status could not be determined
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Table 11. Discordance between maternal and clinician ratings on child autism spectrum 
disorder screening and evaluation in children referred into the Study to Explore Early 
Development, by maternal broader autism phenotype status 
BAP+ 
N=67 
 BAP- 
N=645 
 
 
Discordance   N Percent 95% CI  N Percent 95% CI 
SCQ ADOS              
‘Over’ 22 32.8 23.3, 46.3  130 20.2 17.3, 46.3 
‘Under’ 4 6.0 2.3, 15.4  68 10.5 8.4, 13.2 
 None 41 61.2 50.6, 74.1  447 69.3 65.8, 73.0 
SCQ OARS 
 
       
‘Over’ 
‘Under’ 
 None 
27 40.3 26.3, 33.4  191 29.6 30.1, 53.9 
3 4.5 1.5, 13.5  57 8.8 6.9, 11.3 
37 55.2 44.5, 68.5  397 61.6 57.9, 65.4 
ADI-R ADOS 
 
       
‘Over’ 
‘Under’  
None 
8 11.9 6.2, 22.9  27 4.2 6.2, 22.9 
10 14.9 8.4, 26.4  114 17.7 15.0, 20.9 
49 73.1 63.2, 84.6  504 78.1 75.0, 81.4 
ADI-R OARS 
 
       
‘Over’ 
‘Under’ 
 None 
12 17.9 10.7, 29.9  69 10.7 8.6, 13.4 
8 11.9 6.2, 22.9  84 13.0 10.7, 15.9 
47 70.2 60.0, 82.0  492 76.3 73.1, 79.6 
 
 
CI: confidence interval; 
BAP: broader autism phenotype 
SCQ: Social Communication Questionnaire; 
ADI-R: Autism Diagnostic Interview Revised; 
ADOS: Autism Diagnostic Observation Schedule; 
OARS: The Ohio State University Autism Rating Scale; 
 
a Not discordant is when SCQ or ADI-R has the same result on meeting SEED thresholds for 
ASD or ASD risk as the ADOS or OARS 
b ‘Over-reporting’ is when the SCQ or ADI-R meets SEED ASD risk or ASD criteria while ADOS 
or OARS does not 
c ‘Under-reporting’ is when the SCQ or ADI-R does not meet SEED criteria for ASD risk or ASD 
criteria while ADOS or OARS doe
  
87
 
Figure 5. Risk ratios comparing discordance between maternal and clinician ratings on child autism spectrum disorder 
screening and evaluation instruments in children referred into the Study to Explore Early Development, by maternal 
broader autism phenotype status 
 
 
No BAP and Clinician observations / estimates are the referent category 
SCQ: Social Communication Questionnaire; 
ADI-R: Autism Diagnostic Interview-Revised; 
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ADOS: Autism Diagnostic Observation Schedule; 
OARS: The Ohio State University Autism Rating Scale; 
 
‘Over reporting’ is when the SCQ or ADI-R meets SEED ASD risk or ASD criteria while ADOS or OARS does not 
‘Under reporting’ is when the SCQ or ADI-R does not meet SEED ASD risk or ASD criteria while ADOS or OARS does 
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Table 12 Overall estimates comparing discordance between maternal and clinician ratings on child autism spectrum 
disorder screening and evaluation instruments in the Study to Explore Early Development, by maternal broader autism 
phenotype status, weighted to account for missing Social Responsiveness Scale-adult 
  SCQ ADI-R 
 ‘Over-reporting’ ‘Under-reporting’ ‘Over-reporting’ ‘Under-reporting’ 
  RR 95% CI RR  95% CI RR 95% CI RR  95% CI 
Weighted  
ADOS 1.49 1.02, 2.17 0.72 0.27, 1.91 2.58 1.20, 5.54 0.94 0.51, 1.72 
OARS 1.28 0.94, 1.75 0.63 0.20, 1.97 1.61 0.91, 2.82 1.00 0.50, 1.98 
Unweighted 
ADOS 1.55 1.07, 2.25 0.67 0.26, 1.76 2.85 1.35, 6.03 0.84 0.47, 1.53 
OARS 1.30 0.95, 1.77 0.6 0.20, 1.82 1.67 0.96, 2.92 0.92 0.46, 1.81 
Difference 
ADOS -4.0 6.9 -10.5 10.6 
OARS -1.6 4.8 -3.7 8.0 
 
RR Risk ratio 
CI Confidence interval 
ADI-R: Autism Diagnostic Interview-Revised 
ADOS: Autism Diagnostic Observation Schedule 
OARS: The Ohio State University Autism Rating Scale; 
a ‘Over reporting’ is when the SCQ or ADI-R meets SEED ASD risk or ASD criteria while ADOS or OARS does not 
b ‘Under reporting’ is when the SCQ or ADI-R does not meet SEED ASD risk or ASD criteria while ADOS or OARS does 
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Table 13. Overall estimates comparing discordance between maternal and clinician ratings on child autism 
spectrum disorder screening and evaluation instruments in the Study to Explore Early Development, by 
maternal broader autism phenotype status, evaluating excluding mothers with Spanish as a preferred language 
 
  SCQ ADI-R 
 ‘Over-reporting’ ‘Under-reporting’ ‘Over-reporting’ ‘Under-reporting’ 
  RR 95% CI RR  95% CI  RR 95% CI RR 95% CI 
English speakers only (n=665) 
ADOS 1.40 0.90, 2.18 0.70 0.27, 1.83 2.66 1.13, 6.22 0.94 0.51, 1.75 
OARS 1.14 0.79, 1.66 0.60 0.20, 1.82 1.39 0.74, 2.61 0.96 0.47, 1.97 
Full sample (N=712) 
ADOS 1.63 1.12, 2.37 0.57 0.21, 1.50 2.85 1.35, 6.03 0.84 0.47, 1.53 
OARS 1.3 0.95, 1.77 0.51 0.16, 1.57 1.67 0.96, 2.92 0.92 0.46, 1.81 
Percent difference 
ADOS -16.4 18.6 -7.1 10.6 
OARS -14.0 15.0 -20.1 4.2 
 
 
CI: Confidence interval; 
RR: Risk ratio; 
SCQ: Social Communication Questionnaire; 
ADI-R: Autism Diagnostic Interview-Revised 
ADOS: Autism Diagnostic Observation Schedule; 
OARS: The Ohio State University Autism Rating Scale 
 
a ‘Over-reporting’ is when the SCQ or ADI-R meets SEED ASD risk or ASD criteria while ADOS or OARS does not 
b ‘Under-reporting’ is when the SCQ or ADI-R does not meet SEED ASD risk or ASD criteria while ADOS or OARS does
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Table 14. Over-reporting’ discordance between maternal and clinician ratings on child 
autism spectrum disorder screening and evaluation instruments in the Study to Explore 
Early Development, by Social Responsiveness Scale-Adult domains 
 
  RR 95% CI 
SCQ ADOS 
Overall 1.63 1.12, 2.37 
Social awareness 0.65 0.36, 1.17 
Social cognition 1.09 0.67, 1.78 
Social communication 1.55 0.88, 2.73 
Autistic mannerisms 1.17 0.75, 1.82 
Social motivation 0.94 0.57, 1.54 
SCQ OARS 
Overall 1.30 0.95, 1.77 
Social awareness 1.23 0.80, 1.89 
Social cognition 1.28 0.88, 1.86 
Social communication 1.13 0.68, 1.88 
Autistic mannerisms 0.97 0.68, 1.40 
Social motivation 0.67 0.42, 1.07 
ADI-R ADOS 
Overall 2.85 1.35, 6.03 
Social awareness 1.33 0.40, 4.39 
Social cognition 0.50 0.13, 1.92 
Social communication 3.03 0.65, 14.14 
Autistic mannerisms 1.73 0.63, 4.77 
Social motivation 0.50 0.13, 1.68 
ADI-R OARS 
Overall 1.67 0.96, 2.92 
Social awareness 2.10 1.15, 3.82 
Social cognition 1.94 1.06, 3.55 
Social communication 0.64 0.26, 1.60 
Autistic mannerisms 1.29 0.70, 2.37 
Social motivation 0.51 0.20, 1.30 
 
 
RR: Risk ratio; 
CI: Confidence interval; 
BAP: Broader Autism Phenotype; 
SCQ: Social Communication Questionnaire; 
ADI-R: Autism Diagnostic Interview-Revised; 
ADOS: Autism Diagnostic Observation Schedule 
OARS; The Ohio State University Autism Rating Scale: 
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a RR for ‘over-reporting’ compares domain positive mothers to domain negative mothers 
Bold indicates statistical significance at an alpha=0.05 level 
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Table 15. Risk ratios and 95% confidence intervals for discordance between maternal and clinician ratings on 
child autism spectrum disorder screening and evaluation instruments in the Study to Explore Early 
Development by maternal self-reported history of depression or anxiety, or maternal broader autism 
phenotype 
  SCQ ADI-R 
 ‘Over-reporting’ ‘Under-reporting’ ‘Over-reporting’ ‘Under-reporting’ 
  RR 95% CI RR  95% CI  RR 95% CI RR 95% CI  
Depression 
ADOS 0.93 0.68, 1.28 1.02 0.95, 1.10 0.85 0.39, 1.83 0.8 0.53. 1.19 
OARS 01.99 0.72, 1.36 0.93 0.53, 1.64 1.14 0.73, 1.78 0.90 0.57, 1.42 
Anxiety 
ADOS 1.35 0.95, 1.92 0.66 0.30, 1.47 1.97 0.92, 4.20 1.09 0.69, 1.73 
OARS 1.27 0.96, 1.68 0.99 0.47, 2.08 1.13 0.64. 2.0 1.10 0.64, 1.89 
Maternal BAP 
ADOS 1.63 1.12, 2.37 0.57 0.21, 1.50 2.85 1.35, 6.03 0.84 0.47, 1.53 
OARS 1.30 0.95, 1.77 0.51 0.16, 1.57 1.67 0.96, 2.92 0.92 0.46, 1.81 
 
 
CI: confidence interval; 
RR: Risk ratio; 
SCQ: Social Communication Questionnaire; 
ADI-R: Autism Diagnostic Interview-Revised 
ADOS: Autism Diagnostic Observation Schedule 
OARS: The Ohio State University Autism Rating Scale 
 
a ‘Over-reporting’ is when the SCQ or ADI-R meets SEED ASD risk or ASD criteria while ADOS or OARS does not 
b ‘Under-reporting’ is when the SCQ or ADI-R does not meet SEED ASD risk or ASD criteria while ADOS or OARS does
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4A.2 Additional analyses for Aim 1 
 
 Our goal for aim 1 was to determine whether maternal BAP was associated with higher 
risk of discordance with a clinician on instruments that measured child ASD. This analysis 
required a series of assumptions and decisions that impacted our results. We ran a series of 
supplemental and sensitivity analyses to better understand the effects of these choices. Our 
results for these analyses are presented here and provide a larger context and illustrate the 
robustness of our results. These analyses also highlight intriguing avenues for future work.  
Correlation analyses 
 In this study, we used two ways to parameterize BAP (SRS-A total score and domain 
scores), four instruments to measure ASD (SCQ, ADI-R, ADOS, and OARS), and discordance 
outcomes comparing those instruments. Because we had so many different aspects to our 
analyses, it was important to make sure that these factors were not overly correlated so we 
were not presenting redundant results. Correlational analyses for our study sample are 
presented in Tables 16-18. There was moderate correlation when comparing BAP domains 
(Table 16) with a range from 0.31 (social cognition vs. social motivation) to 0.84 (overall BAP vs. 
social communication). This moderate level of correlation was not surprising since if a mother 
was BAP+ she would have some of the traits that comprise the subdomains. When assessing 
correlation between ‘over-reporting’ outcomes (Table 17), we found very weak to moderate 
correlations. This indicates that different mothers ‘over-reported’ on different instruments; our 
results are not the representation of a group of mothers that had ‘over-reported’ for all four 
comparisons. In regards to meeting instrument thresholds, correlations were higher between 
evaluation instruments (ADI-R, ADOS, OARS) than with the screener (SCQ), but still lower than 
expected. Correlation with the SCQ was low likely due to the choice to maximize case finding, 
which lowered the SCQ threshold. We expected instruments to not be overly correlated based 
on results from Wiggins et al. (197) work using the full SEED sample; however, we expected 
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higher correlation between the ADI-R and the OARS, since the OARS was the clinician’s overall 
opinion after completing the ADI-R and ADOS. Overall, these results do not change our 
interpretations of results in chapter 4a.   
Psychometric properties of instruments 
 This work is similar in approach to an assessment of psychometric properties of ASD 
evaluation instruments by BAP status. Table 19 presents these results. As suspected, 
specificity for the SCQ (which used an altered lower cutoff score of 11) was low to maximize 
case finding. Qualitatively, sensitivities were higher and specificities were lower for all 
instruments for BAP+ mothers compared to BAP- mothers. This reiterates our findings of 
elevated RRs for ‘over-reporting’.  
Weighting to control for differences by study site 
 Reporting differences may be due to differences in preferred language. Our sensitivity in 
chapter 4a restricted our sample to mothers whose preferred language was English. We also 
examined this effect by weighting to control for study site. Study site acts as a variable that can 
account for language, since two sites conducted the evaluations in Spanish. Additionally, site 
can be considered a design variable in SEED that may need to be included in analyses 
regardless of DAG theory. Our assessment of study site was a sensitivity analysis because 
intra- and inter-site reliability was so strong in SEED and we did not consider site to be a 
confounder because it did not precede BAP. There are qualitative differences when comparing 
the SCQ to the ADOS or the OARS ( Table 20). We found a 41% reduction of effect when 
weighting for site when looking at the ADI-R vs. OARS. Neither RR was significant and the other 
ADI-R or OARS comparisons did not have that large of an effect. We saw a smaller attenuation 
when addressing preferred language. This larger change might be due partially to the difference 
in language between sites, differences in clinicians, or statistical chance.
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Table 16 Correlation between overall broader autism phenotype status and broader autism phenotype domains measured 
by the Social Responsiveness Scale-adult in mothers in the Study to Explore Early Development 
 
 Domain Percent BAP total Awareness Cognition Communication Mannerisms Motivation 
BAP Total 9.4 1 0.57 0.64 0.84 0.68 0.56 
Social awareness 7.0 1 0.46 0.48 0.43 0.37 
Social cognition 13.8 1 0.62 0.55 0.31 
Social communication 9.3 1 0.59 0.57 
Autistic mannerisms 13.9 1 0.40 
Social motivation 10.5 1 
 
 
Percent is percent of all mothers who had a T score ≥ 60  
BAP Broader Autism Phenotype 
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Table 17 Correlation between whether a child met discordance criteria comparing two instruments from the Study to 
Explore Early Development  
‘Over' correlation SCQ v OARS SCQ v ADOS ADI-R v ADOS ADI-R v OARS 
SCQ v OARS 1 0.58 0.22 0.42 
SCQ v ADOS 0.42 0.09 
ADI-R v ADOS 0.42 
ADI-R V OARS 1 
 
Table 18 Correlation between whether a child meets ASD thresholds on an instrument used in the Study to Explore Early 
Development 
Meeting criteria SCQ ADOS ADI-R OARS 
SCQ 1 0.14 0.05 -0.02 
ADOS 0.49 0.47 
ADI-R 0.57 
OARS 1 
 
 
 
Key for strength of correlation  
 
 
 
 
 
 
 
 
 
SCQ Social Communication Questionnaire 
ADOS Autism Diagnostic Observation Schedule 
ADI-R Autism Diagnostic Interview-Revised 
OARS Ohio State University Autism Rating Scale 
‘Over-reporting’ is when the mother’s reporting meets ASD thresholds when the clinician’s reported / observed score des not 
0.8-1 Very strong 
0.6-0.79 Strong  
0.4-0.59 Moderate 
0.2-0.39 Weak 
0-0.19 Very weak 
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Table 19. Psychometric properties for measures used in chapter 1 analysis, overall and 
by BAP status 
  ADOS OARS 
Full sample 
Sn Sp PPV NPV Sn Sp PPV NPV 
SCQ 0.87 0.10 0.76 0.18 0.74 0.10 0.65 0.27 
ADI-R 0.77 0.79 0.92 0.52 0.80 0.67 0.82 0.64 
BAP+ 
Sn Sp PPV NPV Sn Sp PPV NPV 
SCQ 0.91 0.04 0.65 0.20 0.81 0.06 0.56 0.40 
ADI-R 0.77 0.68 0.81 0.60 0.79 0.59 0.71 0.68 
BAP- 
Sn Sp PPV NPV Sn Sp PPV NPV 
SCQ 0.86 0.10 0.77 0.20 0.76 0.11 0.59 0.26 
ADI-R 0.77 0.81 0.93 0.50 0.80 0.68 0.83 0.64 
 
SCQ Social Communication Questionnaire 
ADOS Autism Diagnostic Observation Schedule 
ADI-R Autism Diagnostic Interview-Revised 
OARS Ohio State University Autism Rating Scale 
BAP Broader autism phenotype 
Sp Specificity 
Sn Sensitivity 
PPV Positive Predictive Value 
NPV Negative Predictive Value 
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Using the standard SCQ cutoff  
 Our study relied on instrument cutoffs used in SEED. As mentioned previously, SEED 
used a SCQ cutoff of ≥11 to maximize case finding, which differed from the standard ≥15 (196). 
It was important to also assess associations using the more widely used cutoff, as that may be 
what is used in clinical practice ( Table 21). Estimates were less precise and the ‘under-
reporting’ model between the SCQ and OARS when using the ≥15 cut-off was not estimable. 
There was no change >15% for models that converged and inferences remained the same.  
Analyses on the additive scale 
 Our main results are presented on the multiplicative scale. We chose to use risk ratios 
for two reasons: 1) the multiplicative scale is generally used in ASD research and 2) our 
outcome (discordance) was common, which means that a large RR does not hide a small 
absolute effect. However, we also ran our analyses on the additive scale for comparison (Table 
22). BAP was associated with a 12-percentage point difference in risk of ‘over-reporting’ 
between the SCQ and the ADOS (95% CI: 0.00, 25.0) and 10-point difference between the SCQ 
and the OARS, although not reaching statistical significance (95%CI: -3.0, 22.0). The difference 
in risk of ‘over-reporting’ between mothers with and without BAP on the ADI-R vs. ADOS and 
the ADI-R vs. OARS were nine and eight percentage points respectively and did not reach 
statistical significance. These results differed in terms of statistical significance, but not in effect 
size or in our inferences.  
 We also assessed associations between ‘over-reporting’ and BAP domains on the 
additive scale. These are presented in Table 23. No domains were significantly associated with 
‘over-reporting’. On the multiplicative scale we found significant elevated risk for ‘over-reporting’ 
between the ADI-R and the OARS on social awareness and social cognition domains. These 
risks were elevated on the additive scale (12 and 11 percentage point increase respectively) but 
did not meet statistical significance. The difference in significance may be a result of model 
approaches. Inferences did not largely differ between the measurement scales.
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 Table 20 Risk ratios and 95% confidence intervals for discordance between maternal and clinician ratings on child  
autism spectrum disorder screening and evaluation instruments in the Study to Explore Early Development; change by 
weighting for site 
  SCQ ADIR 
  ‘Over-reporting’ ‘Under-reporting’ ‘Over-reporting’ ‘Under-reporting’ 
 RR 95% CI RR 95% CI RR 95% CI RR 95%CI 
Weighted for site 
ADOS 1.74 1.20, 2.53 0.54 0.20, 1.41 2.54 1.14, 5.67 0.82 0.43, 1.60 
OARS 1.31 0.94, 1.82 0.72 0.26, 1.99 1.18 0.64, 2.17 0.85 0.40, 1.82 
Not weighted for site 
ADOS 1.63 1.12, 2.37 0.57 0.21, 1.50 2.85 1.35, 6.03 0.84 0.47, 1.53 
OARS 1.30 0.95, 1.77 0.51 0.16, 1.57 1.67 0.96, 2.92 0.92 0.46, 1.81 
Percent change 
ADOS 6.3 -5.6 -12.2 -2.4 
OARS 0.8 29.2 -41.5 -8.2 
 
 
CI confidence interval 
SCQ social communication questionnaire 
ADI-R autism diagnostic interview revised 
ADOS autism diagnostic observation schedule 
OARS Ohio State University Autism Rating scale 
RR Risk ratio 
 
‘Over reporting’ is when the SCQ or ADI-R meets ASD criteria while ADOS or OARS does not 
‘Under reporting’ is when the SCQ or ADI-R does not meet ASD criteria while ADOS or OARS
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 Table 21 Risk ratios and 95% confidence intervals for discordance between maternal and 
clinician ratings on child autism spectrum disorder screening and evaluation 
instruments in the Study to Explore Early Development by cutoffs on the social 
communication questionnaire  
  ‘Over' ‘Under' 
 RR 95% CI RR 95% CI 
SCQ 15 
ADOS 1.64 0.95, 2.86 0.66 0.40, 1.11 
OARS 1.52 0.97, 2.40 - - 
SCQ 11 
ADOS 1.63 1.12, 2.37 0.57 0.21, 1.50 
OARS 1.3 0.95, 1.77 0.51 0.16, 1.57 
Percent change 
ADOS 0.6 13.6 
OARS 14.5 - 
 
 
 
CI Confidence interval 
RR Risk ratio 
SCQ Social Communication Questionnaire 
ADOS Autism Diagnostic Observation Schedule 
OARS Ohio State University Autism Rating Scale 
 ‘Over reporting’ is when the SCQ or ADI-R meets ASD criteria while ADOS or OARS does not 
‘Under reporting’ is when the SCQ or ADI-R does not meet ASD criteria while ADOS or OARS 
does 
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Table 22 Risk differences and 95% confidence intervals for discordance between 
maternal and clinician ratings on child autism spectrum disorder screening and 
evaluation instruments in the Study to Explore Early Development 
  SCQ ADIR 
  ‘Over-reporting’ ‘Under-reporting’ ‘Over-reporting’ ‘Under-reporting’ 
 RD 95% CI RD 95% CI RD 95% CI RD 95% CI 
ADOS 0.12 0.00, 0.25 -0.04 -0.13, 0.05 0.09 -0.03, 0.18 -0.02 -0.12, 0.09 
OARS 0.10 -0.03, 0.22 -0.05 -0.14, 0.04 0.08 -0.03, 0.19 0.00 -0.10, 0.10 
 
CI Confidence interval 
RD Risk difference 
SCQ Social Communication Questionnaire 
ADOS Autism Diagnostic Observation Schedule 
ADI-R Autism Diagnostic Interview-Revised 
OARS Ohio State University Autism Rating Scale 
‘Over reporting’ is when the SCQ or ADI-R meets ASD criteria while ADOS or OARS does not 
‘Under reporting’ is when the SCQ or ADI-R does not meet ASD criteria while ADOS or OARS 
does 
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 In order to maximize our sample size, we included children with past history of a non-
ASD DD if they received the full ASD evaluation, even though not all children in this group got 
the full evaluation. Ideally, we would have data on all children with past history of DD to better 
estimate sensitivity and specificity of instruments. However, we believe that our approach was 
valid since we included children with past DD if they screened positive or a clinician suspected 
ASD. Since DD is heterogeneous and many DDs do not present with any ASD symptoms, we 
do not think that excluding these children biased our results. If the child did not meet the 
lowered SCQ cutoff or raise concern in clinicians, it is highly unlikely that there would be 
discordance, regardless of BAP status. Nonetheless, we conducted analyses restricting our 
sample just to children with past diagnosis of ASD. This restriction enabled us to evaluate the 
effect of including these children with DD and inversely assess differences in reporting based on 
a child having a past diagnosis of ASD. Restricting to this group reduced our sample by 30% 
(N=495)(Table 24). Estimates were much less precise and none met statistical significance 
(ADOS vs. ADI-R ‘over-reporting’ was not estimable). We did still see elevated RRs for ‘over-
reporting’. As mentioned in chapter 4a, the differences in phenotype between DD with ASD 
symptoms and DD without ASD symptoms are drastic. It would have been ideal to have children 
with DD without ASD symptoms to have full ASD evaluations to better estimate sensitivity and 
specificity by BAP status; however; ASD evaluation instruments are primarily used among 
children with ASD symptoms and we believe that our results are meaningful, even without all 
DDs.  
Influence of culture on the BAP-instrument discordance relationship 
 As mentioned previously, it could be hypothesized that culture plays a role in the 
maternal BAP-discordance relationship. We chose to preliminarily explore this by stratifying by 
race or ethnicity. Results are presented in Figure 6 and Table 25. Due to the amount of 
comparisons we only present ‘over-reporting’. We defined race as white, black, or other, and 
ethnicity as Hispanic or non-Hispanic. There was a significant increased risk of ‘over-reporting’ 
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by BAP on the SCQ vs. ADOS for white mothers (RR: 1.85, 95% CI: 1.10, 3.11). On the SCQ 
vs. OARS, there was no significant effect for any race or ethnicity. BAP was associated with 
‘over-reporting’ on the ADI-R vs. ADOS for white mothers (RR: 3.55, 95% CI: 1.63, 7.74) and 
Hispanic mothers (RR: 4.42, 95% CI: 1.32, 14.82). BAP was associated with ‘over-reporting’ on 
the ADI-R vs. OARS for Hispanic mothers (RR: 3.25, 95% CI: 1.28, 8.29). These results are 
difficult to interpret due to the number of comparisons and small sample sizes. Hispanic 
ethnicity was associated with ‘over-reporting’ when using the ADI-R, which may suggest that the 
structured interview may be received differently by ethnicity. Patterns were not clear enough to 
make any firm statements. As yet, little is known about BAP and race / ethnicity and race 
/ethnicity and the ASD evaluation process. Once more is known, this type of analysis could be 
re-examined.  
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Table 23 Risk differences for ‘over-reporting’ discordance between maternal reported 
and clinician observed or estimated instruments and meeting thresholds for broader 
autism phenotype domains on the Social Responsiveness Scale Adult 
    RD 95% CI 
SCQ ADOS 
 Overall 0.12 0.00, 0.25 
Social awareness 0.06 -0.08, 0.21 
Social cognition -0.02 -0.14, 0.11 
Social communication -0.16 -0.34, 0.02 
Autistic mannerisms 0.00 -0.13, 0.12 
Social motivation 0.08 -0.05, 0.21 
SCQ OARS 
 Overall 0.10 -0.03, 0.22 
Social awareness 0.05 -0.12, 0.22 
Social cognition 0.10 -0.03, 0.24 
Social communication 0.07 -0.10, 0.25 
Autistic mannerisms -0.03 -0.17, 0.10 
Social motivation -0.13 -0.26, 0.004 
ADIR ADOS 
 Overall 0.09 -0.03, 0.18 
Social awareness -0.03 -0.15, 0.09 
Social cognition -0.02 -0.12, 0.08 
Social communication 0.03 -0.08, 0.14 
Autistic mannerisms 0.08 -0.02, 0.18 
Social motivation -0.02 -0.08, 0.05 
ADIR OARS 
 Overall 0.08 -0.03, 0.19 
Social awareness 0.12 -0.06, 0.30 
Social cognition 0.11 -0.04, 0.25 
Social communication -0.09 -0.28, 0.10 
Autistic mannerisms 0.02 -0.12, 0.16 
Social motivation -0.06 -0.16, 0.05 
 
CI 95% confidence interval 
SCQ Social Communication Questionnaire 
ADOS Autism Diagnostic Observation Schedule 
ADI-R Autism Diagnostic Interview-Revised 
OARS Ohio State University Autism Rating Scale 
 ‘Over reporting’ is when the SCQ or ADI-R meets ASD criteria while ADOS or OARS does not
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Table 24. Risk ratios and 95% confidence intervals for discordance between maternal and clinician ratings on child 
autism spectrum disorder screening and evaluation instruments in the Study to Explore Early Development; 
change by restricting for past ASD diagnosis  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CI 95% confidence interval 
SCQ social communication questionnaire 
ADI-R autism diagnostic interview revised 
ADOS autism diagnostic observation schedule 
OARS Ohio State University Autism Rating scale 
 
‘Over-reporting’ is when the SCQ or ADI-R meets ASD criteria while ADOS or OARS does not 
‘Under-reporting’ is when the SCQ or ADI-R does not meet ASD criteria while ADOS 
  SCQ ADI-R 
  ‘Over-reporting’ ‘Under-reporting’ ‘Over-reporting’ ‘Under-reporting’ 
 RR 95% CI RR 95% CI RR 95% CI RR 95% CI 
  Past ASD diagnosis only (n=495) 
ADOS 1.41 0.35, 5.73 0.68 0.17, 2.63 - - 1.09 0.65, 1.81 
OARS 1.42 0.55, 3.68 0.40 0.06, 2.80 1.47 0.48, 4.49 1.18 0.46, 3.00 
  Full sample (n=712) 
ADOS 1.58 1.10, 2.20 0.57 0.22, 1.50 2.52 1.21, 5.27 1.05 0.64, 1.72 
OARS 1.45 1.09, 1.90 0.53 0.17, 1.60 1.65 0.97, 2.81 0.99 0.54, 1.79 
  Percent difference 
ADOS -12.1   16.2   - 3.7   
OARS -2.1   -32.5   -12.2   16.1   
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Figure 6. Effect measure modification on the multiplicative scale for the effect of race/ 
ethnicity on the association between maternal broader autism phenotype status and 
‘over-reporting’ discordance in ASD evaluation measures 
 
* Indicates statistical significance.  
SCQ Social Communication Questionnaire 
ADOS Autism Diagnostic Observation Schedule 
ADI-R Autism Diagnostic Interview-Revised 
OARS Ohio State University Autism Rating Scale 
 ‘Over-reporting’ is when the SCQ or ADI-R meets ASD criteria while ADOS or OARS does not 
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AD…
SCQ-
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Table 25 Race / ethnicity stratified risk ratios and 95% confidence intervals for 
discordance between maternal and clinician ratings on child autism spectrum disorder 
screening and evaluation instruments by broader autism phenotype status in the Study 
to Explore Early Development 
Measure Race/ Ethnicity RR 95% CI 
SCQ-ADOS 
White 1.85 1.10, 3.11 
Black 1.12 0.62, 2.01 
Other 1.22 0.36, 4.16 
Hispanic 1.39 0.74, 2.62 
Non-Hispanic 1.53 0.97, 2.40 
    
SCQ-OARS 
White 1.10 0.65, 1.89 
Black 1.13 0.75, 1.68 
Other 1.6 0.64, 4.00 
Hispanic 1.18 0.80, 1.74 
Non-Hispanic 1.53 0.92, 2.56 
    
ADIR-ADOS 
White 3.55 1.63, 7.74 
Black 2.88 0.56, 14.84 
Other - - 
Hispanic 4.42 1.32, 14.82 
Non-Hispanic 1.95 0.78, 4.85 
    
ADIR-OARS 
White 1.69 0.75, 3.45 
Black 1.52 0.62, 3.74 
Other 1.77 0.26, 12.21 
Hispanic 3.25 1.28, 8.29 
Non-Hispanic 1.24 0.60, 2.55 
 
RR risk ratio 
CI confidence interval 
SCQ Social Communication Questionnaire 
ADOS Autism Diagnostic Observation Schedule 
ADI-R Autism Diagnostic Interview-Revised 
OARS Ohio State University Autism Rating Scale 
‘Over-reporting’ is when the SCQ or ADI-R meets ASD criteria while ADOS or OARS does not 
 
 
 
 
  
109 
4B. Association between parental broader autism phenotype and child ASD phenotype 
subgroup in the Study to Explore Early Development 
 
Overview  
 Autism spectrum disorder (ASD) is heterogeneous in presentation and etiologic origin. 
Phenotype varies in level of social and communication ability, associated features, and medical 
comorbidities. Etiology and genotype are just as diverse, with a myriad of genetic origins and 
environmental risk factors. Creating more phenotypically similar subgroups and using parental 
broader autism phenotype (BAP) as a marker for potential genetic predisposition for ASD may 
improve efficiency in evaluating etiologic factors. Our goal was to assess the association 
between parental BAP and child phenotype among children age 3-5 years, using latent classes 
derived from multiple behavioral and developmental measures collected in the multi-site 
community-based Study to Explore Early Development (N=707). BAP in at least one parent was 
associated with a child having increased odds of being in a class with average expressive and 
receptive language, fine motor skills, and visual reception, plus increased co-occurring 
conditions like anxiety and depression (OR: 2.44, 95% CI: 1.16, 5.09). Results were similar if 
the father alone had BAP. Child sex did not modify the parental BAP-child ASD phenotype 
relationship. Children of parents with BAP were more likely to have a phenotype qualitatively 
similar to BAP presentation; this may have implications for etiologic research and crafting 
parent-mediated interventions. 
Introduction 
 Autism spectrum disorder, defined by impairment in social communication and social 
interaction as well as repetitive and restricted behaviors and interests (RRBI)(1), is 
heterogeneous in phenotype and genotype (1, 25, 234, 235).  Verbal ability, age at 
developmental milestones, and many other diagnostic traits and associated features vary 
greatly among individuals with ASD (1, 25). Gaugler et al. (26) present a genotypic model with 
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genetic components explaining 59% of variance in ASD liability. These genetic contributors 
include chromosomal abnormalities, copy number variants, and rare highly penetrant genes. 
Other potential causes of ASD include epigenetics, gene by environmental interaction, and 
environmental risk factors (236). The myriad of potential causes and presentations create 
challenges when trying to understand etiological mechanisms (11, 29, 103, 234, 235).  
 Looking at ASD subgroups comprising more phenotypically similar individuals may 
increase resolution in detecting etiologic associations, provide more clarity on the ASD 
phenotype, and elucidate developmental trajectories (27, 29, 237). Studies have used singular 
traits like intellectual disability or developmental regression to parse phenotype (238-240) while 
data driven techniques like cluster analysis and latent class analysis have been used to create 
subgroups from a wider range of phenotypic variables (27, 28, 101-103). These subgroups have 
been used to assess differences in child problem behaviors and to create severity gradients 
(28), assess differences in child phenotype by IQ (101), explore associations with specific genes 
(27), and map possible treatment trajectories (102).  
 Past approaches have focused on families with multiple children with ASD or with 
familial ASD-like traits to subset their samples (104-107). Mechanisms that cause ASD likely 
differ by family predisposition for the disorder (107) and sub-setting this group before conducting 
genetic analysis can increase precision and efficiency.  Traits that subset ASD etiology can 
serve as endophenotypes, which are a measurable phenotypic traits, that allows for a 
psychiatric disorder to be sub-grouped into more etiologically similar groups. Endophenotypes 
can be neurophysiological, biochemical, cognitive, or neuropsychological, but must be 
associated with the disorder in the population, be heritable, state independent (apparent in an 
individual whether they have the disorder or not), co-segregate in families, and be found in 
higher rates in unaffected relatives of probands than in the general population (30, 31). 
Narrowing samples of families with a child with ASD to those with specific traits or groups of 
traits that meet these guidelines has been effective in increasing the efficiency of linkage 
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analyses, GWAS, and other techniques that look for specific causal genes or SNPs (108-114, 
241, 242).  
 The broader autism phenotype (BAP) in parents of children with ASD may be a source 
of endophenotypes that can help improve understanding of some of ASD’s core features (243). 
BAP is a set of sub-clinical characteristics of ASD prevalent in many families of children with 
ASD. BAP traits include pragmatic difficulties, broadly defined communication difficulties, poor 
social skills, cognitive rigidity, anxiety, and aloofness (16). BAP and the individual traits that 
make up BAP may be endophenotypes for ASD since BAP is heritable in the general population 
(125) and is significantly more prevalent among relatives of probands with ASD (17-20, 23, 130, 
164, 180). BAP may serve as a tool to efficiently explore the relationship between ASD 
genotype and phenotype.  
Our objective was to evaluate the association between parental BAP and child ASD phenotype 
subgroups derived from a wide range of developmental and behavioral traits. Additionally, we 
explored whether these associations differed by which parent had BAP or the child’s sex.  
Methods 
 This study used data from Phase 1 of the Study to Explore Early Development (SEED), 
a community-based case-control study designed to better understand ASD etiology and 
phenotypic presentation (196). Six sites (California, Colorado, Georgia, Maryland, North 
Carolina, and Pennsylvania) collected data on maternal pregnancy and health history, child 
developmental history, and other familial data for children between the ages of 30 and 68 
months between 2007 and 2012. Children had to have been born in the study catchment area, 
lived there at time of first contact, and lived with a caregiver aged  >18 years (196). Children 
were identified and recruited through educational or medical providers who served children with 
ASD or developmental delay (DD) or through random sampling of birth certificates.  
Study sample 
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 This study utilized phenotypic data on all children with ASD as determined by SEED. 
Child ASD status was determined by first conducting the Social Communication Questionnaire 
upon study entry. If a child screened positive (scored ≥ 11 to maximize case finding (228)), had 
a past diagnosis of ASD, or was suspected by a study clinician to have ASD during the child’s 
developmental assessment, the child then had a full ASD evaluation which included the Autism 
Diagnostic Observation Schedule (ADOS) (198) and the Autism Diagnostic Interview-Revised 
(ADI-R) (67). Final case status was determined through a SEED-derived algorithm using the 
standard cut-off scores from the ADI-R and ADOS (Wiggins et al., 2015).  In addition to the ASD 
diagnostic measures, additional phenotypic and demographic descriptions were collected using 
the Child Behavior Checklist (207), the Mullen Scales of Early Learning (208), the child’s birth 
certificate, and SEED specific caregiver interviews and questionnaires. 
  For this analysis, siblings of children who were previously enrolled were excluded 
because they may violate our assumption of independence between observations. When 
evaluating associations with parental BAP, our inferences are only applicable to children who 
had BAP measures completed for their biological mother and father.  
Creating child phenotypic classes 
 We used an extended latent class analysis (LCA) to create ASD phenotypic classes 
based on all ASD cases. We replicated the approach of Wiggins et al. (under review) who 
previously created latent classes in these data. LCA assumes that there are unobservable 
subpopulations, often associated with certain patterns of observable data, within the larger 
study population (213): in this case, we are using ASD phenotype variables to explore if these 
can be used to categorize people into latent classes.  . While standard LCA models can use 
only categorical observed variables, an extended LCA model allows for use of continuous, 
dichotomous, and categorical variables to estimate and explore any potential underlying latent 
classes. For each individual, these models provide probabilities of being in each class based on 
their observed outcome variables.   
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 Twenty-seven indicators were chosen with the purpose of differentiating the ASD 
phenotype while differentiating among those with ASD, rather than those with and without ASD. 
Indicators were selected based on careful literature review and the expertise of psychologists, 
pediatricians, and epidemiologists (Wiggins et al.) and are presented in Table 26. Gestational 
age and gastrointestinal issues were dropped as indicators in the LCA due to poor 
discrimination between classes. 
 The four-class model was determined to best fit our data after comparing models with up 
to 5 classes based on the Bayesian Information Criterion (BIC), Lo-Mendel-Rubin Likelihood 
Ratio Tests (LMR-LRT) and entropy. We also wanted to ensure interpretability of latent classes 
and adequate class size (no classes including < 2% of the total population). The four-class 
model had an LMR-LRT P value of 0.001, suggesting a noticeable improvement for 4 versus 3 
classes, and entropy of 0.92, which shows good model fit. The smallest class size was 85, 
roughly 12% of the total sample. A five-class model had a non-significant LMR-LRT P value 
(0.567), signifying no improvement on the four-class model and no noticeable improvement in 
BIC. Item response probabilities and means are presented in Table 1 and class descriptions are 
provided in Table 2. Further details on this LCA method in SEED are provided in Wiggins et al. 
(under review). 
BAP measurement 
 BAP was measured using the Social Responsiveness Scale-Adult (SRS-A)(123). 
Although not originally designed to measure BAP, the SRS-A has shown good consistency with 
other BAP and quantitative autistic trait measures (122, 149). The SRS-A is a 65-item Likert 
scale questionnaire that a parent was asked to have a friend, spouse, or relative complete on 
the parent and then return to SEED. This measure has strong internal validity, exhibiting a 
Cronbach’s alpha internal consistency coefficient of 0.95 (122, 123). The SRS-A has been 
shown to be independent of individual’s IQ and age, and the informant’s education level (60, 
123, 201, 244) with minimal differences due to gender, race or ethnicity, or the identity of the 
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informant (153). Raw overall and domain SRS-A scores were adjusted to create T-scores, 
which have a mean of 50 and a standard deviation of 10. For this study we used the standard 
‘mild range’ recommendation of ≥60 to classify a parent with BAP (BAP+) (60). Additionally, we 
categorized BAP by parent type: mother and father were BAP+, father only was BAP+, mother 
only was BAP+, or both parents were BAP-.  
Analytic approach 
  We used an inclusive LCA approach to generate odds ratios (ORs) that compare 
phenotypic class membership by presence of parental BAP. In this method, we first fit the LCA 
model to determine the appropriate number of latent classes based on model fit and 
interpretability, as described above, then reran the LCA to include, as predictors of class 
membership, our BAP covariate and an indicator for missing SRS-A data. We used multinomial 
logistic regression to derive ORs using estimated model posterior-probabilities for the inclusive 
classes. This inclusive model improves validity of effect estimates since it incorporates 
classification error, specifically not requiring the need to assign individuals to latent classes with 
some uncertainty in a separate step, and accounts for the potential effect of the covariate when 
deriving latent classes (211). A disadvantage of this approach is that estimated posterior 
probability for class membership is slightly different when models contain different covariates 
(e.g. when using BAP as a dichotomous variable versus splitting by parent type or including 
child sex). To address these issues, we compared our inclusive approach with a ‘three-step 
approach’ (which assigns each individual a class then weights for classification error) as a 
sensitivity analysis (212) (Figure 8). Results were similar between methods and we choose to 
present results for the inclusive LCA because of the potential reduction in bias and the minimal 
variation in class make up across models.  
  There were data missing on parental BAP for approximately 17% of children with ASD 
in SEED. In order to use data on all cases and ensure that classes were appropriate, we 
included an indicator for missing BAP in our analyses. Past work has shown that using an 
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indicator is less biased than restricting to those with complete data for LCA (214). A model with 
missing indicators creates class distributions for both observed and missing data, which 
provides information on missing data mechanisms (214). In most cases, a missing indicator 
approach is biased in epidemiological analyses because it removes the effects covariates have 
on one another, preventing adequate control of confounding (215, 216). However, there were no 
confounders in our analysis and our dependent variables (whether dichotomous BAP or BAP by 
parent type) were exclusive, eliminating the issue of covariance. We ran additional sensitivity 
analyses to assess the effect of using inverse probability weights to account for missing SRS-
As, finding no meaningful differences compared to our missing indicator approach (Figure 8).  
 We additionally explored the effects of which parent or parents had BAP by rerunning 
our inclusive LCA using BAP categorized by parent type. Additionally, we explored the effect of 
child sex as a modifier of the parental BAP-child phenotype association by adding child sex, a 
child sex by parental BAP status interaction term, and a missing indicator by child sex 
interaction term to our original inclusive LCA. Child sex was not associated with missing SRS-
As (χ2 P value=0.2); therefore, we believe the missing indicator approach is still unbiased (215). 
Interaction was tested using a Wald test with an alpha level= 0.05. For all models, class 2 
served as the referent class because it was the class with the most cognitive impairment and 
had lower levels of social and communicative functioning 
 As a construct, BAP is theorized to be independent of IQ, age, and race (123). Since we 
consider BAP to be an underlying genetic trait, we do not believe that there are non-genetic 
characteristics that can cause BAP. Factors like socioeconomic status, parental education, child 
age at diagnosis, and child service usage are potential mediators because they may be caused 
by BAP and affect child phenotype and may be examined in future analysis. For these reasons 
we did not statistically adjust for confounding in these analyses. This is consistent with past 
work that has assessed the relationship between parental autism-like traits and child phenotype 
(20, 130, 181).  
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 Analyses were conducted in SAS 9.3 (217) and Mplus 7 (218). 
Results 
 Of 707 children with ASD in our sample, 524 children had available SRS-A data and 100 
had at least one parent who was BAP+. Table 28 presents demographics by BAP status (any 
parent BAP+, both parents BAP-, SRS-A missing for at least one parent). Of mothers in the 
BAP+ group, 17.8% were black, 16.2% were of Hispanic ethnicity, and 24.2% had less than 
twelve years of education. Of mothers in the BAP- group, 13.4% were black and 11.0% were of 
Hispanic ethnicity, while 12.7% had less than twelve years of education. Of mothers missing 
BAP data (either on themselves or on the child’s father, n=183), 39.7% were black, 12.5% were 
of Hispanic ethnicity, and 6.6% had less than 12 years of education. Paternal and maternal 
demographics were similar across all three BAP groups.   
 When at least one parent was BAP+, the odds of the child being in class 4 (average 
expressive and receptive language, mild language delays, high cognitive rigidity, lower ASD 
symptom severity, increased co-occurring conditions) compared to class 2 (most impairment in 
cognitive functioning, latest age at language acquisitions) were 2.44 times that of both parents 
being BAP- (95% CI: 1.16, 5.09) (Figure 7).  Compared to class 2, neither class 1 (least 
impairment in cognitive functioning, high restricted interests) (OR: 0.73, 95% CI: 0.36,1.48), or 
class 3 (more reported developmental regression, significant impairment in cognitive functioning 
(OR: 0.86, 95% CI: 0.44, 1.66) were associated with parental BAP status. Missing SRS-A data 
(compared to not missing data) was not statistically associated with any class (data not shown).  
 Compared to both parents being BAP-, both parents being BAP+ had an elevated but 
not statistically significant association with child’s membership in class 4 vs. class 2  (OR: 2.4, 
95% CI: 0.54, 10.57)(Table 29). When only mothers were BAP+ (N=20), there were no 
significant associations between classes and maternal BAP, but estimates were imprecise. 
Fathers being BAP+ alone (N=64) compared to both parents being BAP- was associated with a 
child being in class 4 compared to class 2 (OR: 2.71, 95% CI: 1.09, 6.77). Because we used an 
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inclusive LCA model, the model estimated posterior probabilities of class distribution were 0.4% 
different than when we dichotomized BAP.  
 There was no evidence that the child’s sex modified associations observed between 
parental BAP and child’s phenotypic subgroup based on non-significant P values for interaction 
terms. Adding child sex and the interaction term into the LCA model shifted the model estimated 
posterior probability by 0.5% from the LCA with dichotomized BAP. Some suggestive patters of 
association by sex are present. Among boys, the relationship between any parent being BAP+ 
and phenotypic class was similar to overall results, as there was a significant effect comparing 
class 4 to class 2 (OR: 2.68, 95% CI: 1.06, 6.79) (Table 30). Results for girls were imprecise 
due to small sample size (N=20) but ORS for any parent being BAP+ were elevated for the child 
being in class 4 compared to class 2 (OR: 3.92, 95% CI: 0.74, 20.76). Class 1 and 3 had ORs 
that suggest an inverse association (ORs 0.50, 0.44 respectively) but these results were 
imprecise.  
Discussion 
 In a study of children aged 3-5 years with ASD, having a BAP+ parent was associated 
with increased odds of having an ASD phenotype marked by mild language and motor delays, 
average expressive and receptive language, and an increased propensity for co-occurring 
conditions like anxiety, depression, aggression, and attention problems. Other phenotypic 
classes had no statistically significant association with parental BAP. Additionally, this positive 
association remained was statistically significant if fathers alone were BAP+.  ORs were 
elevated but imprecise if both parents were BAP+ or if mother alone was BAP+. The association 
was similar for both boys and girls. 
 These results are in agreement with past work that has found that parental BAP is 
associated with child ASD phenotype which found increased parental scores on a measure of 
BAP were related to increased scores on a measure of the child’s ASD presentation (19, 20, 92, 
132, 165). We extend off this prior work by defining child ASD phenotype using latent classes 
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derived from multiple instruments and data sources (caregiver interview, medical record review, 
and clinician observation). This improved phenotypic classification enables a wider description 
of ASD presentation that is not reliant on one instrument or on one informant. Best practices 
when diagnosing ASD include using multiple informant and multiple instruments to better 
encompass a child’s presentation (10); these methods are also useful to best define phenotype 
for research studies.    
 The strong association between parental BAP and a child phenotypic class with less 
severe social and communication impairments, lower ASD symptom severity, and more co-
occurring conditions may support a heritable origin for this subset of children with ASD. 
Qualitatively, BAP is similar to this class. BAP is a ‘milder’ presentation of ASD symptoms with 
average cognitive functioning and high levels of anxiety, depression, and attention issues (24). 
With the high heritability of ASD (26), these traits may be genetically transmitted (123). The 
association between parent and child traits that we found is similar to work done by Losh et al. 
(243) who found that children exhibit ASD traits similar to traits that their parents exhibited 
during their own childhood. Other studies have found that traits like RRBI (162, 245), anxiety 
(181), and general social ability (165) present more similarly between parents with BAP and 
their children with ASD than parents without BAP and their children with ASD. These traits that 
overlap between parent and child may serve as endophenotypes, as they are associated with 
the disorder, are state independent, and are likely heritable (30, 31). Conducting genetic 
analysis among parents with BAP and their phenotypically similar children likely would reduce 
heterogeneity in both phenotype and genotype, increasing the likelihood of meaningful genetic 
findings and discovery of etiologic mechanisms for specific ASD traits. 
 There was an elevated but imprecise association between both parents having BAP and 
a child being in class 4 compared to class 2. The prevalence of BAP for any parent in our study 
was 19.0% which is consistent with the literature (10%-50%) (17-19, 21-24) and prevalence of 
BAP is even lower among mothers of children with BAP (24); consequently, power is an issue 
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when trying to assess the additive or multiplicative effects of having two parents with BAP. A 
larger sample may allow for exploration into autosomal recessive inheritance of ASD, which Lim 
et al. (246) found to explain 3% of liability. Our results for mother alone being BAP+ compared 
to both parents being BAP-, which were imprecise, were similar in direction, but smaller in 
magnitude than results when fathers alone or both parents were BAP+. This result is in line with 
previous studies that found no associations or much weaker associations between maternal 
BAP and child scores on ASD measures, relative to associations with paternal BAP (19, 20, 92, 
170, 185). This difference between parents with BAP could be a result of our limited sample 
size, or a reflection of differing genetic transmissions of ASD. Parents may transmit genes or 
epigenetic dysregulation that cause ASD through sex specific pathways (24, 247, 248). If these 
genes are also associated with BAP in the parent, it is possible that we could see different BAP-
child phenotype relationships by parent. 
 In the full SEED sample there was no statistically significant difference in class 
distribution between boys and girls (Wiggins et al under review) and our results did not show 
significant modification of the association between parental BAP and child ASD phenotype by 
child sex. Child sex may play a role in ASD etiology, based on a ‘female protective effect’ (249) 
or differences related to diagnostic practice and under-identification of ASD in females (250). 
However, our results suggest that pathways associated with parental BAP do not drive sex 
differences in ASD. However, these findings are limited by small sample size. Further work 
should explore how parental BAP affects the biological mechanisms that lead to female ASD in 
a larger sample of girls.   
 The association of parental BAP with child ASD phenotype may have clinical 
implications. Parr et al. (183) found that maternal BAP was negatively correlated with outcomes 
from a parent-mediated intervention. If children of BAP+ parents present differently, it may be 
necessary to adapt interventions to the child’s needs and the parent’s socio-communicative 
ability. Additionally, children of parents with BAP were more likely to be in a class with higher 
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levels of co-occurring conditions. Further research needs to be done on phenotypic trajectory, 
but knowing if a parent of a child has BAP may help clinicians and interventionists tailor 
treatment to prevent development or lessen symptoms of negative co-occurring conditions in 
children at greater risk.   
 This study had limitations. There was missing parental SRS-A data for 183 children with 
ASD. We used a missing indicator approach, which enabled us to use all available information 
when deriving latent classes. Those with missing data did not differ in class distribution 
compared to those without missing data, which suggests that these missing data did not cause 
bias. Additional sensitivity analyses that weighted for this missingness had results similar to the 
full sample missing indicator approach. We did not know who acted as the informant on the 
SRS-A for 37.5% of fathers and 75.7% of mothers. It is likely that some mothers and fathers 
filled out SRS-As on themselves and this could affect accuracy in reporting BAP (92, 251). The 
SRS-2, which added a self-report version of thee SRS-A, had an inter-rater agreement was 
moderate between the two versions (r=0.61 to r=0.78)(153). In another study, adults tended to 
rate his or her own social responsiveness higher than an informant, but this pattern was not 
associated with gender or ASD case status (92). These properties of the SRS-A suggest that 
having some parents self-report in our study would lead to non-differential misclassification, 
since reporting method would not be associated with BAP status or child phenotype. Our lack of 
data on who acted as the informant prevents us from conducting formal sensitivity analyses but 
we believe that any effect would only minimally attenuate our results because of moderate 
correlation between reporting types and the probability that many SRS-As were still filled out by 
an informant. Few children had both parents BAP+, had only mothers that were BAP+, or were 
girls. Future work will have to examine these relationships in a sample with larger number of 
BAP+ mothers and girls with ASD. Although SEED was a community-based, the sample is 
comprised of six sites that may not fully represent other geographic areas with differing 
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socioeconomic and demographic distributions. Additionally, this was a sample of children 
between 3-5 years of age; results may look different for children in a different age range.  
 Strengths of this study include usage of a large community-based sample of children 
with ASD. These attributes of SEED gave us more statistical power for analyses and make 
results more generalizable than clinic-only samples. Additionally, SEED collected extensive 
phenotypic data that allowed us to better describe child ASD phenotypic subgroups without 
having to rely solely on one instrument. We have shown that using parental BAP is an 
improvement on past studies that used multiplex or simplex families to mark increased risk of 
hereditary ASD because there was no potential for reproductive stoppage to bias our 
subgrouping. Although sample size was limited for some groups, we were able to explore 
effects of which parent was BAP+ and interaction by child sex, highlighting avenues for future 
research.  
Conclusion 
 BAP in parents of children with ASD was significantly associated with the child being in a 
phenotypic class that presented with average expressive and receptive language, mild language 
and motor delays, and more co-occurring conditions like anxiety, depression, and sleep 
problems. Children in this class have a presentation that includes traits qualitatively similar to 
those that make up BAP in adults. Future work should explore endophenotypes and genetic 
mechanisms using parental BAP and this more homogenous ASD subgroup to improve 
efficiency.   
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Table 26. Indicator variables and item response probabilities or means for children with autism spectrum disorder in 
the Study to Explore Early Development, using an inclusive latent class analysis approach 
 Source Variable type 
(range) 
Scores 
indicating 
impairment 
Latent Class response 
 1 2 3 4 
Categorical variables  (response probabilities)      
Current diet restrictions GIQ Yes / No Higher 0.26 0.36 0.30 0.40 
Early recognition of epilepsy/seizure 
disorder 
Caregiver 
interview 
Yes / No Higher 0.00 0.13 0.02 0.05 
History of regression ADI-R Yes / No Higher 0.16 0.34 0.29 0.27 
Insistence on sameness ADI-R Yes / No Higher 0.72 0.63 0.66 0.90 
Problems with age at first social 
smile 
EDQ Yes / No Higher 0.13 0.24 0.15 0.31 
Repetitive behavior with objects ADI-R Yes / No Higher 0.77 0.94 0.82 0.96 
Repetitive motor mannerisms ADI-R Yes / No Higher 0.74 0.96 0.78 0.83 
Restricted interests ADI-R Yes / No Higher 0.85 0.73 0.81 0.92 
Self-injurious behaviors ADI-R Yes / No Higher 0.38 0.58 0.37 0.79 
Unusual sensory response ADI-R Yes / No Higher 0.91 0.97 0.94 0.97 
Continuous variables (response means)      
Age at verbal language development ADI-R Months Higher 19.92 30.57 25.14 24.25 
Age at walking ADI-R Months Higher 13.69 16.32 14.11 13.58 
Aggressive behaviors  CBCL T-scores Higher 55.92 61.96 57.93 76.07 
Anxiety/depression CBCL T-scores Higher 53.58 56.24 53.38 69.37 
Attention problems CBCL T-scores Higher 59.03 67.12 61.59 70.90 
Autism severity ADOS Total severity scores 
(1-10) 
Higher 6.73 7.88 7.21 6.46 
Emotionally reactive CBCL T-scores Higher 57.93  61.74 57.35 77.67 
Expressive language skills MSEL Age equivalent 
scores (2-70) 
Lower 50.77 14.50 34.03 46.10 
Fine motor skills MSEL Age equivalent 
scores (4-68) 
Lower 54.52 23.08 37.57 49.89 
Receptive language skills MSEL Age equivalent 
score 
(1-69) 
Lower 56.98 15.22 34.33 48.24 
Sleep problems Sleep habit 
questionnaire 
Total problem score Higher 47.38 53.87 49.34 59.65 
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ADI-R Autism Diagnostic Interview-Revised 
ADOS Autism diagnostic observation schedule 
EDQ Early Development Questionnaire  
CBCL Child Behavior Checklist  
MSEL Mullen Scale of Early Learning 
SCQ Social communication questionnaire  
Social communication abilities SCQ Total score (1-35) Higher 13.04 20.97 16.93 20.53 
Somatic complaints CBCL Total score (0-91) Higher 57.18 60.80 58.14 67.70 
Visual reception skills MSEL Age equivalent 
score (5-69) 
Higher 61.33 23.13 40.50 53.68 
Withdrawn behaviors CBCL T-scores Higher 64.89 76.37 67.00  76.54 
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Table 27. Phenotypic subgroups in the Study to Explore Early Development, derived using latent class analysis 
Class Percent* Description 
1 28.1 
 
Children in this group had the least impairment in terms of cognitive functioning and the youngest age 
of language development. They were less likely to have developmental regression than children in 
other classes. This class had high rates of restricted interests and unusual sensory responses 
 
2 26.6 
Children in this group had the most impairment in cognitive functioning. Members of this group acquired 
language at later ages (if at all) and were latest to walk unsupported. This group had the highest rate of 
seizures, unusual sensory responses, and more repetitive motor mannerisms. 
3 33.3 
 
Children in this group had significant impairments in cognitive functioning and were similar to class 1 
except that they had more reported developmental regression and delayed language development. 
This group also had high levels of unusual sensory response.  
 
4 12.0 
Children in this group had average nonverbal functioning and mild language and motor delays. This 
class had high rates of cognitive rigidity, and relatively higher rates of aggressive behaviors, 
anxiety/depression, attention problems, emotional reactivity, self-injurious behaviors, sleep problems, 
and somatic complaints than other groups. This group also had high levels of unusual sensory 
response. 
 
 
* Percentage is from a latent class model that included our broader autism phenotype covariate
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Table 28. Demographic characteristics by parent’s broader autism phenotype status in 
the Study to Explore Early Development 
    
One or both parents 
BAP+ 
Both parents 
BAP- Missing BAP 
    N=100 N= 424 N=183 
    N % n % N % 
Child Sex    
 Male 80 80.0 355 83.7 144 78.7 
 Female 20 20.0 69 16.3 39 21.3 
Maternal Race       
 White 64 63.4 290 68.4 88 48.1 
 Black 18 17.8 57 13.4 68 37.2 
 Asian 9 8.9 43 10.1 8 4.4 
 Other 6 5.9 18 4.2 9 4.9 
 Multi-racial 4 4.0 16 3.8 10 5.5 
Paternal Race       
 White 62 62.0 289 68.2 91 52.3 
 Black 19 19.0 65 15.3 69 39.7 
 Asian 7 7.0 39 9.2 8 4.6 
 Other 9 9.0 19 4.5 6 3.4 
 Multi-racial 3 3.0 12 2.8 3 1.7 
 Missing     7  
Maternal Ethnicity   
 Hispanic 16 16.2 46 11.0 23 12.6 
 Not-Hispanic 84 83.8 378 89.0 160 87.4 
Paternal Ethnicity   
 Hispanic 19 19.4 40 9.5 22 12.6 
 Not-Hispanic 79 80.6 383 90.5 153 87.4 
 Missing 2  1  8  
Maternal Education (years)   
 <12  24 24.2 54 12.7 12 6.6 
 12 to <16 58 58.6 266 62.7 101 55.2 
 >=16  17 17.2 104 24.5 70 38.3 
 Missing 1      
Paternal Education (years)   
 <12  33 33.3 88 20.5 21 12.1 
 12 to <16 43 43.4 235 54.7 95 54.6 
 >=16  23 23.2 107 24.9 58 33.3 
 Missing 1    9  
Site       
California 18 18.0 76 17.9 18 9.8 
Colorado 19 19.0 85 20.0 38 20.8 
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Georgia 18 18.0 81 19.1 39 21.3 
Maryland 19 19.0 48 11.3 41 22.4 
North Carolina 12 12.0 77 18.2 15 8.2 
Pennsylvania 14 14.0 57 13.4 32 17.5 
Phenotypic classa       
 1 26 26.0 106 25.0 56 30.6 
 2 22 22.0 134 31.6 43 23.5 
 3 30 30.0 144 34.0 59 32.2 
 4 22 22.0 38 9.0 25 13.7 
 
BAP Broader autism phenotype 
BAP+ defined as a Social Responsiveness-Adult T score ≥ 60 
a Phenotypic classes were from the inclusive latent class model with any parent BAP+. Classes 
are assigned by highest posterior probability (analyses did not assign children to classes but 
used estimated model probabilities). 
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Figure 7. Odds ratios and 95% confidence intervals comparing child autism spectrum 
disorder phenotypic classes by parental broader autism phenotype in the Study to 
Explore Early Development 
 
Class 2 and neither parent having the broader autism phenotype is the referent class.
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Table 29. Odds ratios comparing child autism spectrum disorder phenotype class by 
parental broader autism phenotype status in the Study to Explore Early Development, by 
parent type 
 
 
 
 
 
 
 
 
BAP: Broader Autism Phenotype; 
OR: Odds Ratio; 
CI: Confidence Interval; 
Neither parent having BAP is the referent class 
Ns were derived using classes assigned by posterior probabilities, analyses used model-
estimated probabilities 
  
Both parents BAP+ 
N=16 
Mother only BAP+ 
N=20 
Father only BAP+ 
N=64 
CLASS N  OR 95% CI N OR 95% CI N OR 95% CI 
1 2  0.34 0.06, 1.87 9 0.28 0.72, 19.61 19 1.07 0.47, 2.45 
2 5  REF  6 REF  15 REF  
3 5  0.77 0.20, 2.94 2 1.06 0.33, 3.46 17 0.82 0.21, 3.12 
4 4  2.40 0.54, 10.57 3 1.63 0.34, 7.68 13 2.71 1.09, 6.77 
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Table 30. Sex stratified odds ratios comparing child autism spectrum disorder phenotype 
classes by parental broader autism phenotype in the Study to Explore Early Development 
 
 
BAP: Broader autism phenotype 
OR: Odds Ratio, 
CI: Confidence Interval, 
P value is for the interaction term for child sex and parent broader autism phenotype status 
Neither parent having BAP was referent 
Ns were derived using classes assigned by posterior probabilities, analyses used model-
estimated probabilities 
 
 
 
Boys with any parent BAP+ 
N=80  
Girls with any parent BAP+ 
N=20  
CLASS N OR 95% CI  N OR 95% CI P value 
1 20 1.22 0.56, 2.65  6 0.50 0.11, 2.34 0.7 
2 20 REF   3 REF   
3 25 1.23 0.57, 2.61  5 0.44 0.08, 2.41 0.2 
4 15 2.69 1.06, 6.79  6 3.92 0.74, 20.76 0.8 
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Figure 8. Odds ratios comparing child autism spectrum disorder phenotype classes by 
any parent having the broader autism phenotype in the Study to Explore Early 
Development, by latent class and missing data methods 
 
 
Class 2 with neither parent having BAP is the referent 
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4B.2. Additional analyses for aim 2.  
 
Additional analyses  
 
 Because of the intricacies of latent class modeling and our missing data, we explored a 
series of additional and sensitivity analyses. These tables and figures are presented here to 
justify our choices and illustrate the robustness of our results. 
Weighting to address missing data 
 As mentioned previously, SRS-As were missing for some parents. Table 31 presents 
demographics by parent SRS-A completion for our weighted samples. The group with only one 
parent SRS-A had mothers that were 43.1% black and 14.9% Hispanic. When neither parent 
had SRS-A data mothers were 26.9% black and 9.7% of Hispanic. We believe that these 
missing data are unlikely to be a source of selection bias since it is unlikely that missingness is 
associated with BAP or child phenotype. Our weighting approach accounted for these 
demographic differences and this weighted sample has characteristics nearly identical to the 
total SEED ASD sample. Two slightly different weights were created: one that included 
estimated posterior probability of class in the weighting model (taken from class derivation using 
the full N=707) and the other did not include the class variable. Including or excluding the class 
variable did not greatly change weight values. We used the weights with class included to better 
account for any associations between missingness and class.  
Alternative LCA approaches 
 As thoroughly discussed in chapter 3f, there were three ways to approach our LCA with 
covariates. In chapter 4b, we present our results using the inclusive method. Here, we present 
results for the three-step and classify analyze approaches. Table 32 presents results for our aim 
2.1 analysis for all three methods (all with an indicator for missing SRS-A data). Results were 
qualitatively similar between the three approaches, as all had significant positive association for 
being in class 4 vs. class 2. As expected, the classify-analyze approach attenuated effects 
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(class 4 OR 12.5% lower than the three-step, 23.1% lower than the inclusive LCA). Confidence 
interval ratios were most precise for the classify-analyze approach, then the three-step, and 
lastly the inclusive. This is to be expected as the classify-analyze approach does not accurately 
account for variance, and the three-step model includes fewer covariates in the LCA. 
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Table 31. Aim 2 demographics by SRS-A response and by inverse probability weighting 
    ASD cases  No SRS-As  One SRS-A Both SRS-A Weighteda Weightedb 
    N=707 N=67 N=116 N=524 N=707 N=707 
    N % N % N % N % % % 
Child Sex         
 Male 579 81.9 51 76.1 93 80.2 435 83.0 82.7 82.6 
 Female 128 18.1 16 23.9 23 19.8 89 17.0 17.4 17.4 
Maternal Race        
 White 441 62.4 36 53.7 52 44.8 353 67.4 62.4 62.5 
 Black 143 20.2 18 26.9 50 43.1 75 14.3 20.8 20.8 
 Asian 60 8.5 5 7.5 3 2.6 52 9.9 8.8 8.7 
 Other 33 4.7 4 6.0 5 4.3 24 4.6 4.6 4.6 
 Multi-racial 30 4.2 4 6.0 6 5.2 20 3.8 3.4 3.4 
Paternal Race        
 White 442 63.1 40 61.5 51 45.9 351 67.0 61.8 61.9 
 Black 153 21.9 17 26.2 52 46.8 84 16.0 21.6 21.7 
 Asian 53 7.6 5 7.7 3 2.7 46 8.8 7.7 7.6 
 Other 34 4.9 3 4.6 3 2.7 28 5.3 5.9 5.9 
 Multi-racial 18 2.6 1 1.5 2 1.8 15 2.9 3.0 3.0 
 Missing 7  2  5    
Maternal Ethnicity        
 Hispanic 85 12.4 6 9.7 17 14.9 62 12.0 11.3 11.3 
 Not-Hispanic 610 89.1 56 90.3 98 86.0 456 88.0 88.7 88.7 
 Missing 12  5  1  6  
Paternal Ethnicity        
 Hispanic 81 11.6 6 9.2 16 14.5 59 11.3 11.3 11.3 
 Not-Hispanic 615 88.4 59 90.8 94 85.5 462 88.7 88.7 88.7 
 Missing 11  2  6  3   
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    ASD cases  No SRS-As  One SRS-A Both SRS-A Weighteda Weightedb 
    N=707 N=67 N=116 N=524 N=707 N=707 
    N % N % N % N % % % 
Maternal Education (years) 
 <12  36 5.1 4 6.0 8 6.9 24 4.6 4.4 4.5 
 12 to <16 305 43.2 38 56.7 63 54.3 204 39.0 42.8 42.9 
 >=16  365 51.7 25 37.3 45 38.8 295 56.4 52.7 52.7 
 Missing 1      1  
Paternal Education (years)       
 <12  53 7.6 5 7.9 16 14.4 32 6.1 6.6 6.6 
 12 to <16 295 42.3 34 54.0 61 55.0 200 38.2 41.9 42.0 
 >=16  349 50.1 24 38.1 34 30.6 291 55.6 51.5 51.4 
 Missing 10  4  5  1  
Site         
 California 112 15.8 6 6.0 12 10.3 94 17.9 15.1 15.1 
 Colorado 142 20.1 19 19.0 19 16.4 104 19.8 20.3 20.4 
 Georgia 138 19.5 14 14.0 25 21.6 99 18.9 19.7 19.6 
 Maryland 108 15.3 20 20.0 21 18.1 67 12.8 16.6 16.5 
 North Carolina 104 14.7 2 2.0 13 11.2 89 17.0 14.4 14.5 
 Pennsylvania 103 14.6 6 6.0 26 22.4 71 13.5 13.9 13.9 
 
aWeighted for maternal age, maternal education, maternal race, maternal ethnicity, and site  
bIncludes child ASD phenotypic class in weighting model  
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Table 32 Comparisons between the three approaches to latent class analysis for overall associations between any 
parent having the broader autism phenotype and class- weighted 
Missing Indicator 
  Three-step  Inclusive Classify-analyze 
Class OR 95% CI CIR OR 95% CI CIR OR 95% CI CIR 
1 0.69 0.36,1.32 3.67 0.73 0.36, 1.48 4.11 0.81 0.44, 1.47 3.34 
3 0.88 0.47, 1.64 3.49 0.86 0.44,1.66 3.77 0.95 0.54, 1.66 3.07 
4 2.23 1.09, 4.57 4.19 2.44 1.16, 5.09 4.38 1.98 1.03, 3.80 3.69 
 
 
% Change 
  Inclusive vs. Three-step Inclusive vs. C-A Three-step vs. C-A 
Class OR CIR OR CIR OR CIR 
1 7.04 12.12 -9.27 23.05 -15.23 9.75 
3 -1.88 8.12 -9.49 22.73 -7.75 13.51 
4 9.42 4.66 23.11 18.94 12.51 13.64 
 
OR Odds ratio; 
CI Confidence interval; 
CIR Confidence interval ratio 
C-A Classify analyze 
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LCA missing data approaches  
 We also had two approaches for missing data. We used an indicator for missing SRS-As 
in our primary analysis and results are presented in chapter 4b. Here we present results 
weighting our sample to account for this missing data (Table 33). Results were similar to results 
from our primary analysis. All LCA approaches with weighted data had a significant association 
between parental BAP and being in class 4 compared to class 2 with no other meaningful 
associations between class 1 or class 3 and class 2. The classify-analyze approach had the 
lowest estimates (which we know to be biased) but the most precise confidence intervals. The 
three-step and inclusive approaches differed in point estimate by 12.7% for class 1, 8.22% for 
class three, and 1.01% for class 4. Confidence intervals were slightly more precise for the three-
step compared to the inclusive approach. Again, these differences are to be expected because 
of the handling of variances and covariates in these approaches. These results agreed with our 
primary analysis, supporting the robustness of these results. 
Change in class distribution due to inclusive LCA 
 We mentioned in section 4B that the inclusive approach slightly changes class 
distribution. Table 34 presents class distribution for our three sub-aims, illustrating these 
differences. Using indicators for missing SRS-A data, model estimated posterior probabilities 
between aim 2.1 and aim 2.2 differed for 2.7 children (0.4%), aim 2.1 and aim 2.3 differed for 
3.2 children (0.5%), and aim 2.2 and aim 2.3 differed by 0.5 children (0.07%). Weighting our 
sample to account for missing SRS-As (Table 35) created greater differences. Aim 2.1 differed 
from aim 2.2 by 12.7 children (2.4%), aim 2.1 differed from aim 2.3 by 21.08 children (4.2%), 
and aim 2.2 differed from aim 2.3 by 3.4 children (0.6%). Overall, changes were minimal which 
supports the use of the inclusive LCA. The weighted sample may have more differences 
because the smaller sample size increases variability in modeling.  
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Full results using alternative approaches 
 Lastly we present full results for the other three combinations of methods (LCA inclusive 
with a weighted sample, three-step with indicators for missing SRS-As, three-step with a 
weighted sample). As seen in Table 32 and Table 33, results for any parent being BAP+ were 
very similar. As we further categorized BAP and stratified by child sex, results between methods 
had larger differences. However, our inferences are not different across any of these 
approaches.  
Inclusive LCA with weights 
 Table 36, Table 37, and Table 38, present results using inclusive LCA with weighting for 
SRS-A missingness. These results were very similar to the missing indicator approach. Children 
with any parent BAP+ had 2.54 the odds of being in class 4 vs. class 2 compared to children 
with two BAP- parents (95% CI: 1.21, 5.31). Results by parent type were similar to our primary 
analysis: both parents being BAP+ had elevated but non-significant ORs comparing class 4 to 
class 2 and this association was significant if the father alone was BAP+. Stratifying by child sex 
also had similar results to our primary analysis. These results further affirm our choice in using a 
missing indicator.  
Three-step approaches 
 Tables 39-41 present results for the three-step approach with indicators for missing 
SRS-A data. Tables 42-44 present result from the three-step approach with weighted for 
missing SRS-A data. These results were similar to results using the inclusive approach with 
missing indicators, illustrating the robustness of these results
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Table 33. Comparisons between the three approaches to latent class analysis for overall associations between any parent 
having the broader autism phenotype and class- weighted 
Three-Step  Inclusive Classify-Analyze 
Class OR 95% CI CIR OR 95% CI CIR OR 95% CI CIR 
1 0.88 0.47, 1.62 3.45 0.77 0.38, 1.56 4.11 0.68 0.40, 1.15 2.88 
3 0.79 0.41, 1.52 3.71 0.85 0.34. 1.69 4.97 0.85 0.52, 1.38 2.65 
4 2.51 1.24, 5.08 4.10 2.54 1.21, 5.31 4.39 2.24 1.27, 3.95 3.11 
 
 
 
% Change 
  Inclusive vs. Three-Step Inclusive vs. C-A Three-Step vs. C-A 
Class OR CIR OR CIR OR CIR 
1 -12.72 19.10 12.71 42.79 29.13 19.89 
3 8.22 34.08 0.15 87.30 -7.46 39.70 
4 1.01 7.12 13.26 41.10 12.13 31.72 
 
OR Odds ratio; 
CI Confidence interval; 
CIR Confidence interval ratio 
C-A Classify analyze 
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Table 34. Differences in class distribution between inclusive models with missing 
indicators 
 Aim 2.1 Aim 2.2 Aim 2.3 
Model Any one parent BAP+ By parent type Child sex 
 Class N % N % N % 
1 196.6 27.8 197.6 28.0 197.84 28.0 
2 187.5 26.5 187.3 26.5 186.8 26.4 
3 237.2 33.5 237.5 33.6 236.23 33.4 
4 85.8 12.1 84.6 12.0 86.11 12.2 
 
 
Table 35 Differences in class distribution between inclusive models, weighting for 
missingness 
 Aim 2.1 Aim 2.2 Aim 2.3 
 Model Any one parent BAP+ By parent type Child sex 
 Class N % N % N % 
1 140.31 26.78 131.33 25.06 132.02 25.20 
2 137.18 26.18 151.54 28.92 151.39 28.89 
3 184.43 35.20 183.38 35.00 181.79 34.84 
4 62.06 11.84 57.75 11.02 58.8 11.22 
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Table 36. Odds ratio for any one parent having BAP, inclusive model weighted for 
missing SRS-As 
CLASS OR 95% CL 
1 0.77 0.38, 1.56 
3 0.85 0.34. 1.69 
4 2.54 1.21, 5.31 
   
 
 
Table 37. Odds ratio for classes by which parent has BAP, inclusive model weighted for 
missing SRS-As 
  Both parents BAP+ Mother BAP+  Father BAP+  
CLASS OR 95% CL OR 95% CL OR 95% CL 
1 0.43 0.11,3.61 0.21 0.03, 1.51 1.27 
0.54, 
3.01 
3 1.03 0.27, 3.90 0.75 0.22, 2.53 0.89 
0.40, 
1.97 
4 4.34 0.87, 21.63 1.47 0.31, 7.10 3.24 
1.23, 
8.50 
       
 
 
Table 38. Odds ratio for classes by child sex and any parent having BAP, inclusive model 
with weights for SRS-A missingness 
  Boys Girls 
CLASS OR 95% CI OR 95% CI P value 
1 0.85 0.37, 1.95 0.48 0.10, 2.28 0.5 
3 0.91 0.44, 1.88 0.67 0.15, 2.88 0.7 
4 2.31 0.93, 5.72 6.57 1.01, 42.43 0.3 
 
Referent class is class 2, no parent with BAP 
P value for interaction term between child sex and parent BAP 
OR Odds ratio; 
CI: Confidence interval 
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Table 39 Class distribution for three-step approach with missing indicators 
Total 
  N=707 
 Class N % 
1 197.74 27.97 
2 187.46 26.51 
3 237.51 33.59 
4 84.29 11.92 
 
 
Table 40 Odds ratios by parent BAP type and class, three-step approach with missing 
indicators 
  Both parents BAP+ Mother BAP+ Father BAP+ 
CLASS OR 95% CL OR 95% CL OR 95% CL 
1 0.28 0.04, 1.87 0.23 0.03, 1.57 1.00 0.47, 2.13 
3 0.73 0.19, 2.87 1.15 0.36, 3.60 0.82 0.37, 1.83 
4 2.33 0.57, 9.50 1.44 0.32, 6.48 2.50 1.05, 5.93 
       
 
Table 41 Odds ratios by child sex for any parent with BAP, three-step approach with 
missing indicators 
 
 
 
 
 
 
 
Referent class is class 2, no parent with BAP 
P value for interaction term for child sex times parent BAP 
OR Odds ratio; 
CI Confidence interval 
 
 
 
 
 
 
 
 
  Boys Girls 
CLASS OR 95% CI OR 95% CI P value 
1 0.76 0.37, 1.55 0.43 0.08, 2.23 0.5 
3 0.97 0.48, 1.95 0.59 0.15, 2.36 0.9 
4 2.01 0.89. 4.51 4.13 0.73, 21.21 0.2 
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Table 42. Class distribution for three-step approach weighted for missingness 
CLASS Total 
  N % 
1 137.90 26.32 
2 140.48 26.81 
3 184.52 35.21 
4 61.09 11.66 
 
Table 43. Odds ratio for any parent with BAP, three step-approach weighted for 
missingness 
CLASS OR 95% CL 
1 0.88 0.57, 2.17 
3 0.79 0.66, 2.46 
4 2.51 1.24, 5.08 
 
Table 44. Odds ratios by which parent had BAP, three step-approach weighted for 
missingness 
  
Both parents BAP+ 
  
Mother BAP+ 
  
Father BAP+ 
  
CLASS OR 95% CL OR 95% CL OR 95% CL 
1 2.73 0.43, 17.02 3.38 0.52, 21.61 0.89 0.41, 1.92 
3 2.01 0.30, 13.41 3.90 0.62, 24.50 0.73 0.33, 1.60 
4 6.84 0.98, 47.81 5.29 0.64, 42.66 2.58 1.10, 6.02 
       
 
Table 45. Odds ratio for any parent with BAP by child sex, three-step approach weighted 
for missingness 
  Boys Girls 
CLASS OR 95% CI OR 95% CI P Value 
1 0.89 0.42, 1.89 0.41 0.07, 2.39 0.4 
3 0.89 0.43, 1.86 0.73 0.18, 2.88 0.8 
4 2.26 0.95, 5.36 7.01 1.30, 37.92 0.2 
Referent class is 2 with no parent with BAP 
P value is for interaction between child sex and any parent having BAP 
OR odds ratio 
CI confidence interval
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CHAPTER 5. DISCUSSION 
 
5A. Aim 1 Discussion 
Summary of findings 
 The diagnostic process for ASD is complex and involves multiple instruments and 
informants. We assessed whether disagreement between these instruments was associated 
with maternal BAP in a sample of children with past history of ASD or DD identified in SEED. 
The broader autism phenotype is a set of subclinical ASD traits more prevalent in families of 
children with ASD. Mothers with BAP were at significantly higher risk of reporting that their child 
met instrument ASD risk (based on the SCQ) or ASD diagnostic thresholds when a clinician 
reported otherwise. (based on the ADOS or OARS) Risk ratios for these associations ranged 
from 1.30 (SCQ vs. OARS) to 2.85 (ADI-R vs. ADOS). Risk ratios were higher when the 
maternal reported instrument was a semi-structured interview compared to a brief screener. We 
did not see any ‘under-reporting’ effects, although there was a suggestion of an inverse 
association when looking at the SCQ. Overall, our results were unchanged after sensitivity 
analyses adjusted for Spanish language use, study site, a more conservative SCQ cut-off, or 
weighting for missing BAP data. 
 Maternal BAP sub-domains were not meaningfully associated with reporting 
discordance. This may suggest that the entire constellation of BAP leads to discordance, rather 
than one specific trait or group of traits. Alternatively, there may not have been adequate 
sample size to detect associations in these subdomains, or, associations with these domains 
are more specific to reporting on certain child ASD traits, rather than meeting instrument cut-off 
scores. 
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 Maternal self-reported history of past depression diagnosis was not associated with 
reporting discordance. This indicates that reporting discordance may be due to the autism-like 
traits of BAP, rather than larger maternal psychopathology. Self-reported history of a diagnosis 
of an anxiety disorder had an elevated association for ‘over-reporting’ on the ADI-R vs. ADOS, 
but did not meet statistical significance. This may be an effect of anxiety as a state based trait 
that might present more in the one-on-one maternal interview then a brief telephone 
questionnaire. Risk ratios for anxiety and ‘over-‘ or ‘under-reporting’ were still much lower than 
for BAP, which again supports the specificity of these results to BAP.  
  In regards to our hypotheses for aim 1: 
 Hypothesis 1.1: Mothers with BAP, compared to those without, will be more likely to 
report that a child reaches the threshold for ASD risk on screening instruments when a clinician 
does not observe or deduce that the child has ASD. 
 Results 1.1: Mothers with BAP were at increased risk of ‘over-reporting’ on the SCQ vs. 
ADOS or OARS as compared to mothers without BAP. There was no significant association 
between BAP and ‘under-reporting’, although effect estimates were below one.  
 Hypothesis 1.2: Compared to mothers without BAP, mothers with BAP will be more likely 
to report on an ASD interview instrument that their child meets ASD thresholds when a clinician 
observation or best estimate does not meet ASD thresholds. 
 Results 1.2: Mothers with BAP were at elevated risk for ‘over-reporting’ on the ADI-R 
vs. ADOS or OARS compared to mothers without. These effect estimates were higher than 
when the screening instrument was used. Further, there were no significant associations for 
‘under-reporting’.  
 Hypothesis 1.3: There will be no clinical difference in discordance between maternal-
reported and clinician-observed or estimated instruments with regard to maternal self-reported 
history of a depression or anxiety disorder diagnosis.  
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 Results 1.3: Mothers with self-reported history of depression diagnosis did not differ 
from those without in regards to ‘over-’ or ‘under-reporting’ on any combination of measures. For 
self-reported history of an anxiety disorder diagnosis, there were no significant associations with 
‘over’ reporting, but effect estimates were elevated.  
 
Results in context of study design and past literature 
Sampling approach 
 These results need to be interpreted in context of study design and limitations. SEED is 
a large community-based case-control study. For this work, the case-control design was not 
utilized but rather, we derived our sample from children identified as most likely cases. 
Therefore, this sample consisted of only mothers whose children had past evaluations for ASD 
or DD, preventing us from making inferences on mothers who had never experienced a child’s 
neurodevelopment diagnostic process. Having experienced previous evaluations may lead to a 
reduction in anxiety and better ability to remember child developmental milestones. It would be 
important to assess these patterns in mothers who have children at high risk for ASD with no 
past history of ASD or DD evaluation to determine whether these effects are magnified in a 
more stressful setting. Further, since SEED was for research purposes and no formal diagnoses 
were given, results are not translatable to the diagnostic process. Replicating this study in a 
clinical sample may illuminate these effects in a more stressful, meaningful environment. 
Alternatively, SEED enabled us to assess these associations in a broader sample with more 
variety in ASD severity. SEED was designed to examine younger children (3-5 years) so results 
are specific to that age range. This age range is ideal for improving early interventions, but 
children are still evaluated at lager ages. When a child is older a mother has to report on more 
past symptoms and a differing array of current symptoms and any discordances may delay 
diagnosis further. Future work should replicate this study in an older group of children.  
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Consistency with past literature 
 The fact that there is discordance between ASD reporting instruments is consistent with 
past work in SEED (197) and in specific studies comparing the ADI-R and ADOS (62, 64). Few 
studies have assessed predictors of this discordance; as yet, a study found that the child’s level 
of repetitive and restricted behaviors was not associated with discordance in SEED instruments 
(197) nor was child age associated with ADI-R ADOS discordance(224). We believe that this is 
the first work to assess maternal characteristics as a source of discordance in ASD evaluations. 
These results agree with the literature on ‘over-reporting’ for child psychiatric conditions among 
mothers who have those conditions. This ‘depression-distortion’ literature is slightly different in 
that the mother usually has a confirmed diagnosis and the child has less severe traits that are 
being reported on. Our study was the inverse, but there still was an increased likelihood that 
maternal reported instruments reached ASD thresholds compared to clinician measures when 
the mother had BAP.  
Exposure and outcome misclassification 
 There is the possibility that BAP was misclassified. As described in chapter 2, there are 
many different methods and instruments to measure BAP. We used the SRS-A, which is a brief 
informant-reported questionnaire, but it has limitations. We were missing who the informant was 
for a majority of our sample (~75%). A mother was asked to have a friend or spouse report on 
her, but could have self-reported her traits, which the SRS-A was not designed for. A study by 
Ingersoll et al. (122) adapted the wording of the SRS-A to be self-report (by changing the 
pronouns) and found that it still met criterion validity and was in line with other self-report BAP 
measures. The SRS-2 added a self-report version of the SRS-A, again only adjusting the 
wording to enable self-administration. This version showed lower intra-class correlation with the 
informant version than the intra-class correlations between two different informants; however, 
standardized mean differences in score were small and the SRS-2 manual standardizes both 
versions to the same set of scores (153). De La Marche et al. (92) evaluated difference between 
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self- and informant reporting on the SRS-2 and found that parents over-reported their social 
ability, and this was not associated with gender or ASD case status. Based on that result, we 
would expect the effect of our mixed informant type to be non-differential and minimal; we do 
not expect mothers with BAP to be more likely to self-report and scoring does not appear to 
differ by level of ASD traits (92). Our results would likely be attenuated, as mothers with and 
without BAP will look more similar due to overall over-reporting. However, based on the effect 
sizes seen in the SRS-2, we expect minimal attenuation. We were unable to simulate these 
effects due to the extent of our missingness and the series of assumptions we would need to 
make to test these effects (e.g. of those missing, who was a self-report, then, of those who self-
report, who was inaccurate). Ideally, we would have had a BAP measure that incorporates 
multiple informants including clinicians to best capture BAP, but that type of measurement may 
not be feasible in a study with the size and goals of SEED.  
 The cutoffs we used for evaluation instruments were well validated and standardized, 
but they were dichotomized. We were unable to assess discordance using a continuous 
measure. The four instruments that we used all had continuous scales, but they did not easily 
align such that we could calculate differences. In the future, this work should be replicated using 
instruments that more easily align or by creating a way to compare continuous scores across 
instruments. This would allow us to examine the magnitude of difference in reporting. 
 
Recommendations 
Future research needs 
 Since this work is novel and has some limitations, results are not generalizable to 
populations outside SEED. Therefore, recommendations for future action are conservative. We 
still have many questions about BAP and the diagnostic process: Do people with and without 
BAP report differently on the same set of events? Does mode of an interview (in person 
interview, self-report, over the phone interview) affect response differentially through BAP? How 
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heterogeneous is the BAP phenotype and does this heterogeneity affect reporting? In the prior 
section we listed a series of future analyses that could build off this work. Hopefully our results 
will foster others to pursue these promising projects.  
 Our results are in agreement with past literature that ASD evaluation measures are not 
always concordant. In this study, maternal BAP was associated with this discordance across 
instruments and methods. We recommend that clinicians continue to use their best judgment 
during the diagnostic process when trying to incorporate information that may be in opposition to 
what they observe. Continued research into parental BAP and its manifestation will be useful in 
clarifying how clinicians should respond to this differential diagnostic discordance by BAP. 
There is also the possibility that children who have a parent with BAP present differently. In aim 
2 we found that there were differences in child presentation by parental BAP status. A more 
subtle presentation may be more difficult for a clinician to observe in the limited time for an 
instrument like the ADOS. Better understanding the relationship between parent BAP and child 
phenotype may reduce some diagnostic discordance.  
Intervention planning 
 This work may have implications for further research that incorporates child behavioral 
intervention. A preliminary study by Parr et al. (183) found that effectiveness of a parent-
mediated intervention was negatively impacted by a mothers level of BAP traits. Many 
interventions are crafted to a child’s specific needs; the reporting ability of a parent in 
communicating a child’s needs may affect the programs prescribed. If parental BAP affects 
informant ability, then these interventions may be negatively impacted because of 
miscommunication between parent and interventionist. Studies that repeat our approach to try 
and quantify reporting discordance for intervention creation may provide insight into improving 
intervention design. 
 In summation, more work is needed that explores how maternal BAP affects the ASD 
diagnostic process. Our study is the first to find differential reporting by BAP status, but the 
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extent of this impact on time to diagnosis or intervention planning is not yet known. At this point, 
there is no biomarker or test for ASD. Even if one were found to be valid, the heterogeneity of 
ASD will likely inhibit the usefulness of a ‘magic bullet’ diagnostic test from being able to 
diagnose all children with ASD. For the foreseeable future, the diagnostic process and treatment 
development and implementation for young children with ASD will be heavily reliant on a 
caregiver reporting the child’s developmental and medical history, and strengths and 
challenges. The utility of our specific findings may not yet affect clinical practice; however, 
figuring out better methods of interpreting parents’ reports regarding the child’s behaviors for the 
brief period that a caregiver has with a clinician or interventionist, are vital. We believe that this 
work is a small step in that direction. 
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5B. Aim 2 Discussions 
 
Summary of findings 
 
 Our goal was to determine whether parental BAP was associated with child ASD 
phenotype classes derived from extensive data collected from children aged 3-5 years in SEED. 
We found that children with ASD who had parents with BAP had increased odds of being in a 
phenotypic class marked by typical non-verbal functioning, mild language and motor delays, and 
increased levels of co-occurring conditions. There were no associations with other classes. 
These results were robust across latent class methods and approaches to handling missing 
data. Although our sample size was low, we explored how this effect differed by which parent 
had BAP and by child sex. Results suggest that having a BAP+ father was associated with 
being in a class with average expressive and receptive language, mild language and motor 
delays, and increased levels of co-occurring conditions like anxiety or depression. Child sex did 
not modify the relationship between parental BAP and child class.  
 In regard to our specific hypotheses: 
 Hypothesis 2.1 a. parental BAP will be associated with child phenotype subgroups that 
have a less severe ASD presentation.  
 Results 2.1 a. BAP was associated with a class that had less severe impairment in non-
verbal functioning with milder language and motor delays. It could be said that this class had a 
less severe presentation in regards to social communication; however, this class had more co-
occurring conditions like self-injurious behavior and aggression that can be burdensome and 
make intervention difficult.  
 Hypothesis 2.1.b. Parental BAP will be associated with subgroups of ASD in children 
that are qualitatively similar to those defining the parent BAP. 
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 Results 2.1 b. The class that was associated with BAP included traits commonly seen in 
BAP, like mild language impairment, anxiety, and depression. This result highlights potential 
endophenotypes that can be further studied to find specific genetic mechanisms for ASD by 
harnessing increased homogeneity between parents with BAP and children with ASD in this 
class.  
 Hypothesis 2.2: Fathers with BAP will be more strongly associated with less severe child 
ASD subgroups compared to mothers with BAP.  
 Results 2.2: The association between fathers with BAP and the class with typical non-
verbal functioning and mild language delay was elevated and statistically significant. In regards 
to mothers, sample size was low, but our results do not suggest that there is an association with 
child phenotypic class. Further work with a larger number of BAP+ mothers will need to be done 
to explore this relationship. 
 Hypothesis 2.3: Associations between parental BAP and child ASD will be stronger 
among boys compared to girls.  
 Results 2.3: This objective was more exploratory in nature due to the limited sample of 
girls. We found no statistical differences between sex in regards to the relationship between 
parental BAP and class. Both sexes had increased associations with the average receptive and 
expressive language ability and mild language delay class.  
 
Results in context of study design 
Using the SEED sample 
 These results are drawn from a sample that was recruited or volunteered to participate in 
a research study. Almost all of these children were identified from educational and health 
agencies that typically serve children with DDs. Children with ASD in the SEED sample were 
socio-economically and racially diverse (206); however, response rate for SEED was low (64-
68% non-response)(196). Although our sample was diverse, this response rate gives pause to 
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the generalizability of our results. Additionally, SEED only collected data on children 3-5 years 
of age so our results are applicable only to that age range. Although natural history of ASD has 
not been extensively studied, phenotypic classes would likely differ greatly in an older sample. 
We have stressed the phenotypic diversity of ASD, but this diversity extends to demographics. 
Families of all races, ethnicities, education levels, and socio-economic statuses can have 
children with ASD. These factors may affect the ASD phenotype through service usage, 
identification, or genetic predisposition. We acknowledge that our results are dependent on the 
type of sample we evaluated. Future work should assess these questions in differing 
populations.  
Improvement on class building 
 This work is bolstered by the usage of multiple measures and informants in creating 
phenotypic classes. As evaluated in aim 1, a parent with BAP may differentially report child ASD 
symptoms; relying on a sole informant report on child phenotype may lead to inaccurate 
phenotypic classification. This study creates classes from maternal interviews, medical records, 
and clinician observation. Past work relied only one parental reported measure (Table 4). This 
work is an improvement on those studies because the child phenotype is not defined from one 
perspective. When diagnosing ASD, a multi-informant multi-instrument evaluation is 
recommended because of the comprehensive description of child ASD (10); using that same 
approach also improves description of ASD phenotype for research studies.  
Use of the SRS-A 
 This study relied on the SRS-A, which was an informant reported measure for BAP. As 
discussed in section 5a, we had missingness for informant type (75.7% missing in mothers, 
37.5% missing in fathers). There is a high likelihood that some of this missingness indicates that 
the respondent self-reported (based on discussions with SEED staff). Adapting the SRS-A to be 
in the second person was shown to be valid in comparison to other self-reported BAP measures 
(122). A self-report was added for the SRS-2 and was moderately correlated with the informant 
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report (inter-rater agreement between 0.61 and 0.78) (92, 153). Inter-rater agreements were 
weaker than when comparing two informant reports (153). Ultimately, we believe that 
misclassification due to informant effects would be non-differential, as SRS-A informant effects 
are not associated with gender or level of ASD traits (92). Any misclassification would make our 
BAP+ and BAP- groups look more similar, attenuating effects. Based on the SRS-2, differences 
in SRS score is minimally affected by informant type and any affect on our results would be 
small. Using the SRS-2 and allowing the respondent the option to complete a self-report will 
improve our measurement of BAP, but the ideal measure of BAP would synthesize multiple 
informants and clinical opinion.  
 
Recommendations  
Finding etiologic origins 
 These results support the usage of heterogeneity reducing techniques to improve ASD 
research. There was a strong relationship between parental BAP and a child phenotype that 
had higher cognitive functioning, lower ASD severity, and co-occurring conditions that are also 
prevalent in people with BAP. Additional steps could look at specific traits that line up between 
parents and children to identify etiologic pathways. Using a sample of parents with BAP who 
have children with an ASD phenotype marked by average expressive and receptive language, 
mild language and motor delays, and increased co-occurring conditions, may be an efficient 
way to explore genetic origins. Because ASD has similar characteristics to other disorders (like 
DD, ID, obsessive compulsive disorder, anxiety), examining these traits may be insightful for the 
larger field of psychiatric genetics. The National Institutes of Mental Health launched the 
Research Domain Criteria to look at features of mental health disorders that may present across 
different conditions (252). Identifying etiologic pathways can contribute to identifying multiple 
traits/conditions shared by people with different formal diagnoses. 
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Looking at older ages 
 Additionally, the majority of the ASD research focuses on a younger age range. There is 
still much to learn about the ASD phenotype in adolescence and adulthood. It will be important 
to better understand how the parent-child phenotype lines up as the child develops into 
adolescence and adulthood. Preliminary research suggests high level of psychological burden 
and suicidal tendencies in adults with ASD (43). Determining whether these traits are linked to 
parent traits could be a way to preemptively intervene.  
Effecting intervention 
 The relationship between parental BAP and child phenotype has implications for 
intervention. Parr et al. (183) found that children had poorer outcomes in a parent-mediated 
intervention if the mother was in the upper 50th percentile of BAP scores. This study was limited 
by sample size and by dichotomizing groups by greater than or less than mean BAP score. 
Nonetheless, this suggests BAP may be a factor in intervention efficacy. This makes sense, as 
a parent may be asked to teach skills and traits that they themselves may not fully grasp. If 
parent traits align with child traits, adapting these interventions to accommodate these parental 
traits could increase their effectiveness. Additionally, timing of ASD diagnosis is a key factor for 
optimal outcomes (11); work is being done in SEED to evaluate age at first concern for child 
ASD and service usage by parental BAP status. If BAP is a factor in age at identification, 
presentation may differ due to increased or decreased service usage during the important early 
developmental window. Lastly, knowing that co-occurring conditions may track between parent 
and child, clinicians and interventionists should be hyper-aware for the development of 
conditions like depression or anxiety in these children who are likely at a higher risk for these 
conditions.  
Future work 
 Our results suggest further work needs to be done on the association between mothers 
with BAP and child phenotypic classes. BAP in mothers is less common than in fathers (Table 
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3), which necessitates large samples for adequate power. In addition, our sample of girls with 
ASD was low and future work should delve deeper into potential sex differences. SEED is a 
relatively large sample of children with ASD, but with estimated prevalence of identified ASD in 
girls being 5.3 in 1000 (32) finding girls is difficult. Utilizing online registries like the Interactive 
Autism Network or Simons Simplex Collection could provide enough power for analyses, but 
there is a likely trade-off in having to rely on self- or informant-reported measures of BAP and 
child phenotype. With more BAP+ mothers and girls with ASD, we could explore whether 
associations between which parent had BAP and child class was modified by child sex. 
Examining mothers and girls could be useful for exploring X-linked transmission ASD sex 
differences.  
 In conclusion, any parent being BAP+ was associated with a child having an ASD 
phenotype defined by average receptive and expressive language, mild language and motor 
delays, and increased co-occurring conditions. This work is meaningful in its implications for 
efficiently studying ASD etiology. Results support parental BAP as an ASD endophenotype, and 
further suggest that the traits of BAP can be used as individual endophenotypes. Future work 
should explore potential genetic etiologies in this parent BAP- child ASD class subgroup.  
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CHAPTER 6. CONCLUSIONS 
 
 
 It may be redundant, but autism spectrum disorder exists on a spectrum. This 
dissertation goes into great detail on how this spectrum exists beyond the criteria that lead to a 
formal diagnosis. It is important for researchers to use the full extent of the spectrum to better 
understand the mechanisms that cause ASD and find ways to craft interventions that can 
alleviate some of the disorders more negative aspects.  
 Our two main findings are that mothers with BAP are more likely to report on ASD 
evaluations that their child meets ASD risk or ASD thresholds on evaluation instruments when a 
clinician’s report does not, and that having a parent with BAP is associated with the child having 
an ASD phenotype defined by average receptive and expressive language, mild language and 
motor delays, and increased co-occurring conditions like anxiety and depression. These results 
are significant. Maternal report is vital for accurately diagnosing ASD; understanding factors that 
affect discordance with clinician reports will improve ability to make an accurate final diagnosis. 
Identifying a strong association between parental BAP and a specific child ASD phenotypic 
class allows for efficient genetic research using this more homogenous sample to assess 
endophenotypes.  
 Our society is slowly shifting into one that is more accepting of people with ASD rather 
than trying to ‘cure’ or marginalize them. With this being the case, it is not farfetched to think 
that the prevalence of autistic traits in the population will increase. As we emphasize the 
strengths of people with autism, we will likely see more of these traits accumulate in future 
generations through assortative mating and acceptance of the traits that make people with 
autism unique. It will be imperative that we identify children that have significant impairment 
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associated with their ASD so we can prevent negative outcomes through targeted genetic and 
biologically based therapies or early intervention. In bettering our understanding of diagnostic 
discordance and finding efficient ways to conduct etiologic research, we move closer to creating 
a world where ASD is no longer a disability but a difference.
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APPENDIX 1. STUDY TO EXPLORE EARLY DETETICION DATA COLLECTION TOOLS (from Schendel et al. 2014 (196)) 
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APPENDIX 2. STUDY TO EXPLORE EARLY DEVELOPMENT DATA COLLECTION 
PROCEDURE (from Schendel et al. (196)) 
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APPENDIX 3. SOCIAL RESPONSIVENESS SCALE-ADULT QUESTIONNAIRE (from 
Constantino et al. (107)) 
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APPENDIX 4. LATENT CLASS FIT STATISTICS FOR CHILDREN WITH AUTISM SPECTRUM 
DISORDER ENROLLED IN THE STUDY TO EXPLORE EARLY DEVELOPMENT From 
Wiggins et al. (under review) 
 
 Latent Class Distributions  Entropy  BIC1 SABIC1 LMR-LRT p 
values1  
Number of 
classes 
1 2 3 4 5     
1 100 NA NA NA NA NA 80528 80401 NA 
2 55 45 NA NA NA 0.93 78305 78096 <0.001 
3 40 44 16 NA NA 0.92 77379 77087 0.018 
4 28 26 34 12 NA 0.92 76722 76347 0.001 
5 21 25 25 19 10 0.91 76493 76036 0.567 
 
1 Bayesian Information Criterion (BIC), Sample adjusted BIC (SABIC), and Lo-Mendel-Rubin 
Likelihood Ratio Test (LMR-LRT)
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APPENDIX 5. ITEM RESPONSE PROBABILITIES AND ITEM RESPONSE MEANS (95% CONFIDENCE INTERVAL) BY LATENT 
CLASS FOR CHILDREN WITH AUTISM SPECTRUM DISORDER ENROLLED IN THE STUDY TO EXPLORE EARLY 
DEVELOPMENT From Wiggins et al (under review) 
 Latent Class  
 1 2 3 4 
Categorical variables 
(response probabilities) 
    
Current diet restrictions 0.26(0.19-0.33)A 0.36(0.29-0.43)A 0.30(0.23-0.37)A 0.40(0.28-0.52)A 
Early recognition of 
epilepsy/seizure disorder 
0.00(0.00-0.00)A 0.13(0.07-0.18)B 0.02(#0.00-0.04)A 0.05(#0.00-
0.10)AB 
History of regression 0.17(0.11-0.23)A 0.34(0.27-0.42)B 0.29(0.22-0.36)AB 0.25(0.13-0.38)AB 
Insistence on sameness 0.72(0.65-0.79)A 0.63(0.55-0.71)A 0.66(0.59-0.74)A 0.90(0.83-0.97)B 
Problems with age at first 
social smile 
0.13(0.08-0.18)A 0.24(0.16-0.31)AB 0.15(0.10-0.20)AB 0.31(0.19-0.42)B 
Repetitive behavior with 
objects 
0.77(0.71-0.84)A 0.94(0.91-0.98)B 0.82(0.77-0.88)A 0.96(0.91-#1.00)B 
Repetitive motor mannerisms 0.74(0.67-0.80)A 0.96(0.92-1.00)B 0.78(0.72-0.84)A 0.83(0.74-0.93)AB 
Restricted interests 0.86(0.80-0.91)AB 0.73(0.66-0.80)A 0.81(0.75-0.87)AB 0.92(0.84-0.99)B 
Self-injurious behaviors 0.38(0.31-0.46)A 0.58(0.50-0.66)B 0.37(0.30-0.44)A 0.78(0.68-0.89)C 
Unusual sensory response 0.91(0.87-0.96)A 0.97(0.94-1.00)A 0.94(0.91-0.97)A 0.97(0.93-#1.00)A 
Continuous variables 
(response means) 
    
Age at verbal language 
development 
19.89(18.62-21.16)A 30.58(27.81-33.35)B 25.16(23.32-26.99)C 24.32(21.79-
26.86)C 
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Age at walking 13.69(13.22-14.16)A 16.31(15.09-17.53)B 14.11(13.38-14.84)A 13.60(12.86-
14.34)A 
Aggressive behaviors 55.94(54.66-57.23)A 61.94(60.02-63.86)B 57.98(56.24-59.71)A 76.18(71.96-
80.41)C 
Anxiety/depression 53.60(52.55-54.65)A 56.24(54.92-57.55)B 53.38(52.33-54.43)A 69.56(65.96-
73.16)C 
Attention problems 59.05(57.73-60.37)A 67.11(65.60-68.61)B 61.61(60.20-63.03)A 70.95(68.94-
72.97)C 
Autism severity 6.73(6.51-6.95)A 7.89(7.64-8.13)B 7.21(6.98-7.44)C 6.47(6.11-6.82)A 
Emotionally reactive 57.96 (56.49-59.44)A 61.72(59.89-63.55)B 57.39(55.75-59.02)A 77.79(74.13-
81.45)C 
Expressive language skills 50.73(48.69-52.76)A 14.49(12.77-16.21)B 34.03(31.98-36.08)C 46.23(42.47-
49.99)A 
Fine motor skills 54.49(52.90-56.09)A 23.07(21.78-24.37)B 37.56(35.21-39.90)C 49.98(46.46-
53.51)A 
Receptive language skills 56.97(54.92-59.01)A 15.21(13.40-17.02)B 34.32(32.04-36.60)C 48.27(43.91-
52.62)D 
Sleep problems 47.39(45.88-48.91)A 53.86(51.95-55.78)B 49.38(47.65-51.11)A 59.66(56.02-
63.29)C 
Social communication abilities 13.08(12.08-14.08)A 20.97(20.10-21.83)B 16.94(15.95-17.94)C 20.51(19.14-
21.88)B 
Somatic complaints 57.20(56.05-58.36)A 60.79(59.42-62.17)B 58.16(57.02-59.30)A 67.72(65.24-
70.21)C 
Visual reception skills 61.33(59.81-62.84)A 23.13(21.90-24.36)B 40.50(37.46-43.54)C 53.66(49.89-
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57.44)D 
Withdrawn behaviors 64.92(63.36-66.47)A 76.38(74.59-78.16)B 66.98(65.23-68.72)A 76.66(74.05-
79.26)B 
Note: subscripts indicate between-class differences based on confidence intervals that do not overlap; # For interval estimates, a lower 
bound was reported as 0.00 when the lower bound estimate was <0.00 and an upper bound was reported as 1.00 when the upper bound 
estimate was > 1.00.  
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